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 My dissertation research provides major contributions to the current 
understanding of intracellular protein trafficking in two important areas: vesicular 
fusion and peroxisome biogenesis.  
I began with a study of SNAREs, highly conserved proteins that form the 
core fusion machinery within secretory and endosomal trafficking systems. I 
examined the regulation of an integral member of this protein machinery, 
syntaxin 5, by its mammalian endoplasmic reticulum/Golgi Sec1/Munc18 protein 
binding partner rSly1. To address their functional relationship, I produced a 
conformation-specific monoclonal antibody to use in immunostaining experiments 
and in vitro ER-to-Golgi transport assays. Results from the manipulation of 
rSly1/syntaxin 5 interactions indicate that rSly1 function is intimately associated 
with syntaxin binding, not promoting availability of the SNARE motif, but perhaps 
supporting a later step in SNARE complex formation. 
 My research continued with an examination of peroxisome matrix protein 
import, a mode of protein transport that utilizes two distinct peroxisomal targeting 
signals (PTS1 and 2) to bind exclusively to two different cytosolic receptors that 
define separate import pathways. A few matrix enzymes contain a PTS2 that is 
cleaved off after import, in plants and mammals. The identity of the PTS2 
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processing protease is unknown. Bioinformatic analysis of the Arabidopsis 
genome revealed a 76kDa Deg-protease, AtDEG15, predicted to be peroxisomal. 
Analysis of protein extracts from Arabidopsis plants with a knockout mutation in 
atdeg15 reveals that the precursor form of the PTS2 protein thiolase (THL) was 
not processed. Using reverse transcription, I isolated and cloned AtDEG15. In 
vitro peroxisome import, protease assays, and mutagenic analysis demonstrated 
that AtDEG15 is a novel PTS2-specific processing protease. 
 Two proteins found in Arabidopsis thaliana have been identified that 
possess both a putative PTS1 and a PTS2, long-chain acyl-CoA synthetase 7 
(LACS7) and alpha-crystallin domain protein 31.2 (ACD31.2). While both proteins 
have been localized to the peroxisome, the PTS responsible for their localization 
remains unclear. Mutagenic analysis and standard in vitro import assays showed 
that either the PTS1 or PTS2 is sufficient to direct ACD31.2 and LACS7 import. 
 Thus, using cellular and molecular biological techniques, my research has 





















 The complexity of the eukaryotic cell lies in its system of membranes that 
provide the very boundaries within which life exists. The plasma membrane 
provides the physical demarcation between the cellular biochemical activities and 
the extracellular world. Within the cell, membranes separate and organize 
different biochemical processes to avoid interference between them, generating 
compositionally and morphologically distinct compartments that characterize the 
eukaryotic cell. Therefore, a major mystery of the eukaryotic cell is its capacity to 
transfer material between distinct compartments without compromising their 
individual integrity or functionality. Cell biology is an area of biological science 
concerned with explaining individual cell function in logical terms of cell structure. 
Its roots lie in the commonality of all cells and its success is due to the great 
number of scientific approaches and technological advances employed. In 
particular, cell biologists’ general understanding of biological membranes and the 
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trafficking of proteins between them has been one of the greatest scientific 
advancements for more than a century.   
Notably, the study of intracellular protein trafficking began with the 
functional definition of the secretory pathway whereby secretory proteins are 
translocated across the membrane of the endoplasmic reticulum (ER), traverse 
through the Golgi and undergo exocytosis at the plasma membrane (Figure 1).  
One of the most significant observations was that transport steps within the 
secretory pathway are mediated by transport vesicles that carry proteins from 
membrane-to-membrane and lumen-to-lumen, or extracellular space (156). In 
fact, the notion of membranous sacs carrying and delivering proteins to different 
organelle compartments is how we currently define the mechanism of secretory 
protein transport.  
Additional experiments revealed that distinctive signal sequences, or 
targeting signals, located on newly translated proteins permit movement from the 
cytosol across ER membranes (17-19). Translocation across ER membranes 
takes place during synthesis, i.e. co-translationally, and proteins are transported 
across the ER membrane into the ER lumen. However, signal-dependent 
translocation across membranes is more robust, flexible, and applicable to a 
wider range of intracellular locations than originally thought. It was later realized 
that the nucleus, mitochondria, chloroplasts, and peroxisomes also utilize 
destination-specific targeting signals to import their nuclear-encoded proteins 
released in the cytosol after synthesis, i.e. post-translationally (71, 107, 124, 146, 
204) (Figure 1).  
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Work on protein translocation led to the development of in vitro assays to 
reconstitute the insertion of proteins into the ER or the import of proteins into 
peroxisomes, chloroplasts, or mitochondria (8, 20, 27, 59, 231). These in vitro 
assays helped facilitate the stepwise dissection and identification of important 
components required for complex biochemical events. Coupled with genetic 
studies to identify mutants with trafficking defects, molecular cloning techniques, 
and the aforementioned morphological studies, in vitro assays have become one 
of the most powerful tools used to reveal the machinery involved in such 
trafficking processes as membrane fusion, vesicle formation, organelle 
biogenesis and protein sorting. 
The cell biological analysis of human diseases was perhaps the lone force 
that helped to catapult the protein trafficking field to the forefront of scientific 
attention. Mutations that result in defects in protein trafficking are the molecular 
basis of many hereditary and autoimmune diseases. For example, diabetes 
mellitus results from mutations in the receptor that binds to insulin thereby 
impairing its transport from the ER (5, 6, 93). Familial hypercholesterolaemia is a 
consequence of a host of transport defects ranging from failure of the low-density 
lipoprotein receptor to exit the ER to its failure to recycle back to the cell surface 
following endocytosis (5, 6, 93). Peroxisomal import and biogenesis defects 
cause neurodegenerative diseases and mental retardation such as those found 
in Zellweger’s Syndrome and rhizomelic chondrodysplasia puntata (203, 225). 
Taken together, the work uncovering trafficking malfunctions associated with 
human diseases led to the incorporation of genetics into the mainstream of cell 
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biology. It was this transition that has taken the field of cell biology to the level of 
scientific research that we know today. The current generation’s cell biologists 
are concerned with understanding the mechanisms of membrane trafficking at 
the molecular and biochemical levels. This transition was characterized by the 
addition of cell culture systems, enveloped viruses, and yeast genetics to the 
previously established tools of the trade. Moreover, immunoelectron microscopy, 
antibody probes, and immunoflourescence microscopy upgraded the traditional 
tools.   
Given the number of techniques developed to study membrane transport, 
it seems reasonable to think that the basic mechanisms that govern individual 
trafficking events are now quite well understood. But a number of underlying 
details remain controversial and have yet to be resolved. While biochemical 
assays can measure the production of budded vesicles (12, 183, 191), they are 
inadequate in measuring the intermediates leading to them. The same can be 
said for in vitro reconstitution of fusion events (186, 234) that occur at rates too 
slow to account for additional mediators and regulatory factors that increase 
fusion rates in vivo. In the area of protein trafficking, the task at hand is to 
translate the results of the genomic, genetic, and biochemical understanding of 
the last two decades into useful information that leads to a comprehensive, 
mechanistic understanding of intracellular protein transport systems.    
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PART 1: PROTEIN TRANSPORT THROUGH THE ENDOMEMBRANE 
SYSTEM REQUIRES VESICLE FUSION 
Due to the pioneering efforts of the 70’s and 80’s on the biochemistry of 
synaptic vesicles, the genetic dissection of secretion in yeast, and the in vitro 
reconstitution of Golgi transport, scientists have come to generally understand 
the basic mechanism of vesicular transport. First, budding vesicles from a 
“donor” membrane, loaded with the appropriate cargo, travel and become 
tethered to a potential target membrane. Second, upon proper “recognition”, the 
loosely tethered vesicle becomes tightly docked. Finally, a mutiprotein complex 
facilitates fusion of the two membranes to complete cargo delivery (22). A more 
detailed version of the steps of vesicular transport is shown in Figure 2. Several 
families of proteins have been implicated in controlling the specificity and 
mechanism of vesicle targeting and fusion events. Among these, soluble N-
ethylmaleimide sensitive factor attachment protein receptors (SNAREs) are 
presently accepted as the core machinery for the job of executing fusion (94, 
128, 198).  
 
SNAREs as Mediators of Vesicle Fusion 
 SNAREs form a superfamily of small membrane associated proteins (18-
42kDa) with 25 members in Saccharomyces cerevesiae, 36 members in humans 
and 54 members in Arabidopsis thaliana (21, 92). They have a simple domain 
structure distinguished by a stretch of 60-70 amino acids arranged in heptad 
repeats termed SNARE motifs. At their carboxyl terminus, most SNAREs have a 
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single transmembrane domain that is connected to the SNARE motif by a short 
linker region. Although this structural prototype refers to most SNAREs, there are 
subsets that lack the transmembrane domain. Instead, these SNAREs are post-
translationally modified with hydrophobic structures that mediate membrane 
anchorage. These SNAREs include a small group that is represented by the 
neuronal SNARE SNAP-25 (25 kD synaptosome-associated protein), which 
contains two different SNARE motifs joined by a flexible linker that is 
palmitoylated (81, 84, 95, 117, 184). SNARE Ykt6 also lacks the transmembrane 
domain. Instead, Ykt6 is associated with the membrane by a CAAX box that is 
farnesylated and perhaps also palmitoylated (60, 82, 127). 
 SNAREs were initially given functional distinctions as either vesicle-
associated (v-SNARE) or associated with the target membrane (t-SNARE) (4, 
210, 230). However, v-SNAREs and t-SNAREs can also be structurally 
distinguished as R- or Q- types, respectively, based on the residue positioned at 
the zero ionic layer of the four-helix bundle formed during complex formation and 
subsequent fusion (4, 55, 61, 210). Analysis of SNARE complex formation in 
reconstituted lipid vesicles revealed that t-SNAREs can be further designated as 
either a heavy chain, Qa or light chains Qb and Qc derived from either the same 
or from two different SNARE proteins (4, 55, 61, 210) (Table 1).  One member of 
each subfamily contributes a single SNARE motif to the resulting Qa:Qb:Qc:R 
configuration of the functional SNARE complex (21, 92, 97, 235).  
 How SNAREs are distributed between the membranes or which 
combinations of SNAREs are fusogenic is still a matter of debate. In both 
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constitutive and regulated exocytosis, the R-SNARE is predominantly localized 
on the vesicle donor membrane, whereas the Q-SNAREs function as acceptors 
located on the plasma membrane. For intracellular fusion events, the SNARE 
topologies are less clear. With experiments reconstituting heterotypic fusion of 
SNARE-containing liposomes, Rothman and colleagues demonstrated that only 
a single 3:1 combination of SNAREs is fusogenic, with exquisite specificity 
conferred by precise cognate SNARE pairing mediated by the SNARE motif (30, 
128, 157, 159). In contrast, SNAREs mediating homotypic fusion of early 
endosomes fuse liposomes in five out of seven possible combinations (242). This 
finding led to the idea that, at least in the case of homotypic fusion, the 
conserved SNARE structure allows for flexibility in intermediates needed for 
fusion rather than specificity as initially thought.   
 To appreciate the role of SNAREs in vesicle fusion we must first review 
the interaction of SNARE complexes and the SNARE conformational cycle.  
Simply put, SNAREs present on opposing membranes combine and engage in 
coiled-coil interactions that bridge two opposing membranes about to undergo 
fusion (Figure 3). These interactions result in a metastable “trans” complex of 
four interacting SNARE motifs oriented at very close proximity to the membrane 
surface. Assembly of the four-helix bundle is thought to supply enough free 
energy to bring opposing membranes close enough to fuse, resulting in a cis-
SNARE complex in the fused membrane (34, 81, 230). α-SNAP, or soluble NSF 
associated protein, then binds to the SNARE complex and recruits NSF, N-
ethylmaleimide sensitive factor (176). ATP hydrolysis by NSF dissociates the cis-
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SNARE complex, releasing it for further rounds of vesicle fusion (125). 
Confidence in this SNARE-mediated model of fusion comes from the fact that it is 
structurally analogous to the activated form of viral fusogen proteins (96). In 
addition, reconstitution experiments showed that v- and t-SNAREs present on the 
surface of different liposomes was enough to promote fusion in vitro (94, 230). 
 
Regulation of SNARE-Mediated Vesicle Fusion 
 As the molecular events leading to fusion become more clear, it is evident 
that a number of additional factors are required to bring about SNARE-mediated 
fusion in vivo. Biophysical fusion assays demonstrate that only the biologically 
relevant, specific and precise pairing between v- and t-SNARE combinations 
result in membrane fusion in vitro (128, 157). However, in vitro reconstituted 
fusions are much slower than in vivo fusion events, implying that there must be 
some other factors involved that accelerate the fusion process (230). Each fusion 
event must satisfy two fundamental physical requirements: 1) be fast enough or 
occur at a high enough probability to meet the physiological requirements of that 
trafficking step, and 2) be specific enough such that vesicles release their 
contents after fusing with the appropriate target membrane (96). To this end, 
there is considerable interest in uncovering potential SNARE regulatory factors 
necessary to provide specificity, help with SNARE complex assembly or help with 
the fusion event itself (96, 180). 
 A plethora of accessory proteins have been implicated in regulating the 
action of SNAREs (67) (Table 2). For example, cytosolic factors such as Gate-16 
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and LMA1 bind to SNAREs, subsequent to α-SNAP/NSF-mediated dissociation, 
keeping them inactive until the next round of fusion (49, 141, 236). Another 
potential regulatory mechanism comes from the putative Ca2+ sensor, 
synaptotagmin, which interacts with SNAREs and promotes synaptic vesicle 
fusion in response to the influx of Ca2+ (56, 96, 209). Synaptotagmin also acts in 
cooperation with other neuronal proteins Complexins I, II and Munc13, which 
help to provide spatial and temporal regulation of neuronal synaptic exocytosis 
through the stabilization and priming of SNARE complexes (16, 29, 67, 79, 172, 
177, 181, 219).  
Regulation by amino-terminal domains 
 Perhaps the most interesting mechanism of SNARE complex regulation 
lies within the structures of the individual SNARE proteins. Several SNAREs 
possess amino (N)-terminal domains (NTDs) that have critical functions in 
regulating fusion events. Certain v/R-SNAREs are further classified as ‘longins’ 
or long based on possession of a highly conserved stretch of 120-140 amino 
acids with a profilin-like fold called the longin domain (LD) at their amino terminus 
(57, 182) (Figure 4). Bioinformatic analysis has identified three subfamilies of 
longins in mammals: Ti-VAMP/VAMP7, Ykt6, and Sec22b. The crystal structures 
of both Ykt6 (214) and Sec22b (70) have revealed a five-stranded beta sheet 
packaged by three alpha helices longin domain structure (57). In the case of 
Ykt6, a SNARE capable of functioning in multiple transport steps (118), the LD 
contains a hydrophobic patch that can fold back to interact intramolecularly with 
the SNARE motif to influence Ykt6 SNARE pairing and subcellular localization 
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(214). The LD of ER/Golgi SNARE Sec22b also contains a hydrophobic patch in 
a similar spatial orientation as that of Ykt6 (70). The crystal structure of the 
mammalian Sec23/24-Sec22b complex reveals that interaction between the 
Sec22b SNARE motif and its LD serves as a conformational transport signal for 
packaging into COPII vesicles (120). Although it has not yet been solved, the 
structure of the Ti-VAMP/VAMP7 LD is assumed to have a similar profilin-like 
fold that has also been implicated in SNARE complex formation and protein 
localization (122).  
 Conformation-dependent regulation of SNARE-mediated fusion by the 
NTD has also been suggested to occur among the syntaxin-like t/Q-SNAREs 
(215). In general the regulatory unit, or the NTD, of syntaxins exists 
autonomously from the SNARE motif and consists of a short unstructured amino-
terminal peptide sequence followed by alpha helices, called Ha,b and c, that fold 
into a three-helix bundle (Figure 4). The NTD of plasma membrane syntaxins, 
neuronal syntaxin1A and yeast Sso1, have an additional groove that can 
accommodate the SNARE motif to facilitate a “closed” conformation of the 
SNARE (84, 130). The Habc bundle packs with the amino-terminal half of the 
syntaxin SNARE domain and prevents the SNARE motif from entering into 
SNARE complexes (24, 84, 121, 143). Removal of this apparently negative 
regulatory domain has been shown to accelerate SNARE complex formation in 
vitro (147, 158, 235). In the case of Sso1 the closed conformation is an important 
intermediate that prevents fast SNARE pairing (142, 143). Like the plasma 
membrane syntaxins, mammalian syntaxin 5 appears to display a similar 
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negative effect of its amino-terminal domain on ER/Golgi SNARE complex 
formation in vitro (84, 235). But how conserved is the negative regulatory function 
of this domain across the 12 mammalian, 7 yeast and 24 Arabidopsis syntaxins? 
Although this domain seems promising towards understanding the regulation of 
SNAREs, it remains highly controversial. Indeed not all syntaxins are capable of 
adopting closed conformations. The endosomal and vacuolar syntaxins 7, 13, 
Pep12p and Vam3p as well as Golgi syntaxins 16 and Tlg2p all contain the Habc 
bundle but have been found to reside primarily in the open conformation (47, 84). 
Therefore we must question the role that this domain plays, if any, in SNARE 
complex regulation as a whole in vivo.  
 Although auto-regulatory inhibition to prevent fast SNARE pairing is 
reserved for the Habc domain of plasma membrane syntaxins, other roles are 
likely. Recently, it was shown that the Habc domain of plasma membrane 
syntaxin is also responsible for the trafficking and cluster distribution of 
syntaxin1A on the plasma membrane (54). Members of the Sec1/Munc-18 family 
of proteins, collectively referred to as SM proteins, are major binding partners of 
some syntaxin NTDs and have also been implicated in regulating the activity of 
SNAREs. In this way, the Habc domain could be the site for direct binding for SM 
protein-mediated chaperone activities required to allow specific assembly of t-
SNARE complexes (161), prevent the degradation of unstable SNARE complex 
intermediates (31), or trigger fast exocytosis (180). One final provocative 
hypothesis is that the NTD domain of syntaxin is an escort to bind and guide SM 
proteins to their site of action at a later stage in trafficking (42, 195). However, a 
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recent look at the amino-terminal region of the yeast plasma membrane syntaxin, 
Sso1p, shows that the required function of the NTD can be circumvented when t-
SNARE complex formation is made intramolecular (218). These results suggest 
that the essential function of the NTD of syntaxins is to regulate efficient t-
SNARE complex formation. 
Regulation by SM proteins 
 SM proteins were first discovered during screens for membrane trafficking 
mutants in yeast and C. elegans (1, 149). Less abundant than SNAREs, (four in 
yeast, seven in both mammals and Arabidopsis), all SM proteins are conserved 
hydrophilic proteins of about 60-70 kDa that appear to function at a variety of 
intracellular membrane fusion steps (64). Loss- of- function mutations of any SM 
protein invariably leads to a block of intracellular fusion and a lethal phenotype, 
illustrating the indispensable role these factors play in fusion (64, 162, 180, 215). 
But, in contrast to the consensus and clarity about SNARE proteins, previous 
data on SM proteins in different systems produce perplexing ideas about their 
exact role, site of action and relationship to SNARE proteins.  
 The unifying hallmark of all SM proteins is their high binding affinity and 
specificity for syntaxins. To date, the crystal structures of two SM proteins have 
been solved: munc18-1 and Sly1p complexed with their cognate SNAREs 
syntaxin1A and Sed5p, respectively (25, 131). Despite high structural homology, 
these structures reveal two very different modes of SM/syntaxin binding. In the 
crystal structure of the munc18-1/syntaxin1A complex, syntaxin 1A is found in a 
“closed” conformation, with its amino-terminal Habc domain folded over onto the 
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SNARE interaction domain. “Closed” syntaxin1A is inserted into the cleft of 
munc18-1 in a 1:1 complex that precludes binding to the other presynaptic 
SNAREs or α-SNAP (131) (Figure 5, panel I). In this way, Munc18 acts as a 
negative regulator of SNARE complex formation by binding monomeric 
syntaxin1A and locking it in the closed conformation. In stark contrast, Sly1p is 
bound only to the short amino-terminal peptide sequence that precedes the Habc 
domain of Sed5p by a small groove on the surface of the SM protein, with no 
involvement of the central cleft (25) (Figure 5, panel II). This binding modus 
allows simultaneous interaction of SM proteins and syntaxins alongside SNARE 
complex members, supporting the participation of all proteins in fusion.  
 Other SM protein/SNARE interactions, described in various trafficking 
steps of the ER, Golgi, TGN and early endosomes, also support the latter binding 
mode whereby SM/syntaxin association occurs despite SNARE complex 
formation. Indeed, the yeast syntaxin, Sso1, also adopts a “closed” conformation 
but its corresponding SM protein, Sec1, appears to favor interaction in the 
context of either the binary t-SNARE complex or the fully assembled ternary 
SNARE complex over a weak 1:1 complex that was also observed (33, 142, 194) 
(Figure 5, panel III). Binding in a 1:1 complex was also revealed in the crystal 
structure of Sly1 bound to its Golgi syntaxin Sed5p (25) but Sly1 also can 
associate with a fully assembled SNARE complex (160). The SM protein Vps45 
binds its syntaxin, Tlg2, in a manner analogous to that captured by the Sly1-Sed5 
crystal structure whereby the NH2-terminal peptide of the syntaxin binds with 
high affinity to its cognate SM protein (32). In addition, Vps45 also binds Tlg2-
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containing SNARE complexes via a second mode that involves neither the amino 
terminus of Tlg2 nor the region of Vps45 that facilitates this interaction (32). More 
interestingly, a yeast SM protein, Vps33, is part of a homotypic fusion, protein-
sorting complex (VpsC complex) that functions in Golgi-to-vacuole transport that 
indirectly interacts with the syntaxin homolog Vam3 (113). It appears that this 
interaction is required to allow a coordinated transition from priming of SNARE 
complexes to their subsequent docking at the target membrane prior to fusion 
(188, 228) (Figure 5, panel IV).  
 Thus, the binding between Munc18 and syntaxin1A appears to be 
somewhat of an enigma within the SM protein family. Although a negative 
regulatory role is implied in vitro, it is hard to reconcile the phenotypic findings 
obtained from munc18 deletion, overexpression or otherwise manipulated 
mutants in vivo (64). For the most part, except in Drosophila, these manipulations 
support an activator role of SM proteins. Therefore it seems a matter of debate 
as to whether or not the interaction of Munc18 to a “closed” syntaxin1A really 
represents a bona fide in vivo entity or is just an artifact produced by in vitro 
circumstances, particularly because no other SM protein interferes with the 
formation of SNARE complexes. In fact, neuronal SNARE complexes can be 
isolated from membranes in a complex with Munc18, consistent with the idea that 
SM/syntaxin interactions occur in the presence of SNARE complex formation 
(36). In native membranes, munc18-1 stabilizes a half-closed conformation of 
syntaxin1A that is still capable of participating in SNARE complex assembly 
(241). Recent evidence indicates that Munc18 is also able to participate in other 
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binding modes that are not inhibitory but rather promote assembly of SNARE 
complexes. Arachidonic acid was identified as a vehicle to disrupt the 
Munc18/syntaxin1A interaction through fatty acid metabolism, in an attempt to 
uncover a potential molecular mechanism for the release of syntaxin1A from 
Munc18-imposed control (178). However, it was later revealed that this release of 
inhibition is due to a stimulation of syntaxin1A alone and that Munc18 remains 
associated with syntaxin1A after arachidonic acid-induced syntaxin1A binding to 
SNAP25 (36). Furthermore, munc18-1 stimulates SNARE-mediated membrane 
fusion in reconstituted liposome fusion assays (195), and can bind directly to the 
assembled SNARE complex (45, 179) (Figure 5, panel III). A third mode of 
munc18-1/syntaxin1A interaction was discovered that involves binding at an 
evolutionarily conserved motif at the amino terminus of syntaxin (103, 179). This 
low-affinity binding is considered to be an intermediate between the two previous 
interaction modes (103) (Figure 5, panel II). Such binding modes are perfectly 
compatible with other SM proteins that associate with partially or even fully 
assembled SNARE complexes.  
 Much remains to be learned about the precise mechanism of vesicle 
fusion. However, a picture is emerging as to the unifying connections between 
individual SM/syntaxin interactions that lead to one complete functional model for 
SM/SNARE protein-protein interactions. Perhaps each of the interactions 
observed in vitro represent intermediate stages of a SM protein-controlled 
molecular pathway of specific SNARE complex assembly that results in 
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membrane fusion while also contributing to SNARE proofreading, syntaxin 




PART 2: TRANSLOCATION OF FULLY SYNTHESIZED CYTOSOLIC 
PROTEINS ACROSS BIOLOGICAL MEMBRANES 
 Post-translational protein import does not require the budding and fusion 
of vesicles to translocate proteins across organelle membranes. Instead, newly 
synthesized proteins released into the cytosol are marked with targeting 
information, or signal sequences, specific to the proper organelle destination. In 
some cases, corresponding receptor proteins located in the cytosol exclusively 
recognize targeting sequences, bind, and transfer the proteins to the correct 
organelles.  
 In vitro import assays were developed by adding isolated organelles to 
protein synthesis extracts for prokaryotic plasma membranes, ER, mitochondria, 
chloroplasts and peroxisomes (8, 19, 27, 35, 119, 139, 140, 231). Through 
manipulation of the conditions for import, these reconstitution systems helped 
uncover energy requirements, chaperones and other mechanistic factors 
necessary for import. Much of what is known about the basic mechanisms of 
post-translational import comes from the well-studied mitochondria and 
chloroplast import models. Subsequent to membrane association, proteins are 
threaded through the organelle membrane in a process that requires energy. In 
some cases, chaperones bind to the translocating proteins and, through multiple 
rounds of binding and release, result in the ‘pulling’ of peptide chains through the 
membrane. Finally, other proteins within the organelle catalyze the folding of the 
newly imported proteins into their final functional conformation (reviewed in (2, 
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116, 126, 232)). A basic schematic of protein transport into ER, bacteria plasma 
membrane, mitochondria and chloroplast is depicted in Figure 6.  
 Protein import into the peroxisome also occurs by signal dependent post-
translational import. Results from the progress made over the past five decades 
in understanding the peroxisome suggests that the actual translocation event 
may proceed in manner very different from that defined for the other organelles. 
Despite extensive research uncovering proteins involved in peroxisome protein 
import, a peroxisomal translocation pore has not yet been defined. Nevertheless, 
folded or oligomeric proteins are capable of traversing the peroxisome 
membrane (83, 115, 126, 205, 221, 223). It has been demonstrated, however, 
that oligomeric protein import in peroxisomes is less efficient in vitro than the 
import of semi-folded or monomeric proteins (37). Still, the fact that large 
structures can be incorporated into peroxisomes is clear from the finding that 
even a 9.0nM gold particle conjugated to a peroxisome targeting signal is able to 
traverse the membrane (223). Therefore, the elucidation of peroxisomal protein 
import and translocation mechanisms will add new insights to the general 
scheme of protein translocation and organelle biogenesis.  
 
Peroxisomes 
 First recognized in electron micrographs of animal tissues in the late 
1950s, peroxisomes are structurally and functionally related organelles that are 
found in virtually every eukaryotic cell (175). Peroxisomes were named after 
identifying hydrogen peroxide metabolism as one of the organelle’s conserved 
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functions (13, 39). Now we understand that the peroxisome is a highly versatile, 
metabolically active organelle and the site of many vital biochemical reactions.  
 Peroxisomes are morphologically simple organelles of approximately 0.1-1 
µm in diameter. They are composed of a proteinaceous matrix, sometimes 
containing a paracrystalline core, enclosed by a single membrane (Figure 7). 
Metabolic tasks of peroxisomes vary and are widespread throughout the 
eukaryotic kingdom amongst evolutionarily diverse organisms. Three conserved 
functions are generally found: β-oxidation of fatty acids, metabolism of hydrogen 
peroxide, and defense against oxidative stresses. Other specialized roles vary 
depending on the organism and cell type. Peroxisomes have been implicated in 
synthesis of plasmologens, isoprenoids, and cholesterol; purine and pyrimidine 
metabolism; nitrogen metabolism; biosynthesis of lysine; methanol degradation 
(87, 88, 185, 224, 226). These organelles also contain enzymes that participate 
in the glyoxylate cycle, pentose phosphate pathway, photorespiration and 
seedling development in plants (87, 88, 111, 129, 174, 226). Peroxisomes also 
play key roles in hormone signaling both plants and yeast (9, 212).  
 In plants, peroxisomes are characterized according to tissue location, 
developmental stage and enzymatic composition (98). Plant peroxisomes can be 
classified into four main types: glyoxysomes, leaf peroxisomes, root peroxisomes 
and unspecialized peroxisomes (14, 87, 89, 150). Glyoxysomes are mainly found 
in seedlings where the breakdown of fatty acids takes place through fatty acid β-
oxidation and the glyoxylate cycle (15, 150). When seedlings begin 
photosynthesis, glyoxysomes are transformed into leaf peroxisomes, by 
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exchanging sets of enzymes within the organelle (89, 150, 213). Leaf 
peroxisomes house the glycolate and glycerate pathways of photorespiration. 
When leaves undergo senescence, the reverse transformation back to 
glyoxysomes is observed (89). A third type of peroxisome is found in the 
uninfected cells of nodules on legume roots. These peroxisomes contain uricase, 
one of the last enzymes of ureide biosynthesis (80, 150).  The final class of 
peroxisomes comprise uncharacterized smaller organelles, found in most plant 
organs including roots, that mostly contain the enzymes necessary for hydrogen 
peroxide metabolism (150). Because other specific metabolic roles that this class 
of peroxisomes may play remain unknown, they are classified as “unspecialized” 
(150).  
 Peroxisomes lack DNA and ribosomes. Their nuclear-encoded proteins 
are synthesized on free ribosomes in the cytosol and function after post-
translational import into pre-existing peroxisomes. During peroxisome 
proliferation, as existing peroxisomes enlarge and divide to make new ones, 
there is a constant influx of proteins. Genetic studies have produced a wealth of 
information regarding the genes required for peroxisome biogenesis. To date 32 
genes encoding peroxins (PEX genes) in plants, mammals and yeast, have been 
identified whose products are involved in matrix protein import, membrane 
biogenesis, and organelle proliferation (Table 3). The following discussion will 
examine the current knowledge regarding the mechanisms involved in 




Peroxisome Matrix Protein Import  
 Targeting of peroxisomal matrix proteins occurs via one of two pathways 
requiring evolutionarily conserved peroxisomal targeting signal (PTS) sequences 
present within newly synthesized polypeptides. Two different PTSs exist for 
matrix proteins: PTS1, a carboxyl terminal tripeptide and PTS2, a loosely 
conserved, amino-terminal nonapeptide sequence. The principal role of each 
targeting signal, PTS1 and PTS2, is to mediate recognition of the newly 
synthesized polypeptide by the necessary factors to effect specific import into 
peroxisomes. A few proteins possess putative internal signals that resemble 
neither PTS1 nor PTS2 but are sufficient to direct matrix protein import (150, 
217). However, an interaction between these signals and an import receptor has 
not been shown. Therefore, these putative internal PTSs will not be discussed 
further. 
 
Peroxisome Matrix Targeting Signals 
Peroxisome Targeting Signal 1 (PTS1) 
 Most of the known peroxisomal matrix enzymes possess a PTS1 that, 
unlike the well-studied import mechanisms of the ER, mitochondria and 
chloroplasts, is not removed after import into peroxisomes (207). In addition, 
peroxisomal matrix enzymes bearing a PTS1 must be fully synthesized in the 
cytosol prior to import because of the signal’s extreme carboxyl terminal location 
(205, 206). The PTS1 location is key since placing the PTS1 elsewhere within 
the protein sequence does not lead to peroxisomal targeting (72, 75, 205). Also, 
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the extension of the carboxyl terminus by the addition of residues beyond the 
tripeptide sequence eliminates targeting of proteins to peroxisomes (75, 87, 133, 
151). 
 The first PTS1 described was Ser-Lys-Leu (SKL) located at the carboxyl 
terminus of firefly luciferase that was both necessary and sufficient to direct its 
peroxisomal targeting (72, 75, 102). In fact, the SKL motif is located on proteins 
targeted to the peroxisomal matrix throughout eukaryotic evolution from 
trypanosomes (63, 199, 200) to yeast (3, 43), plants (11, 86, 151, 220), and 
mammals (72, 75, 222).  
 Despite consideration as the prototypical PTS1, many permissible 
substitutions within this tripeptide sequence still effectively target PTS1 proteins 
to peroxisomes (28, 173). For this reason, it became more acceptable to 
consider the PTS1 tripeptide as adhering to an “S-K-L rule,” i.e. small-basic-
hydrophobic residues (75, 211). This seemingly tolerant consensus was still too 
simplistic to describe, in total, the characteristics of a PTS1. First, not all 
functional PTS1s match the original small-basic-hydrophobic consensus. SQL, 
KKL, SSL, and NKL are all capable of targeting alanine glyoxylate 
aminotransferase 1 to peroxisomes in human cells (134). Second, not all 
variations on the PTS1 theme are functional in all species (51, 75, 132, 208). 
PTS1 variants SKF and SKI direct catalases to peroxisomes in yeast, 
Saccharomyces cerevisiae and Hansenula polymorpha, respectively (41, 109). 
Yet these same sequences, found at the carboxyl termini of luciferases in 
monkey kidney cells, fail to reach peroxisomes. Third, residues adjacent to the 
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tripeptide carboxyl terminus play key roles in the competency of the terminus to 
act as a PTS1 (28, 138, 145, 173).  For example, while most plant PTS1s 
conform to the SKL motif, there are a few that possess nonconforming residues 
(Figure 8).  In these cases, accessory residues present upstream of the signal 
enhance efficiency of peroxisomal targeting (138, 145, 173). Particularly, plant 
and mammalian catalases require the basic residue immediately adjacent and 
upstream of the tripeptide for functionality, the former ending -RPSI and the latter 
–KANL (138, 166). These auxillary residues are thought to improve binding to the 
PTS1 receptor for translocation or to mediate conformational changes in the 
PTS1 protein itself that make the PTS1 more accessible to the receptor (28). 
Whatever the reasoning, it is clear the PTS1 must be considered as more than 
just a terminal tripeptide sequence.  
Peroxisome Targeting Signal 2 (PTS2) 
 Few peroxisomal matrix enzymes possess a PTS2. First discovered in the 
protein sequence of the β-oxidation enzyme 3-ketoacyl-CoA thiolase in rat liver, 
the PTS2 sequence is located within the first ~30-40 amino acids of the amino 
terminus, which is usually cleaved during, or shortly after, translocation (152, 
211). Initial comparison of the sequences of the functional PTS2 of other 
peroxisomal enzymes with similar sequences amongst different species led to 
the recognition of a conserved nonapeptide, RLx5(H/Q)L, that appears to be the 
consensus PTS2 (40, 53, 69, 216). Important elements of this sequence, 
however, are still being determined. 
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 Site-directed mutagenesis focusing on the first two and the last two amino 
acids of the nonapeptide sequence of rat liver thiolase, S. cerevisiae thiolase, 
and watermelon malate dehydrogenase demonstrated that these amino acid 
positions are critical for targeting (53, 69, 216). From these studies it was 
determined that a basic amino acid is essential at position 1, whereas the leucine 
at position 2 could be replaced by glutamine. Basic residues could not be 
tolerated at position 8 and subtle changes of the leucine at position 9 significantly 
impaired PTS2 function. Moreover, functional conservation of the PTS2 was 
established when the watermelon enzyme could be imported into the 
peroxisomes of H. polymorpha (53). As more naturally occurring PTS2s were 
discovered, recognition of the sequence variability led to a broadening of the 
accepted PTS2 consensus (169, 173).  
 Sequence comparisons of 32 diverse eukaryotic peroxisomal proteins 
shed some additional light on the nature of the PTS2: the idea that certain amino 
acid substitutions within the PTS2 sequence are functional based on the species 
in which the enzymes are contained. For example, the mammalian thiolases 
have the original consensus, RLx5HL, but the plant thiolases all differ with a 
glutamine at position 2 (58, 173). Interestingly, rat thiolase correctly targets to 
tobacco glyoxysomes, but this targeting is abolished when residue 2 is changed 
to the plant-specific glutamine (58). Surprisingly, coupling mutations in rat 
thiolase that change the valine in position 5 of the nonapeptide to a leucine, and 
the leucine in position 2 of the nonapeptide to a glutamine to form RQQVLLGHL, 
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restores its PTS2 function within the context of the tobacco cells. Thus, position 5 
may add further constraints on the structure of the PTS2.  
 The length of the PTS2 seems to be precisely fixed to nine amino acid 
residues. An 11 amino acid peptide, RIx7HL, is found within the amino terminus 
of enoyl-CoA isomerase in S. cerevisiae (238). Though this sequence matches 
the PTS2 consensus, the 2 additional amino acids render it nonfunctional.    
 Large-scale genomic sequencing and bioinformatics permit a more 
detailed analysis of the PTS2 sequence. When applied to plants, for which there 
is a complete sequence of the Arabidopsis and Oryza sativa genomes and more 
than 20,000 expressed sequence tags for 27 higher plant species, a total of 137 
enzymes containing a PTS2 were revealed (173). These studies demonstrated 
several features of plant PTS2s. First, three of the four residues of the original 
PTS2 consensus (positions 1,8 and 9) are highly conserved. In plants, most of 
the variation occurs at residue 2 (173). Second, RLx5HL and RIx5HL represent 
the most widely present PTS2 sequences, with RQx5HL restricted to only the 
plant thiolases. In fact, Q was not present at position 2 in any mammalian or 
yeast PTS2 (173). Conversely, some amino acid residues found in PTS2s of 
other eukaryotes were not observed at all in plants, such as Q at residue 8 (173). 
Finally, the regions bordering the PTS2 sequence showed conservation, with 
proline frequently present immediately downstream of the PTS2 and alanine, 
leucine and valine commonly found just before the nonapeptide (173). The 
significance of these residues has not yet been determined. The amino acid 
residues frequently found in plant PTS2 sequences are summarized in Figure 9.  
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 Combining the experimental data from the literature on permissible amino 
acid changes within the PTS2 sequence of all the organisms studied thus far, 
has led to the resulting consensus of R-(L/V/I/Q)-xx-(L/V/I/H)-(L/S/G/A)-x-(H/Q)-
(L/A) (163). With this much variability, it seems safe to conclude that the analysis 
of the PTS2 sequence structure is far from over. 
 
The PTS Receptors and Matrix Protein Import 
Receptor PEX5 and PTS1 protein import 
 The receptor PEX5 interacts with matrix proteins containing a carboxyl-
terminal PTS1 (73, 91, 167, 208). In mammals and rice, this receptor exists in 
two isoforms generated through alternate splicing: PEX5L (long) and PEX5S 
(short), which differ in length by a 37 amino acid insert (26, 114, 123, 153, 233). 
Interestingly, only the short form of PEX5 exists in yeast while Arabidopsis 
contains only the long form.  
 The carboxyl terminus of PEX5 typically contains a highly conserved 
tetratricopeptide repeat (TPR) domain essential for PTS1 binding (65, 66, 105). 
The crystal structure of the seven TPRs of human PEX5L co-crystallized with a 
PTS1-containing peptide reveals two clusters of three TPRs (1-3 and 5-7) almost 
completely enclosing the peptide (65). This peptide-binding site is lined by a set 
of highly conserved asparagines that form direct hydrogen bonds with the PTS1 
motif (65, 66, 105). Upon cargo binding, the conformation of the carboxyl terminal 
part of the receptor changes to a slightly more restrictive shape (65, 201) to close 
the gap between TPR domains in the presence of PTS1-containing cargo.  
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 The amino terminus of PEX5 contains a seven-fold repeated pentapeptide 
WXXXF/Y motif that has been implicated in an intricate work of additional 
protein-protein interactions distinct from PTS1 binding (106, 108, 148, 155, 187, 
193). These interactions, although not completely understood, have been 
implicated in receptor-cargo complex docking, complex translocation, and PTS 
receptor recycling. 
 One interesting fact about PEX5 is that it changes its location with respect 
to the membrane during the PTS1 protein import cycle. In the beginning during 
cargo recognition, PEX5 is soluble in the cytosol. Upon docking at the 
peroxisome membrane, it behaves like an integral membrane protein (77). 
Finally, at the end, PEX5 resides in the peroxisome matrix; although it is not clear 
whether it does so in its entirety as a part of a receptor-cargo complex that 
completely traverses the membrane or by partially extending itself into the matrix 
just enough to deliver cargo (38, 78, 110). Accumulating evidence reveals the 
participation of PEX5 in virtually every major step of the PTS1 protein import 
pathway, also known as the PEX5 receptor cycle (Figure 10). PTS1 protein 
import is widely accepted to occur by an “extended shuttle” model of four major 
steps: 1) cargo recognition in the cytosol, 2) receptor-cargo docking at the 
peroxisomal membrane, 3) translocation and subsequent cargo delivery across 
the membrane, and finally 4) monoubiquitin-mediated receptor recycling for 





Receptor PEX7 and PTS2 import 
 PEX7 is a protein, composed almost entirely of WD-40 (B-transducin 
related) repeats, that binds specifically to PTS2 proteins and is the receptor for 
PTS2 matrix protein import (50, 170, 239). In all species, mutants lacking PEX7 
are incapable of PTS2 matrix protein import, but are entirely normal for the import 
of PTS1 proteins (50, 170, 239). 
 Like the PTS1 receptor PEX5, the PTS2 receptor PEX7 resides in the 
cytosol, the peroxisomal membrane, and the peroxisome matrix (26, 135, 144, 
233, 239). The import mechanism indicates that PEX7, like PEX5, is a primarily 
cytosolic receptor that brings PTS2 cargo to the peroxisome (144). But, unlike 
PEX5, the specifics of the PEX7 receptor cycle are less straightforward. Although 
PEX7 is necessary to bind and direct the targeting of PTS2-containing peptides, 
it is not sufficient to do this job on its own (192). Rather, it requires additional 
species-specific soluble chaperones to be fully active (192). These proteins fulfill 
key roles in the import of PTS2 proteins and are referred to as PTS2 co-
receptors (192). 
 The PTS2 co-receptors are a group of peroxins, first described in yeast 
(PEX18/21/20p), whose structural and functional homologs include PEX5 in 
plants and PEX5L in mammals and rice (26, 123, 153, 154, 192, 233) (Figure 
11). The PTS2 co-receptors share evolutionarily conserved structural domains; 
among which exists a 20-30 amino acid domain exclusively responsible for PEX7 
binding (44, 116). The co-receptors are responsible for peroxisomal targeting and 
membrane association (44, 48, 51, 52, 74, 76, 77, 116, 153, 187, 189). In fact, in 
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the absence of PEX18/21p, epitope-tagged PEX7 is completely localized to the 
cytosol in S. cerevisiae (168). In mammals and plants, PEX5L and PEX5 
respectively, act as PTS2 import co-receptors and the amino-terminal 214 amino 
acids have been shown to be sufficient to direct the PEX7/cargo complex to the 
peroxisome (26, 44).  
 Caution must be taken, however, when assigning the role of targeting 
exclusively to the PTS2 import co-receptors. Exceptions exist that demonstrate 
that PEX7 does not necessarily require an additional targeting module. In P. 
pastoris, the association of either PEX7 or PEX20 with the peroxisomal docking 
complex can be independent of the other protein and neither peroxin significantly 
affects the localization of the other (116). Moreover in S.cerevisiae, co-
immunoprecipitation and in vitro binding assays show that PEX7 interacts with 
the membrane docking machinery, regardless of the presence of PEX18 or 
PEX21 (202).  
 A model for the PTS2 matrix protein import pathway consistent with that of 
PTS1 protein import has been proposed: 1) PEX7 recognizes PTS2 cargo in the 
cytosol. This receptor-cargo complex then travels and binds the PTS2 co-
receptors also present in the cytosol; 2) this complex docks onto the peroxisomal 
membrane via the docking machinery; 3) the PTS2 transport complex is 
translocated into the peroxisome matrix; and 4) both PEX7 and the co-receptors 





PTS2 Matrix Proteins are Processed After Import 
 Though the mechanisms of PTS2 protein import appear to be conserved 
among most species, one difference concerns the fate of PTS2 proteins following 
import into the peroxisomes matrix.  In plants and mammals, the PTS2 import 
presequence appears to be cleaved off subsequent to matrix protein import (85, 
90, 100, 101, 112, 150, 152, 211). A completely conserved cysteine residue 35-
45 amino acids downstream of the PTS2 has been suggested for the cleavage 
site of PTS2-containing precursor proteins (85, 90, 100, 101) (Table 4).  
 Although attempts have been made to establish its identity, little is known 
about the enzyme responsible for PTS2 processing. Likely candidates must fulfill 
certain criteria: 1) since PTS1 import defects result in a lack of processing of 
PTS2 proteins and mutations that result in a lack of PTS2 import result in the 
accumulation of precursor protein in the cytosol, potential proteases must 
possess a PTS1 signal for peroxisome matrix (10, 100); 2) because yeast do not 
have proteolytically processed PTS2 proteins, potential candidates are not 
expected to have functional homologs in yeast (137); and 3) finally, the candidate 
protein must contain a proteolytic domain within its amino acid structure.  
  An insulin-degrading enzyme of the metalloproteinase family was 
localized to peroxisomes in mammalian fibroblasts cells (7). Although this 
protease, renamed PP110 for peroxisomal protease of 110kDa, was capable of 
degrading a synthetic presequence of thiolase, it failed to process full-length 
thiolase in vitro (7).  In plants, a 35kDa cysteine endopeptidase was isolated from 
the glyoxysomes of germinating castor bean endosperm via its capacity to 
 
 31 
specifically process the precursor form of the PTS2 protein malate 
dehydrogenase in vivo; the same endopetidase was unable to cleave thiolase at 
the proper processing site in vitro (68). Next, an ATP-dependent Lon protease, 
distinct from the mitochondrial isoform, was identified in rat liver peroxisomes 
(104). Like its bacterial and mitochondrial homologs, however, this protease is 
likely to function as a chaperone, degrading unfolded proteins (104).  
 Recently, more promising candidates for processing the PTS2-containing 
precursor peptide have been recognized. A novel PTS1-targeted protein, called 
Tysnd1 (trypsin domain containing protein 1), was identified in mouse 
peroxisomes. Tysnd1 was responsible for both the removal of the PTS2-
containing leader sequence from prethiolase and for specific processing of PTS1 
proteins involved in the peroxisomal β-oxidation pathway of fatty acids in 
mammals (112). Using a cell-based assay, these authors show that Tysnd1 
overexpression led to the in vitro processing of the peroxisomal enzymes to 
fragments identical to the sizes described for their endogenous forms (112). 
Moreover, Tysnd1 itself is reported to undergo processing in a cysteine-
dependent manner similar to its substrates, perhaps as an auto-activating 
mechanism (112). 
 In plants, the Tysnd1 homolog is a protease-related protein belonging to a 
group of ATP-independent trypsin-like serine proteases for which the E. coli 
DegP is the prototype (90). This protease, referred to as Deg15, has been 
partially purified from the fat-storing cotyledons of watermelon (Citrullus vulgaris) 
and examined for its ability to act as a glyoxysomal processing protease (GPP) 
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(90). In watermelon, DEG15 functions in two forms, a 72kDa monomer and an 
144kDa dimer, whose equilibrium can be shifted in the presence of Ca2+ in favor 
of the dimeric GPP/Deg15 form, reportedly responsible for cleavage of the PTS2 
presequence of malate dehydrogenase at the proper, cysteine-containing 
location (90). The monomer, on the other hand, acts as a general peptidase that 
cleaves denatured peroxisome matrix proteins (90).  
 In Arabidopsis, a knockout mutation in DEG15 prevents processing of 
glyoxysomal malate dehydrogenase to its mature form (90). Although the 
presence of unprocessed malate dehydrogenase in deg15 mutants provides 
evidence that DEG15 may be the PTS2 peroxisomal processing protease in 
plants, its peroxisomal localization and specific cleavage of PTS2 proteins in vitro 
have not yet been experimentally defined. 
 
Redundancy of Matrix Protein Import Pathways 
 Our general understanding of peroxisomal matrix protein import is based 
on the premise that targeting is governed by a single PTS present on the newly 
synthesized protein released into the cytosol. This PTS-containing protein is then 
recognized by a specific import receptor that guides it to the peroxisome. 
Attempts to identify the proteins associated with peroxisomes have led to the 
identification of unique enzymes that contain both a PTS1 and PTS2.  
 PEX8, the yeast importomer complex linker protein, contains both a PTS1 
and PTS2 sequence (171, 227, 229). Mutants in Hansenula polymorpha lacking 
PTS2 import, revealed that the PTS1 and its interaction with PEX5p were 
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required for targeting of PEX8 (240). In addition, deletion of the PTS2 motif on 
PEX8 results in PEX5-directed PTS1 import (240).  Conversely, PEX8 lacking its 
PTS1 sequence follows the PTS2 pathway. In this case, the targeting depends 
on both PEX7 and PEX20 and PEX8 interacts with PEX20 directly (197, 240). 
Since PEX20 interacts with PEX7, it is presumed that all three proteins, PEX8, 
PEX7 and PEX20, form a cargo/receptor/co-receptor complex that aids in the 
PTS2-dependent entry of PEX8 into peroxisomes (116, 197, 240). 
 Two proteins identified in S. cerevisiae, Dci1 and Eci1, belong to the 
isomerase/hydratase family and share 50% sequence identity. Both of these 
proteins are localized to peroxisomes, and both contain sequences that resemble 
PTS1 and 2 (99). It was demonstrated that the putative PTS1 is not required for 
the peroxisomal localization of either of these proteins (99). Furthermore, the 
correct targeting of Eci1 and Dci1 occurs in the absence of either receptor PEX5 
or 7, although PEX5 interacted in two-hybrid assays with Eci1 (99, 238). It was 
later reported that the carboxyl-terminal tripeptide of Dci1 can function as a 
PTS1, and is capable of targeting both Dci1 and Eci1 (238). Interestingly, 
although Eci1 peroxisomal targeting follows the PTS1 pathway, it does not 
require a PTS1 of its own. It was suggested that the PEX5-dependent import of 
Eci1 is due to interaction and co-import with its partner Dci1 (238). 
 Other dual PTS-containing proteins have been identified in plants, 
however their targeting has not been completely characterized.  Long-chain acyl-
CoA synthetase (LACS) 7 possesses both a putative PTS1 and PTS2 and has 
been localized to the peroxisome by fluorescent microscopy (62). In addition, this 
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localization is dependent upon both targeting signals (62). However, in studies 
involving yeast two-hybrid analysis and co-immunoprecipitation, AtLACS7 was 
shown to interact only with the PTS1 receptor PEX5 (23). The lack of interaction 
with PEX7 could be explained by fusion of the Gal4 binding domain to the amino 
terminus of LACS7, resulting in a bait protein with a PTS2 sequence buried too 
deep into the protein sequence of LACS7 to be an effective targeting sequence. 
On the other hand, there are documented examples of amino-terminal fusions to 
enzymes that can still be recognized as PTS2 import proteins in yeast two-hybrid 
systems (50). Still, subcellular localization studies of PTS-dependent variants of 
the green fluorescent protein (GFP) reveal that both the PTS1 and PTS2 of 
AtLACS7 appear necessary to direct its peroxisome entry (62).  
 A screen for novel low-abundance proteins of plant peroxisomes, 
identified a gene in the Arabidopsis genome, At1g06460 or ACD31.2, (190) 
possessing an α-crystallin domain, characteristic of small heat-shock proteins, 
and putative targeting signals for both peroxisome protein import pathways (173). 
Upon transient gene expression of full-length and deletion constructs of ACD31.2 
by fluorescent microscopy, this protein is targeted to peroxisomes in a PTS2-
dependent fashion (173). Though these experiments seem to yield definitive 
evidence for peroxisome localization of ACD31.2, further investigation by in vitro 
import assays may be useful. First, localization determined by fluorescence 
microscopy does not distinguish between intra-organelle localization and 
organelle-membrane association. As discussed earlier, PTSs that deviate from 
the canonical sequence also require accessory residues that assist in protein 
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import.  Therefore, careful consideration of the nature of the deletion constructs 
must be taken. In the analysis involving ACD31.2 localization, only the non-
canonical carboxyl terminal tripeptide sequence was eliminated in the deletion 
construct. In this way, the remaining accessory proteins could still potentially aid 
in receptor/membrane association even though matrix translocation may be 
defective – a result not easily discriminated by fluorescence microscopy alone.  
Also, the construct made to test ACD31.2 import dependence on the PTS2 not 
only possessed a mutated PTS2 sequence, but also a carboxyl-terminal 
fluorescent tag, the presence of which has been previously shown to eliminate 





 The dynamic trafficking of proteins is a critical function of all eukaryotic 
cells. Trafficking defects lead to numerous life-threatening diseases in humans. 
Understanding the mechanisms involved in this fundamental process has direct 
applications for understanding disease states and engineering therapeutic 
interventions in human medicine. In the 200 years since its inception, the field of 
intracellular protein trafficking has seen a lot of action. By the start of the new 
millennium, many of the trafficking systems studied in the past century, if not 
entirely solved, have at least logical, biochemically-defined mechanisms. Indeed, 
we now believe we know the fundamental steps involved in protein transport to 
and between organelles. Nevertheless, gaps remain. 
 It is clear that SNARE assembly is the key to fusion of secretory and 
endosomal membranes in eukaryotes. As such, SNARE structure and assembly 
must be tightly regulated to ensure proper timing and function. Many proteins 
have been implicated. Most interesting among them are the SM proteins. 
SNAREs and SM proteins interact in regulating membrane fusion through tight 
control of the conformational cycle of SNARE fusion complex formation by SM 
proteins. Until recently, quite divergent and conflicting models existed for one 
central role of SM proteins in vesicular fusion and SNARE regulation. Chapter 
two addresses the question of how SM proteins might favor SNARE complex 
assembly; specifically investigating the proposed regulatory role for SM proteins 
as being responsible for maintaining an available open and/or monomeric pool of 
syntaxin molecules for SNARE complex formation. With the use of conformation-
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specific monoclonal antibodies, live-cell imaging, immunocytochemistry and in 
vitro reconstitution of vesicular transport to address the functional relationship of 
the mammalian ER/Golgi SM protein rsly1 and its SNARE binding partner 
syntaxin5, this work will no doubt contribute to the reconciliation of how each of 
these binding modes cooperates to create one complete functional model for 
SM/SNARE protein-protein interaction.  
 Peroxisomal matrix protein import is a mode of protein transport that 
requires two discrete peroxisomal targeting signals (PTSs) to bind exclusively to 
two distinct cytosolic receptors to define two separate import pathways. Little is 
known about the import pathway of matrix enzymes that contain an amino- 
terminal PTS2. In plants and mammals, these enzymes are imported as 
precursor proteins that are processed to their mature forms subsequent to matrix 
entry. The identity of the peroxisomal protease required for processing of PTS2 
proteins is still unknown. High-throughput genomic and proteomic screening 
methods have identified potential candidates. In vitro peroxisome import and 
proteolytic cleavage assays will help to uncover a peroxisomal protease with 
exciting PTS2 protein processing capabilities. Chapter three directly addresses 
the question of the identity of the processing protease. 
 Attempts to identify the proteins associated with peroxisomes have led to 
the identification of unique enzymes, possessing both a PTS1 and PTS2, whose 
import has not yet been fully characterized. Using deletion constructs, mutagenic 
analysis, and in vitro import assays, chapter four addresses the question of which 
import pathway proteins with redundant targeting signals choose.  
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 Overall, the work presented in this thesis represents significant 
contributions to the broader field of protein trafficking. These contributions 
include: 1) a better understanding of SM/SNARE protein interactions as it relates 
to the regulation of vesicle fusion, 2) the identification and initial characterization 
of the PTS2 protein processing protease, AtDEGP15, and 3) the determination of 
signa dependence for two peroxisomal proteins with apparent dual signaling 
capabilities. Each of these accomplishments will serve as foundations for future 
research endeavors.  






Figure 1.1. Eukaryotic intracellular protein trafficking. This scheme is a 
general depiction of protein trafficking between the organelles of the secretory, 
lysosomal and endocytic pathways. Post-translational import of matrix proteins 
into the mitochondria, chloroplast and peroxisome is also shown. Arrows indicate 




Figure 1.2. Basic steps of Vesicular Transport. 1) Initiation. Membrane coat 
components (gray) are recruited to the donor compartment.  Transmembrane 
cargo proteins (black squiggle) and SNAREs (red) begin to gather at the 
assembling coat. 2) Budding. More membrane coat components (black) are 
added to the newly formed vesicle. The cargo becomes concentrated and 
membrane curvature increases. 3) Scission. The neck between the vesicle and 
donor compartments is severed. 4) Uncoating. The vesicle loses its coat and the 
cytosolic coat proteins are recycled for additional rounds of budding. 5) 
Tethering. The vesicle is tethered to the acceptor compartment by the 
combination of a GTP bound Rab (purple) and a tethering factor (blue). 6) 
Docking. The v- and t-SNAREs assemble into a four-helix bundle. 7) This “trans-
SNARE complex” promotes fusion of the vesicle and acceptor membranes 
resulting in a “cis-SNARE complex”. Cargo is transferred to the acceptor 
compartment and 8) the SNAREs are disassembled. This depiction of vesicular 
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Table 1.1. Classification of SNAREs. Functionally SNAREs can be classified 
into v- and t-SNAREs according to their association with either the vesicle or 
target membrane, respectively. A t-SNARE is assembled from one heavy and 
two light chains of SNARE domains. The two light chains can be contributed from 
one or two SNARE proteins. Based on the residue in the zero layer within the 
four-helical bundle of the SNARE interaction domain, SNAREs can be 
structurally divided into R-SNAREs (those having an R/arginine residue) or Q-
SNAREs (those having a Q/glutamine residue). Q-SNAREs are further divided 
based on the amino acid sequence of the SNARE domain into Qa-, Qb-, and Qc-






Figure 1.3. SNARE conformation cycle. Monomeric v-SNARES on the 
vesicle bind to olgiomeric t-SNAREs on the target membrane to form the 
trans-SNARE complex, a stable four-helix bundle that promotes fusion. 
Formation of the cis-SNARE complex in the same membrane is a 
consequence of the fusion event. α-SNAP (pink) binds to this complex and 
recruits NSF (blue), which hydrolyzes ATP to disassociate the complex. 











Synaptotagmin Syntaxin, SNARE 
complex 
Regulated exocytosis 
Munc13 Syntaxin Regulated exocytosis 
GATE16/Apg8 (UFT 
proteins) 
Golgi transport SNAREs Golgi transport, Golgi 
reassembly, autophagy 
LMA1/EEA1 Vam3 (syntaxin homolog) Vacuolar membrane 
fusion (yeast) 
Complexins Syntaxin, SNAP-25, 
SNARE complex 
Regulated exocytosis 
Snapin SNAP-25 Regulated exocytosis 












Table 1.2. Common SNARE regulators. Shown here is partial list of SNARE-
interacting proteins that have been identified to play critical roles in SNARE-



























Figure 1.4. Schematic representation of the domain architecture of Longins 
and Syntaxins. All SNAREs contain the distinguishing SNARE motif (beige). R-
SNARE longins share a long NTD with a profilin-like fold characterized by a five-
stranded, anti-parellel beta sheet flanked by alpha helices that can influence the 
kinetics and proper assembly of SNAREs (214, Gonzalez, 2001 #63). Syntaxins 
have a domain structure set apart by a Habc domain with potential auto-inhibitory 
function to regulate SNARE function in membrane fusion (147, 158, 235). Most 
SNAREs have TMDs, but the Ykt6 longin associates with the membrane by 





Figure 1.5. SM/SNARE protein binding modes. The following SM interactions 
with monomeric and assembled SNAREs have been proposed. From left, panel I 
represents SM protein binding to a “closed” form of syntaxin (Misura, 2000), to 
the amino terminus of syntaxin in panel II (Bracher, 2002), and to the assembled 
SNARE complex in panel III (Peng, 2004). It is possible that each interaction 
represents an intermediate on an SM protein-controlled molecular pathway of 
specific SNARE complex assembly. Panel IV represents a special case in which 
the interaction between syntaxins and SM proteins is indirect through association 
with a large complex that binds directly to the syntaxin (Laage, 2001). The arrows 
indicate states occurring as a series of interactions on a molecular pathway 





Figure 1.6. Conserved translocation schemes. A) Cotranslational 
translocation into the ER. B) Bacterial translocation pathways. C) Chloroplast 
protein translocation. D) Mitochondrial protein import. Illustrations adapted from 




Figure 1.7. Intracellular representations of peroxisomes. The top panel is an 
electron micrograph showing the intracellular milieu of a mature cowpea nodule 
(Webb and Newcomb, 1987). M, mitochndria; N, nucleus; St, starch-containing 
plastid; P, peroxisome. The bottom left panel is a fluorescent micrograph of a 
eukaryotic cell undergoing mitosis (taken by T.J. Deerinck. Cold Spring Harbor 
Laboratories, NY) Peroxisomes are indicated in blue. The bottom center panel 
is a fluorescent microgrph peroxisomes located in human fibroblast skin cells 
stained with anti-catalase antibodies (taken by Antionette L. Williams, University 
of Michigan, Ann Arbor, MI). The bottom right panel is a fluorescent micrograph 
of peroxisomes located in the hypocotyl of an Arabidopsis plant (taken by 




 Identified in   
Gene Hs At Sc Yl Nc Ce Subcellular 
localization 
Characteristics 
PEX1 + + + + + + Cytosolic; 
peroxisomal 
AAA protein; required for matrix protein 
import 
PEX2 + + + + + + Integral PMP RING zinc finger; matrix protein import 
downstream of receptor docking 
PEX3 + + + - + - Integral PMP Possible Pex19p docking factor; PMP import 
PEX4 - + + - + - Peripheral PMP E2 ubiquitin conjugating enzyme; matrix 
protein import 
PEX5 + + + + + + Cytosolic; 
peroxisomal 
TPR protein; PTS1 receptor 
PEX6 + + + + + + Cytosolic; 
peroxisomal 
AAA protein; matrix protein import 
PEX7 + + + - + - Cytosolic; 
peroxisomal 
WD40 protein; PTS2 receptor 
PEX8 - - + + + - Lumenal PMP Matrix protein import downstream of 
receptor docking 
PEX9 - - - + - - Integral PMP Matrix protein import 
PEX10 + + + + + - Integral PMP RING zinc finger; matrix protein import 
downstream of receptor docking 
PEX11 + + + + + - Integral PMP Organelle division and proliferatio; transport 
of medium chain fatty acids 
PEX12 + + + - + + Integral PMP RING zinc finger; matrix protein import 
downstream of receptor docking 
PEX13 + + + - + + Integral PMP SH3 protein; receptor docking 
PEX14 + + + + +  PMP Initial site of receptor docking 
PEX15 - - + - -  Integral PMP Memrane anchor; matrix protein import 
PEX16 + + - + +  Integral PMP PMP import 
PEX17 - - + - - - Peripheral PMP Matrix protein import 
PEX18 - - + - -  Cytosolic; 
peroxisomal 
PTS2 matrix protein import 
PEX19 + + + + + + Cytosolic; 
peroxisomal 
Cytosolic PMP receptor 
PEX20 - - - + + - Cytosolic; 
peroxisomal 
PTS2 matrix protein import 
PEX21 - - + - - - Cytosolic PTS2 matrix protein import 
PEX22 - - + - - - Integral PMP Matrix protein import 
PEX23 - - - + + - Integral PMP Matrix protein import 
PEX24 - - - + - - Integral PMP Peroxisome assembly 
PEX25 - - + - - - Perpheral PMP Peroxisome proliferation 
PEX26 + - - - - - Integral PMP Matrix protein import 
PEX27 - - + - - - Peripheral PMP Peroxisome proliferation 
PEX28 - - - + - - Integral PMP Peroxisome proliferation 
PEX29 - - - + - - Integral PMP Peroxisome proliferation 
PEX30 - - + - - - Integral PMP Peroxisome proliferation 
PEX31 - - + - - - Integral PMP Peroxisome proliferation 
PEX32 - - + - - - Integral PMP Peroxisome proliferation 
 
 
Table 1.3. The PEX genes and characteristics of their protein products 
(peroxins). Information adapted from Wanders and Waterham (2005) and 
AraPerox (www.araperox. uni-goettingen.de), a database of putative Arabidopsis 
proteins from plant peroxisomes (Reumann, 2004). Hs, Homo sapiens; At, 
Arabidopsis thaliana; Sc, Saccharomyces cerevisiae; Yl, Yarrowia lipolytica; Nc, 




Figure 1.8. PTS1 tripeptides of peroxisomal matrix proteins from plants. 
Major PTS1 sequences (red, dark gray shade) are present in at least 10 
sequences and 3 orthologous groups. Minor PTS1 sequences (blue, light gray 
shade) are present in at least 2 sequences. Other non-canonical PTS1  tripeptide 
sequences include: SRV, SNL, SNM, ANL, SML, SSM, and SHL.   





Figure 1.9. PTS2 nonapeptides of peroxisomal matrix proteins from plants. 
Major PTS2 sequences (red, dark gray shade) are present in at least 10 
sequences and 3 orthologous groups. Minor PTS2 sequences (blue, light gray 
shade) are present in at least 2 sequences. Additional PTS2 nonapeptide 
sequences include the minor PTS2 RLx5HF and the unique PTS2 RLx5HV.  
Adapted from Reumann (2004). 
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Figure 1.10. PTS1 protein import model (Receptor PEX5 cycle). Proteins 
harboring a PTS1 are recognized by the soluble receptor PEX5 (shown in blue). 
The receptor/cargo complex docks at the peroxisomal membrane After 
translocation, the receptor/cargo complex dissociates in the peroxisome matrix. 
Subsequently, PEX5 is monoubiquitinated (represented by the open diamond). 
Following membrane dissociation and removal of ubiquitin, PEX5 is recycled 




Figure 1.11. Sequence similarities among the PTS2 co-receptors. A) 
Schematic representation of conserved sequence regions. The number of WxxxF 
motifs (WF) is indicated by the subscript numbers. Clear white boxes represent 
the PEX7 binding domains. The large boxes in the carboxyl terminal halves of 
the PEX5 receptors correspond to the TPR motifs. 
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Figure 1.12. PTS2 protein import model (PEX7 receptor cycle). PEX7 (dark 
blue oval) recognizes and binds to PTS2 cargo in the cytosol, The PEX7-PTS2 
receptor/cargo complex then interacts with PTS2 co-receptors; the interaction 
with receptor PEX5 (light blue oval) is represented here. The entire import 
complex formed in the cytosol docks at the peroxisomal membrane. Following 
translocation, PTS2 proteins are then unloaded into the peroxisome matrix. 
Finally, both PEX7 and its co-receptor PEX5 are recycled back to the cytosol for 



















Plants and mammals 
 
Enzyme 
Species  PTS2 sequence (cleavage recognition site*)  Mature subunit 
___________________________________________________________________________________________ 
Malate dehydrogenase 
Watermelon   QRIARISAHLHPPKSQMEESSALRRANCR*   AKGGAPGFKVAI 
Pumpkin   ERIARISAHLPPKSQMEEGSVLRRANCR*    AKGGAPGFRVAI 
Alfalfa    SRITRIASHLNPPNLKMNEHGGSSLTNVHCR*   AKGGTPGFKVAI 
Rice    RRMERLASHLRPPASQMEESPLLRGSNCR*   AKGAAPGFKVAI 
Rapeseed   KRIAMISAHLQPSFTPQMEAKNSVMGLESCR*  AKGGNPGFKVAI 
Arabidopsis (At5g09660)  
QRIARISAHLTPQMEAKNSVIGRENCR*   AKGGNPGFKVAI 
Arabidopsis (At2g22780)  
            QRIARISAHLNPPNLHNQIADGSGLNRVACR*   AKGGSPGFKVAI 
Citrate synthase 
Pumpkin                        RHRLAVLAAHLSAASLEPPVMASSLEAHCV*   SAQTMVAPPEL 
Arabidopsis (At2g42790)   
             RARLAVLSGHLSEGKQDSPAIERWCT*   SADTSVAPLGS 
Arabidopsis (At3g58740)  
             RARLAVLNAHLTVSEPNQVLPAIEPWCT*   SAHITAAPHGS 
Acyl CoA oxidase 
Pumpkin    RRIERLSLHLTPIPLDDSQGVEMETC*    AAGKAKAKIEVD 
Arabidopsis (At5g65110)  
RRIQRLSLHLSPSLTLSPSLPLVQTETC*   SARSKKLDVNGE 
3-keto-acyl-CoA thiolase 
Cucumber   NRQSILLHHLRPSSSAYTNESSLSASVC*   AAGDSASY 
Pumpkin   NRQSILLHHLRPSSSAYSHESSLSASVC*   AAGDSASY 
Mango    NRQSILLHHLRPSNSSSHNYESALAASVC*   AAGDSAAY 
Rapeseed   ERQRVLLEHLRPSSSSSHSFEGSLSASAC*   LAGDSAAY 
Arabidopsis (At5g48880)  
ERQRVLLEHLRPSSSSSHNYEASLSASAC*   LAGDSAAY 
Rat    HRLQVVLGHLAGRPESSSALQAAPC*    SAGFPQAS 
Human   QRLQVVLGHLRGPADSGWMPQAAPC*    LSGAPQAS 
 
 
Table 1.4. Consensus sequences of known PTS2 matrix proteins in plants 
and mammals. PTS2 sequences are indicated in bold. The conserved Cys near 
the cleavage site for recognition by the peroxisomal processing peptidase is 
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 Although some of the principles of SNAP receptor (SNARE) function are 
well understood, remarkably little detail is known about sec1/munc18 (SM) 
protein function and its relationship to SNAREs.  Popular models of SM protein 
function hold that these proteins promote or maintain an open and/or monomeric 
pool of syntaxin molecules available for SNARE complex formation.  To address 
the functional relationship of the mammalian ER/Golgi SM protein rsly1 and its 
SNARE binding partner syntaxin 5, we produced a conformation-specific 
monoclonal antibody that binds only the available, but not the cis-SNARE 
complexed nor intramolecularly closed form of syntaxin 5.  Immunostaining 
experiments demonstrated that syntaxin 5 SNARE motif availability is non-
uniformly distributed and focally regulated.  In vitro ER to Golgi transport assays 
revealed that rsly1 was acutely required for transport, and that binding to 
syntaxin 5 was absolutely required for its function.  Finally, manipulation of rsly1-
syntaxin 5 interactions in vivo revealed that they had remarkably little impact on 
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the pool of available syntaxin 5 SNARE motif.  Our results argue that although 
rsly1 does not appear to regulate the availability of syntaxin 5, its function is 
intimately associated with syntaxin binding, perhaps promoting a later step in 





 N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) 
proteins are widely accepted to be important constituents of the cellular 
membrane fusion machinery (13, 26, 28).  SNARE complexes are composed of 
stable four-helix bundles of amphipathic helices known as SNARE motifs.  When 
SNAREs in opposing membranes participate in membrane-bridging SNARE 
complexes, the two membranes are brought into very close proximity, a process 
which, at least in vitro, is sufficient to initiate bilayer merger and luminal contents 
mixing (20).  Relatively little is known about the regulation of SNARE protein 
interactions with each other and other membrane trafficking proteins. 
 SNARE complex formation can be regulated by SNARE amino-terminal 
domains (NTDs).  Of the several types of SNARE NTDs, the Habc domains of 
the syntaxin family are the best characterized.  These domains consist of three-
helix bundles that, in the case of exocytic syntaxins, can fold back to pack 
against the SNARE motif and inhibit its entry into SNARE complexes (7, 8, 18, 
19).  In support of a conserved autoinhibitory function for Habc domains, the 
ER/Golgi syntaxin 5 Habc domain potently retards SNARE complex assembly in 
vitro (29).  On the other hand, there is also evidence against a conserved 
autoinhibitory role for Habc domains.  For example, structural studies of several 
other SNAREs indicated that they did not adopt closed conformations in vitro (6).  
In addition, the Sso1p Habc domain, although autoinhibitory, is required for 
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SNARE function; constitutively open mutants are tolerated but removal of the 
domain is lethal (19).  Thus, syntaxin Habc domains may have multiple roles. 
 Another potential regulator of SNARE complex formation is the 
sec1/munc18 (SM) protein family.  These peripheral membrane proteins are 
universally required for all physiological membrane fusion steps, and, like 
SNAREs, comprise a multi-gene family with transport step-specific members (10, 
27).  The most salient feature of SM proteins is their specific interaction with 
syntaxins.  One general hypothesis of SM protein function is that these proteins 
represent conformational regulators of syntaxins.  Initially, the predominant 
model was as negative regulators that bind to the closed SNARE, reinforcing the 
autoinhibitory role of the Habc domains (23).  This may be part of the role of N-
sec1 in synaptic transmission, however, in most systems, SM proteins seem to 
play predominantly required, positive roles, rather than inhibitory ones (10, 27).  
This has led to the suggestion that SM proteins may somehow facilitate SNARE 
complex formation.  In support of a SNARE complex-promoting role, depletion of 
Vps45p or Vps33p causes a reduced level of the endosomal and vacuolar 
SNARE complexes, respectively (3, 24).  In addition, recombinant Sly1p 
promoted immunoprecipitation of ER/Golgi SNARE complexes in vitro (16).  How 
might SM proteins favor SNARE complex assembly?  A leading conjecture has 
been that SM proteins may promote SNARE complex formation by favoring the 
open, or otherwise trans-interaction-available, conformation of syntaxins (27).  In 
support of this, the structure of the syntaxin 1A/N-sec1 binary complex indicates 
that N-sec1may put strain on the closed conformation of the SNARE, perhaps 
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exposing a SNAP-25 binding site and/or favoring the transition to an open 
conformation (17).  Furthermore, in Golgi-to-endosome transport in yeast, the SM 
protein Vps45p was required for formation of the Tlg2p-containing SNARE 
complex, however, this requirement could be bipassed by removal of the Tlg2p 
Habc domain (3).  This data supports a model where Vps45p either directly 
favors the open conformation, or otherwise maintains Tlg2p in a SNARE-
receptive state.   
 The possibility that SM proteins possess a general, conserved role in 
SNARE complex formation is, however, cast into doubt by recent demonstrations 
of diverse modes of interaction between SM proteins and syntaxins.  In the 
neuronal system, N-sec1 binds only the closed syntaxin (31).  In contrast, yeast 
exocytic Sec1p is found only in a complex with the fully assembled SNARE 
complex (4).  Yeast vacuolar Vps33p on the other hand, associates with its 
syntaxin, Vam3p, indirectly through several other proteins (24).  And to deepen 
the complexity, the intracellular SM proteins Sly1p/rsly1 and Vps45p bind to their 
syntaxins, Sed5p/syntaxin 5 and Tlg2p, respectively, via a short N-terminal 
peptide (1, 5, 30).  The diversity in binding mechanisms could indicate diverse 
functions for SM proteins at different transport steps.  It could also suggest that 
the interactions with SNAREs are relevant to SM protein function only in that they 
concentrate the SM protein to the site of membrane fusion, where they perform a 
function unrelated to SNAREs, perhaps in controlling fusion pore dynamics (9).  
In fact, there is still no convincing evidence that syntaxin binding, per se, is even 
critical to the essential function of SM proteins in membrane fusion.  A promising 
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beginning was the demonstration that the blocking of rsly1 binding to syntaxin 5 
caused a morphological disruption of Golgi structure in vero cells (30).   
 On the other hand, the diversity in binding mechanisms could also be 
reconciled with a conserved role in SNARE complex formation if one postulated 
that the various types of interactions represent different stages in a series of 
distinct interactions that SM proteins undergo with syntaxins.  Intriguingly, 
Vps45p appeared to be recruited to the cis-SNARE complex containing Tlg2p, 
remain bound through Sec18p-dependent SNARE dissociation, and then 
dissociate from Tlg2p during a late stage of trans-SNARE complex formation or 
fusion (2).  Likewise, Sly1p pre-bound to Sed5p remained bound during SNARE 
complex formation in vitro (22).  These reports are consistent with a given SM 
protein binding to its syntaxin in multiple conformation states, perhaps employing 
multiple interaction surfaces.  
 Production of a conformation-specific monoclonal antibody against the 
syntaxin 5 SNARE motif allowed us to monitor the availability of the SNARE motif 
and examine its relationship to the SM protein rsly1.  We found that available 
syntaxin 5 is focally regulated relative to total syntaxin 5, indicating that precise 
spatial control of SNARE motif availability is a bona fide feature of cells.  
Endogenous rsly1 largely colocalized with syntaxin 5 and required its association 
with syntaxin 5 to maintain this distribution.  However, the amount of available 
syntaxin 5 did not influence the distribution of rsly1, suggesting that rsly1 is 
bound to both available and unavailable syntaxin 5 in cells.  rsly1 was acutely 
required for transport between the ER and Golgi in permeabilized cells.  
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Furthermore, rsly1 binding to the syntaxin 5 N-terminus was absolutely required 
for its direct role in transport.  Finally, we tested the hypothesis that rsly1 binding 
to syntaxin 5 promotes or maintains the available syntaxin 5 pool in intact cells, 
by competing off rsly1 and monitoring the conformation of syntaxin 5.  
Interestingly, we observed remarkably little change in the availability of syntaxin 
5, even when interactions with rsly1 were largely removed.  Hence, our data are 
inconsistent with opener models of rsly1 function and suggest an essential 
function at a later stage in the SNARE cycle. 
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MATERIALS AND METHODS 
 
DNA constructs.  Bacterial constructs encoding GST-syntaxin 5 (55-333), GST-
syntaxin 5 (251-333), GST-rbet1 cytoplasmic domain, GST-membrin full-length 
and His6-sec22b cytoplasmic domain were described previously (29).  DNA 
inserts for new bacterial constructs, including GST-rsly1 full-length (amino acids 
1-648), GST-Habc (including the first 195 residues of the 34 kD isoform), and 
GST-syntaxin 5 (1-43) were amplified by PCR and subcloned into vector pGEX-
KG (11) with an amino-terminal GST.  Myc-tagged mammalian expression 
constructs, myc-Habc (including the first 195 residues of the 34 kD isoform), 
myc-rsly1 (amino acids 1-648) were prepared by PCR and subcloning into 
pCMV-tag3 (Stratagene; La Jolla, CA) with an amino-terminal myc tag, while 
syntaxin 5 (1-43)-GFP was amplified by PCR and subcloned into pEGFP 
(Clontech; Palo Alto, CA) giving it a carboxy-terminal GFP.  All DNA constructs 
were confirmed by DNA sequencing. 
 
Antibody production and functional evaluation.  GST-syntaxin 5 residues 
251-333 was produced and purified by glutathione-Sepharose chromatography 
as described previously (29).  Following cleavage with thrombin, the liberated 9.5 
kD SNARE motif (residues 251-333) was purified further by preparative SDS-
PAGE and electroelution.  After extensive dialysis against 50 mM NH4CO3, the 
protein solution was completely dried in a Speed Vac and resuspended in PBS.  
Mice were injected intraperitoneally with 200 µl of Ribi adjuvant (Corixa; 
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Hamilton, MT) containing 30 µg of SNARE motif.  Mice were injected a total of six 
times over a period of seven months, after which a strong anti-syntaxin 5 
antibody response was detected in immunoblots of liver membranes.  Mice were 
then maintained for seven months without injections to allow antibody titers to go 
down.  Antigen for final intravenous boosts was purified free of SDS using 
reversed phase chromatography instead of preparative PAGE.  Briefly, 
glutathione-Sepharose-purified, thrombin-cleaved GST-syntaxin 5 (251-333) was 
mixed 1:1 with water containing 0.05% trifluoroacetic acid (TFA) and loaded on a 
3 ml Resource RPC column (Pharmacia; Piscataway, NJ) equilibrated in 
water/0.05% TFA.  The column was eluted with increasing acetonitrile containing 
0.065% TFA.  Fractions containing SNARE motif that were free of GST and other 
contaminants were dried, resuspended in PBS, and 200 µl containing ~40 µg of 
homogeneous SNARE motif was injected intravenously into an immune mouse.  
Later that day, the mouse was injected with another ~40 µg of SNARE motif 
intraperitoneally with Ribi adjuvant as described above.  After three days, the 
mouse was sacrificed, the spleen removed and dissociated and hybridomas were 
produced using standard methods (12).  Only clones that were strongly positive 
for ELISA and decorated syntaxin 5 bands in immunoblots of crude membranes 
were subcloned and re-screened.. 
 Monoclonal antibodies were purified from tissue culture supernatants 
using protein A- and protein G-Sepharose (Pharmacia; Piscataway, NJ), and 
tested for efficiency of immunoprecipitation of dilute, purified syntaxin 5 SNARE 
motif (not shown).  All of the antibodies positive for immunoprecipitation were 
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tested for ability to disrupt ternary SNARE complex formation (18C8 and 9D8 are 
shown in Figure 2).  These binding assays employed purified recombinant 
glutathione-Sepharose-immobilized GST-membrin, soluble syntaxin5 and rbet1, 
prepared and assembled as described in a previous publication (29).  Under 
these conditions, syntaxin5 binds only in the presence of soluble rbet1 (29).  
After the binding incubation and buffer washes, bead pellets were analyzed for 
bound syntaxin5 by immunoblotting.  Purified syntaxin5 SNARE motif was 
incubated with soluble membrin, sec22b and rbet1, and a quaternary complex 
containing these four proteins was isolated by gel filtration as described in Xu et 
al.  The high molecular weight gel-filtered complex, or the original, cleaved 
syntaxin5 preparation in the absence of other SNAREs, was employed in 
immunoprecipitations using protein A-purified 18C8.  Syntaxin5 in the 
immunoprecipitated pellets was detected by immunoblotting.   
 Bead binding studies to examine syntaxin5 intramolecular interactions 
(Figure 3) were conducted using a GST-Habc construct encoding the first 195 
amino acids of the short syntaxin5 isoform (or amino acids 55-251 of the long 
isoform) in conjunction with purified syntaxin5 SNARE motif.  Binding reactions 
were conducted in 400 µl of Buffer A (20 mM Hepes, pH 7.2, 0.15 M KCl, 2 mM 
EDTA, 5% glycerol) containing 0.1 % Triton X-100, 2 mg/ml BSA, 10 µl (packed 
volume) of glutathione-Sepharose beads pre-loaded with ~200 pmoles of GST or 
GST-Habc, and varying amounts of syntaxin5 (252-333) and protein A/G-purified 
monoclonal antibodies.  After binding at 4 °C for 30 minutes, beads were washed 
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three times with Buffer A containing 0.1% Triton X-100, and the bound syntaxin5 
(252-333) was determined by immunoblotting.  
 To produce polyclonal anti-rsly1 antibodies, full-length GST-rsly1 was 
expressed in bacteria, purified by glutathione-Sepharose and preparative SDS 
PAGE, and employed to immunize a rabbit subcutaneously in Freund’s adjuvant.  
Anti-rsly1 antibodies were later affinity purified from immune rabbit serum on a 
column of GST-rsly1 conjugated to cyanogen bromide-activated Sepharose, 
following pre-depletion on a similar column of GST. 
 Antibody Fab fragments were produced by papain cleavage of the intact, 
purified IgG in the presence of cysteine as described (12).  Our conditions 
resulted in complete elimination of intact IgG, as monitored by non-reducing 
SDS-PAGE with Coomassie staining and by an immunoprecipitation assay (not 
shown).  We did not attempt to isolate the Fab fragments free of Fc fragments. 
 
Cell culture and transfections.  NRK cells were maintained in DMEM 
containing 4.5 g/L glucose, 10% fetal calf serum, 100 units/ml penicillin and 100 
µg/ml streptomycin in a 5% CO2 incubator at 37 °C.  For NRK cell transfections, 
plasmid DNA was freed of excess salts and exchanged into PBS using Microcon 
YM-100 centrifugal concentrators.  Trypsinized, suspended NRK cells were 
washed twice with ice-cold PBS and resuspended at a concentration of 3 x 107 
cells/ml; 0.2 ml of cells was mixed with 15 µg of plasmid DNA and incubated on 
ice 10 min in a pre-chilled 4 mm gap electroporation cuvette.  The cells were 
pulsed three times for 4 ms at 1 sec intervals and 250 V using a BTX ECM 830 
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square-wave electroporator.  Cells were then diluted with cold medium containing 
20% serum, plated on polylysine-treated coverslips in three wells of a six-well 
plate, and returned to 37 °C for 24 hours prior to immunofluorescence 
microscopy.  In some experiments, NRK cells were washed twice with warm 
DMEM lacking serum, covered with the same medium containing 50 µM NEM, 
and placed in the incubator for 5 minutes prior to processing for 
immunofluorescence. 
 
Immunofluorescence microscopy.  For normal immunofluorescence on fixed, 
intact cells, the cells were fixed for 30 minutes at room temperature with 4% 
paraformaldehyde in 0.1 M sodium phosphate, pH 7.0, then quenched twice for 
10 min with 0.1 M glycine in PBS.  Cell permeabilization was then carried out for 
15 minutes at room temperature using Permeabilization Solution (0.4% saponin, 
1% BSA, 2% normal goat serum in PBS), followed by incubation in primary 
antibody in Permeabilization Solution for 1 hour.  After three washes with 
Permeabilization Solution, cells were incubated with secondary antibody in the 
same buffer for 30 minutes.  Secondary antibodies were usually FITC- and Texas 
Red-conjugated and purchased from Jackson Immunoresearch (West Grove, 
PA, USA).  For triple-label experiments, we used intrinsic GFP fluorescence, anti-
mouse cy3 and anti-rabbit cy5 secondary antibodies (Jackson).  After the 
secondary antibody incubation, coverslips were washed with Permeabilization 
Solution three further times and mounted using Vectashield mounting medium 
(Vector Laboratories, Burlingame, CA, USA) and sealed with nail polish.  Slides 
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were analyzed using a Nikon E800 microscope employing a 60X CFI Plan Apo 
objective.  Optics included standard FITC, Texas Red and cy5 
excitation/emission filter sets that allowed negligible cross-talk.  Images were 
collected using a Hamamatsu ORCA 2 digital camera and Improvision Openlab 2 
software.  For deconvolution, we used separate excitation and emission filter 
wheels equipped with GFP and dsRed-optimized filters, and captured images 
every 0.2 µm from the top to bottom of the cells (about 30 z-sections).  We then 
deconvolved the stack of images using the Openlab 3D Restoration algorithm.  
We present single optical sections of deconvolved image stacks. 
 For staining of cells with selectively permeabilized plasma membranes 
(Figure 9A), NRK cells grown on round poly-lysine-treated coverslips in 24-well 
dishes were either NEM treated (see cell culture section) or not, then chilled on 
ice and rinsed several times with ice-cold 50 mM Hepes, pH 7.2, 90 mM 
potassium acetate, 2 mM magnesium acetate, followed by incubation for five 
minutes on ice in the same buffer containing 50 µg/ml digitonin.  The digitonin 
was removed and replaced with the same buffer lacking digitonin (control) or 
lacking digitonin and containing purified NSF, α-SNAP, and the ATP-
regenerating system for ER-to-Golgi transport incubations (see below) and 
incubated a further 30 minutes on ice.  After the 30 minutes with or without 
NSF/α-SNAP, cells were fixed on ice for 30 minutes with 4% paraformaldehyde 
in 0.1 M sodium phosphate, pH 7.0, then quenched twice for 10 minutes each at 
room temperature with 0.1 M glycine in PBS.  Blocking was accomplished with 
1% BSA and 2% normal goat serum in PBS for 15 minutes at room temperature, 
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followed by primary antibody in the same solution for one hour.  After washing 
with PBS, secondary antibody incubations were carried out in blocking solution 
for 30 minutes at room temperature.  Following washing with PBS, coverslips 
were mounted and analyzed as above.   
 
Quantitation of 18C8 staining.  Openlab images were converted to 8-bit TIFF 
files and quantified using NIH Image 1.63 software.  The intense Golgi region 
18C8 staining in each cell was selected, and the mean pixel intensity for the 
selection was determined for 18C8 staining, after background subtraction (where 
background was the mean pixel intensity of a region lacking cells in the same 
image).  This number was divided by the background-subtracted mean pixel 
intensity of the precisely corresponding pixels in the syntaxin5- or rsly1-
counterstained paired image.  The log of this staining ratio was calculated for 
each cell in each experimental group, the mean of these values and standard 
errors were calculated for each experimental group, and then these values were 
converted back into staining ratios for presentation purposes.  Each of the bars in 
Figure 9A represents the mean staining ratios for 4 representative fields of cells 
(containing an average of 30 cells per field) where every cell was quantified.  In 
Figure 9B, each pair of bars represents 4-5 fields of cells, where all cells in each 
field were distinguished as being transfected or untransfected by inspection of 
the GFP image, and then the staining ratio for each cell and the mean value for 
each of the four conditions was determined.  The number of cells (N) counted for 
each of the four bars was 29, 16, 54 and 34, respectively.  T-testing determined 
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that the logs of the staining ratios for transfected versus untransfected cells was 
significantly different for both 18C8:rsly1 (p = 2.25 x 10-14) and 18C8:syntaxin5 (p 
= 0.0046). 
 
Partial purification of rsly1 from rat liver.  A freshly dissected rat liver (~15 g) 
was homogenized in a Potter-Elvejem device in Homo Buffer (20 mM Hepes, pH 
7.0, 0.25 M sucrose, 2 mM EGTA, 2 mM EDTA) supplemented with 1 mM DTT, 2 
µg /ml leupeptin , 4 µg/ml aprotinin, 1 µg/ml pepstatin A, 1mM 
phenylmethylsulfonyl fluoride, and centrifuged for 15 minutes at 1000 x g to 
obtain a postnuclear supernatant (PNS).  PNS fractions were then centrifuged at 
100,000 x g for 40 minutes to separate membranes from the cytosol.  
Membranes were re-homogenized in 20 mM Hepes, pH 7.2, 1 M KCl and 2 mM 
EDTA plus protease inhibitors and DTT, and agitated at 3 °C for 90 minutes prior 
to a second 100,000 x g centrifugation.  The supernatant of this centrifugation 
appeared to contain a majority of the total liver rsly1, when compared to the 
cytosol and stripped membrane fractions by immunoblotting (not shown).  The 
high-salt fraction was then desalted on Sephadex G-25 (Pharmacia; Piscataway, 
NJ), and loaded onto a 30 ml Q-Sepharose (Pharmacia; Piscataway, NJ) column 
equilibrated in 20 mM Tris, pH 7.6, 2 mM EGTA.  After gradient elution to 1 M 
KCl in the same buffer, immunoblotting revealed that rsly1 had completely bound 
to the column and eluted in a sharp peak at about 0.28 M KCl.  These fractions 
were pooled, concentrated to 2 ml using a YM-10 membrane in a stirred cell 
concentrator (Millipore, Bedford, MA) and gel-filtered on a 100 ml Superose 12 
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column (Pharmacia; Piscataway, NJ) equilibrated in 25/125 Buffer (25 mM 
Hepes, pH 7.2, 125 mM potassium acetate).  Immunoblotting revealed that rsly1 
eluted sharply at approximately its expected monomer size.  These fractions 
were concentrated in a Centricon 10 (Millipore) centrifugal concentrator and 
stored at –80 °C until use in transport experiments. 
 
ER-to-Golgi transport assay.  Transport experiments were based closely upon 
the original published protocol (25), with modifications.  A 10 cm plate of NRK 
cells were infected with vesicular stomatitus virus strain ts045 at 32 °C for 45 
minutes, followed by a post-infection incubation at the same temperature for four 
hours.  Cells were then transferred to a 40 °C water bath, washed with 
cysteine/methionine-free RPMI medium lacking serum and starved for five 
minutes in the same medium.  The medium was replaced with 1.5 ml of the same 
medium containing 100 µCi of 35S-cysteine and-methionine (ICN Trans-Label; 
Irvine, CA) and incubated 10 minutes at 40 °C.  The medium was then 
supplemented with 5 mM each of unlabeled cysteine and methionine for an 
additional 2 minutes at 40 °C prior to transfer to ice.  The labeled cells were then 
washed several times with ice-cold 50/90 Buffer (50 mM Hepes, pH 7.2, 90 mM 
potassium acetate), and gently scraped from the plate in 3 ml of the same buffer 
using a rubber policeman.  Scrape-permeabilized cells were washed and 
resuspended in ~200 µl of 50/90 Buffer.  An ATP-regenerating system was 
prepared by mixing 100 µl of 0.2 M creatine phosphate in water with 8 µl of 0.5 M 
sodium ATP (neutralized, in water), 20 µl of 1000 U/ml creatine phosphokinase in 
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25/125 Buffer, and 72 µl water.  Transport incubations contained a total of 40 µl 
made up from the following additions: 2.4 µl water, 1 µl 0.1 M magnesium 
acetate in water, 2 µl of ATP regenerating system (see above), 0.6 µl 1 M Hepes 
in water, pH 7.2, 4 µl of a solution of 50 mM EGTA, 18 mM CaCl2 and 20 mM 
Hepes, pH 7.2, 10 µl of dialyzed or G-25-desalted rat liver cytosol prepared 
without protease inhibitors or DTT in 25/125 Buffer, 2 µl of 25 mM UDP-N-
acetylglucosamine in water, 2 µl of 25 mM UTP in water, 11 µl of 25/125 Buffer 
or antibodies/peptides dissolved in this buffer, and 5 µl of permeabilized cells in 
50/90 Buffer.  For experiments to examine the effects of antibodies in transport, 
the assembled reactions including antibodies were incubated on ice for 30 
minutes prior to transport, which takes place during a 90-minute incubation at 32 
°C.  For experiments where cells are pre-incubated with antibodies prior to 
removal of unbound antibodies (Figure 11C), the preincubation was assembled 
on ice identically to a transport reaction containing antibody, however, after 30 
minutes on ice the cells were gently pelleted and washed twice with 50/90 Buffer 
containing 1 mg/ml BSA.  After the third centrifugation, the cell pellets were 
resuspended in full transport cocktail with or without additions and then incubated 
90 minutes at 32 °C for transport.  Following 90-minute transport incubations, 
cells were centrifuged at 15,000 x g for one minute, the supernatant discarded, 
and the pellet dissolved in 20 µl 0.1 M sodium acetate, pH 5.6, containing 0.3% 
SDS, boiled 5 minutes, then diluted to 0.1% SDS with 0.1 M sodium acetate, pH 
5.6.  A 30 µl portion of each sample was then supplemented with 2.5 mU 
endoglycosidase H (Roche; Indianapolis, CA), incubated overnight at 37 °C, and 
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analyzed by 10% SDS PAGE, gel drying and phosphorimaging and/or 
autoradiography. 
 
Other reagents.  Recombinant rsly1 used in the experiments of Figure 11 was 
expressed as a GST-rsly1 fusion protein (see constructs section), purified by 
glutathione-Sepharose, and then cleaved with thrombin to liberate rsly1 from the 
GST tag.  This preparation was then dialyzed into 25/125 Buffer and stored at -
80 °C until use in transport experiments.  No attempt was made to eliminate 
contaminating GST.  HPLC-purified synthetic peptides with the sequences 
MSCRDRTQEFLSACKSLQSRQNGIQTNK and 
MSCRDRAQEALSACKSLQSRQNGIQTNK were purchased from Genemed 
Synthesis (S. San Francisco, CA).  Purified, recombinant, active NSF and α-
SNAP were a kind gift from Dr. Phyllis Hanson (Washington University, St. Louis, 
MO).  Anti-GM130 polyclonal antisera was a kind gift of Dr. Martin Lowe 





A monoclonal antibody to the syntaxin5 SNARE motif that binds mutually 
exclusively with other SNAREs and the Habc domain. Seeking a reagent that 
could report the status of the SNARE motif in vivo or in vitro, we immunized mice 
with purified bacterially expressed syntaxin5 SNARE motif, residues 251-333.  
We then produced hybridomas, which were culled by screening sequentially by 
ELISA, Western blot and immunoprecipitation to yield 17 high-affinity antibody-
producing hybridomas.  Figure 1 shows Western blots of crude rat brain 
membranes using several of the purified monoclonal antibodies.  Diversity in the 
epitopes recognized is apparent since the antibodies differentially recognized a 
syntaxin5 degradation product of ~32 kD.  Monoclonal antibodies were then 
functionally tested for their ability to block formation of a ternary SNARE complex 
assembled from immobilized GST-membrin and soluble syntaxin5 and rbet1 (29).  
Formation of this ternary complex, which likely represents the t-SNARE for ER-
to-Golgi transport (15), is indicated by the rbet1-potentiated binding of syntaxin5 
to GST-membrin-coated glutathione beads (29).  Only one antibody, 18C8, 
significantly inhibited ternary complex assembly.  Inhibition of SNARE complex 
formation by 18C8, but not by an equal concentration of 9D8, is demonstrated in 
Figure 2A.  Thus, it appeared that 18C8 binding to the SNARE motif prevented 
the SNARE motif from engaging other SNAREs.  We wondered whether the 
converse was also true, i.e., would the assembly of syntaxin5 with SNAREs 
prevent 18C8 binding to its epitope?  As shown in Figure 2C and quantified in 
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Figure 2B, isolated syntaxin5 SNARE motif was very efficiently precipitated by 
18C8, however, the same protein, when assembled into an ER/Golgi quaternary 
complex containing syntaxin5, membrin, sec22b and rbet1, was not efficiently 
precipitated, even when present at a much higher concentration.  Thus, it 
appears that 18C8 binds to the syntaxin5 SNARE motif mutually exclusively with 
other SNAREs.   
 Our previous work demonstrated that removal of the syntaxin5 Habc 
domain resulted in vastly greater SNARE complex formation in vitro (29).  This is 
consistent with the Habc domain playing an autoinhibitory role in vivo, a feature 
which has been well-documented for exocytic yeast syntaxins (19).  We 
wondered whether the inhibitory effect of the syntaxin5 Habc domain could be 
due to formation of a closed conformation, and if so, whether 18C8 binding would 
be mutually exclusive with the closed conformation.  We performed a protein 
binding experiment employing a GST fusion of the syntaxin5 Habc domain 
immobilized on glutathione beads and free syntaxin5 SNARE motif in solution.  
As shown in Figure 3B and quantified in Figure 3A, there was indeed a strong 
and specific interaction between the GST-Habc construct and the SNARE motif, 
with significant binding above control.  The intramolecular interaction represented 
by this binding event would presumably be much more efficient and likely 
explains the previously observed inhibitory effect of Habc on SNARE complex 
formation (29).  As shown in Figure 3E and quantified in Figure 3D, 18C8, but not 
10A1, potently inhibited this interaction.  This establishes that the 18C8 epitope is 
required for Habc binding to the SNARE motif, making it also very likely that a 
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tightly closed Habc domain would preclude 18C8 binding, just as it inhibits 
SNARE complex formation.  In summary, Figures 2 and 3 demonstrate that 18C8 
has binding properties that make it a very good candidate for a probe to report 
the status of the syntaxin5 SNARE motif in vitro or in vivo. 
 
18C8 immunostains only the available syntaxin5 in NRK cells. 18C8 
immunostaining in fixed NRK cells resembled that of a polyclonal anti-syntaxin5 
antibody (Figure 4A vs. B).  This particular polyclonal antibody has been 
employed to isolate multiple overlapping protein complexes containing syntaxin5, 
rsly1, GOS-28, membrin, sec22b, and rbet1 (14).  This antiserum also efficiently 
immunoprecipitates the isolated syntaxin5 molecule in vitro and completely 
inhibits ER-to-Golgi transport in permeabilized NRK cells (not shown).  Thus, it 
seems very likely that this antibody recognizes multiple conformations of 
syntaxin5.  On the other hand, based upon Figures 2 and 3, we predicted that 
18C8 would only stain the pool of syntaxin5 molecules with available, 
unengaged, SNARE motifs.  To test this prediction, we inhibited N-
ethylmaleimide-sensitive factor (NSF) in living cells at 37 °C using N-
ethylmaleimide (NEM).  As evident in Figure 4C vs. D, NEM treatment completely 
abrogates 18C8 staining without altering anti-syntaxin5 staining intensity.  The 
loss of 18C8 staining was not due to destruction of the 18C8 epitope, since 18C8 
recognized syntaxin5 in Western blots of control as well as NEM-treated cells 
(Figure 4G).  In addition, the effect on 18C8 staining did not appear to result from 
any direct action of NEM on the cells or preparation, since treatment of cells with 
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NEM at low temperatures that prohibit vesicle transport, followed by washout of 
NEM in the cold, did not effect the staining, however, subsequent warming of the 
cells after NEM washout led to a loss of 18C8 staining within 5 minutes (Figure 
4E and F).  The results demonstrate that 18C8 staining disappears as a 
downstream metabolic consequence of NEM treatment and likely results from 
inaccessibility of the SNARE motif as SNARE complexes accumulate.  A 
complimentary result was that addition of purified NSF, α-SNAP, and MgATP to 
permeabilized cells increased 18C8 staining intensity (see below, Figure 9A).  
Thus, 18C8 is a useful probe of SNARE motif accessibility in intact cells. 
 
Syntaxin 5 availability is spatially regulated in cells.  Although 18C8 
epifluorescent staining was very similar overall to polyclonal anti-syntaxin 5 
staining, we noticed differences in staining emphasis within the Golgi area.  This 
prompted us to examine their precise spatial co-distribution by deconvolution 
microscopy.  In the single optical sections shown in Figure5, 18C8 was often 
brightest in small focal areas containing relatively little anti-syntaxin 5 staining 
(arrows).  Most areas contained both types of staining, but there were also 
regions that contained intense anti-syntaxin 5 staining and little 18C8 
(arrowheads).  The overall pattern on merged images suggests that syntaxin 5 
distributed throughout the Golgi area is regularly punctuated by focal regions 
containing little total but primarily available syntaxin 5.  This result is quite 
different from what would be expected if a constant fraction of syntaxin 5 were 
available wherever syntaxin 5 were present, and strongly suggests that 
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mechanisms exist to actively promote and/or discourage the availability of 
syntaxin 5 in a spatially defined manner.  We do not know what factor(s) 
determine 18C8 staining hotspots, but speculate that these may represent 
receptive sites for VTC fusion with the Golgi or with other VTCs.  These results 
further validate 18C8 as a probe of syntaxin 5 availability because they 
demonstrate that the variance in availability of syntaxin 5 at steady state is well 
within the capacity of 18C8 to report.  
 
Persistent rsly1 localization to the Golgi area requires syntaxin 5 binding 
but is not influenced by syntaxin 5 availability. We produced a polyclonal 
antibody to rsly1.  As shown in Figure 6A, the epifluorescence staining pattern for 
anti-rsly1 includes some presumably diffuse cytosolic staining as well as intense 
membrane staining in the Golgi area.  The staining pattern is specific as it was 
blocked by recombinant rsly1 (Figure 6B).  We wondered whether the 
immunostained rsly1 was bound to syntaxin 5 in the Golgi and if so, which pool of 
syntaxin 5, available or sequestered, it was bound to.  Since NEM treatment was 
shown to shift all of the 18C8-available syntaxin 5 SNARE-motif into a 
sequestered state (Figure 4), we treated NRK cells with NEM under identical 
conditions and tested whether the rsly1 staining intensity or distribution changed.  
If rsly1 were bound primarily to the open syntaxin 5 but not when in a cis-SNARE 
complex, then rsly1 staining would be expected to dramatically decrease as with 
18C8.  If it were bound primarily to the SNARE complex, as is the case with 
Sec1p (4), then we would expect the increased number of rsly1 binding sites 
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upon NEM treatment to recruit soluble rsly1 to the membrane and intensify the 
Golgi staining.  As shown in Figure 6C & D, there was no noticeable change in 
rsly1 staining upon an NEM treatment shown to cause massive sequestration of 
the SNARE motif.  This indicates that either rsly1 localization was independent of 
syntaxin 5 binding altogether, or was dependent upon syntaxin 5 but not 
influenced by the oligomeric state of syntaxin 5.  The results are consistent with 
the persistence of VPS45p-Tlg2p interactions in sec18 yeast strains at the 
restrictive temperature (2). 
 To address whether binding to syntaxin 5 was in fact important for rsly1 
retention in the Golgi area, we transfected cells with the first 105 residues of the 
34 kD syntaxin 5 isoform containing an N-terminal myc epitope (myc-Habc).  
Since this construct included the binding site for rsly1, it should compete with 
endogenous membrane-bound syntaxin 5 for rsly1 binding.  We found that cells 
expressing myc-Habc had dramatically reduced rsly1 staining in the Golgi area 
(not shown).  In general there appeared to be a decrease in total cellular anti-
rsly1 staining intensity. rsly1 binds to an N-terminal sequence of syntaxin 5 (30) 
whose disposition could change during syntaxin 5 opening, closing, or complex 
formation.  We next expressed a construct containing GFP fused to the first 43 
amino acids of the syntaxin 5 N-terminus (syn 5 (1-43)-GFP), including the 
necessary and sufficient rsly1 binding site.  A very similar construct was 
previously employed to examine morphological consequences of rsly1-syntaxin 5 
interactions in vero cells (30).  As shown in triple-label images in Figure 7A and 
C, cells expressing syn 5 (1-43)-GFP (arrows) displayed dramatically less rsly1 
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Golgi area staining than nontransfected cells (arrowheads), similar to that 
described above for myc-Habc transfectants.  In contrast to results published in 
vero cells (30), we found mostly minor consequences on Golgi morphology as 
indicated by GM130 staining (Figure 7G and I), even in highly expressing cells.  
Note that we cannot say for sure whether rsly1 in transfected cells was merely 
redistributed, presumably to a less-concentrated cytosolic pool, or whether the 
protein was destabilized and degraded when its syntaxin 5 binding function was 
blocked.  We did not observe an effect of the proteasome inhibitors MG-132 and 
lactacystin on the change in rsly1 staining (not shown).  Whether due to 
mistargeting or to degradation, the effects of myc-Habc and syn 5 (1-43)-GFP 
expression on rsly1 staining indicate that syntaxin 5 interactions are required for 
the Golgi retention of rsly1.  Taken together with the NEM results of Figure 6 and 
previous immunoprecipitations (14), our results favor the hypothesis that rsly1 in 
the Golgi is bound to syntaxin 5 whether available or sequestered in cis-SNARE 
complexes. 
 
Inhibition of rsly1-syntaxin 5 interactions results in a modest increase in 
syntaxin 5 availability. We noticed that Golgi 18C8 staining was present, albeit 
often at reduced levels, in cells expressing syn 5 (1-43)-GFP, even when rsly1 
staining almost entirely disappeared (Figure 7A-F).  This is made clear in the 
merge of 18C8 and rsly1 staining in Figure 7F, where transfected cells have 
green Golgi staining but untransfected cells have yellow Golgis.  This seemed to 
indicate that some available syntaxin 5 persisted in the absence of rsly1 binding, 
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however, did not distinguish whether the reduction in 18C8 staining was due to a 
reduction in SNARE motif availability versus a decrease in the total amount of 
syntaxin 5 in those cells.  Several syntaxins have been demonstrated to be 
unstable in the absence of their SM binding partner (27).  We therefore 
performed triple label experiments to examine the relationship between syn 5 (1-
43)-GFP expression, 18C8 staining, and total syntaxin 5 staining using the 
polyclonal syntaxin 5 antisera described above.  As evident in Figure 8A-E, 
transfected cells (arrows) generally, but not always, displayed less 18C8 and 
anti-syntaxin 5 staining than untransfected cells (arrowheads), consistent with a 
moderate destabilization of syntaxin 5 in the absence of rsly1 binding.  Although 
the destabilization of Tlg2p in the absence of Vps45p could be reversed by 
proteasome inactivation (3), we were unable to affect the loss of syntaxin 5 
staining in transfected cells with MG-132 and lactacystin (not shown).  Despite 
the trend toward lower total syntaxin 5 staining in transfected cells, there was 
sufficient high quality staining to compare the relative 18C8 and anti-syntaxin 5 
staining in transfected versus untransfected cells.  Figure 8A-E demonstrates 
that the relationship between 18C8 staining intensity and anti-syntaxin 5 intensity 
is qualitatively equivalent in untransfected cells (arrowheads), low to moderately 
expressing cells (short arrows), and high expressing cells (long arrows).  This 
seemed to indicate that the loss of rsly1-syntaxin 5 interactions did not 
significantly alter the relative pool of available syntaxin 5 SNARE motif.  Note that 
rsly1 readily and efficiently co-immunoprecipitates with syntaxin 5 using 18C8, 
indicating that rsly1 and 18C8 do not bind syntaxin 5 mutually exclusively (A. 
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Joglekar and J. Hay, unpublished observations).  This eliminates the possibility 
that removal of rsly1 from syntaxin 5 would have any direct effect on 18C8 
staining intensity per se. 
 To validate the above impressions quantitatively, we used a ratiometric 
18C8 staining intensity relative to colocalizing markers.  To calculate the relative 
18C8 staining intensity, the bright area of 18C8 Golgi staining was quantified for 
each cell in a field, along with the precisely corresponding area in the same cells 
co-stained for either rsly1 or anti-syntaxin 5.  For each Golgi, the relative 18C8 
staining intensity was calculated and averaged over many cells (see Materials 
and Methods for details).  To test whether this method was sensitive enough to 
detect changes in syntaxin 5 conformation, we performed an experiment using 
NRK cells whose plasma membranes had been selectively permeabilized with 
digitonin.  As shown in Figure 9A (open bars), the 18C8:rsly1 staining ratio in 
control NRK cells had a value of ~1:1.55 and the 18C8:syntaxin 5 staining ratio 
had a value of ~1:1.15.  Note that these baseline values arbitrarily vary between 
experiments depending upon day-to-day variations in staining intensity and 
camera exposure times.  Within each staining series, however, ratios should be 
quantitatively comparable.  When the permeabilized cells were incubated on ice 
with purified, recombinant NSF, α-SNAP, and MgATP prior to fixation and 
staining, a significant increase above control for both 18C8:rsly1 and 
18C8:syntaxin 5 staining ratios was detected (Figure 9A, gray bars), as expected 
if NSF activity were to favor available syntaxin 5.  On the other hand, a strong 
decrease in the relative18C8 staining intensity was found in cells preincubated 
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with NEM at 37 °C prior to permeabilization and fixation (Figure 9A, black bars).  
The experiment in Figure 9A demonstrates that both increases and decreases in 
available syntaxin 5 are possible in NRK cells and quantifiable using 18C8 
staining ratios. 
 We next quantitated the syn 5 (1-43)-GFP transfection experiments 
discussed above.  As shown in Figure 9B (left-hand open bar), the 18C8:rsly1 
staining ratio for nontransfected cells had a value of about 1:1.  Cells that had 
been transfected with syn 5 (1-43)-GFP, however, had a dramatically higher 
value of 1.8:1 (Figure 9B, left-hand solid bar), confirming the impression from 
Figure 7 that the 18C8-positive Golgi syntaxin 5 was substantially depleted of 
rsly1.  Nontransfected cells had an 18C8:syntaxin 5 ratio of about 1.1:1 (Figure 
9B, right-hand open bar).  If rsly1 binding favored an open or monomeric 
conformation of syntaxin 5 or in any other way maintained an available pool of 
syntaxin 5, a significantly lower 18C8:syntaxin 5 staining ratio would be expected 
in syn 5 (1-43)-GFP-transfected cells.  However, as seen in Figure 9B (right-hand 
solid bar), the 18C8:syntaxin 5 ratio slightly increased in the transfected cells.  
Thus, our results are inconsistent with opener models of rsly1 function.  The 
modest increase in 18C8:syntaxin 5 ratio was statistically significant (p = 0.0047; 
Student’s T-test).  There are several potential explanations for this effect, 
including the possibility that rsly1 favors SNARE complex formation or stabilizes 
SNARE complexes by a later or more direct mechanism than by altering SNARE 




 For a further test of conformational effects of rsly1 on syntaxin 5, we 
overexpressed full-length, myc-tagged rsly1 in NRK cells.  As shown in Figure 
10A & B, the transfected myc-rsly1 presumably saturated Golgi binding sites and 
filled up the cytoplasm.  Based upon the α-rsly1 staining in transfected and 
untransfected cells such as in Figure 10B, we estimate that the exogenous 
expression was at least 10-fold over endogenous.  As shown in Figure 10C-F, 
the 18C8 staining in cells overexpressing myc-rsly1 (arrows) appeared similar in 
nature and intensity to surrounding nontransfected cells (arrowheads).  This 
observation is consistent with the modest changes in syntaxin 5 availability 
caused by dramatic reduction in rsly1-syntaxin 5 interactions (Figures 7-9).  
Taken together, these sets of experiments argue against rsly1 playing a major 
role in promoting or maintaining syntaxin 5 availability, the most commonly 
invoked model of conserved SM protein function (27). 
 
rsly1-syntaxin 5 interactions are directly required for ER to Golgi transport 
in permeabilized cells. SM proteins are essential for transport in many systems, 
however, it is not clear whether their interaction with syntaxins is part of their 
essential function.  We addressed this issue using an in vitro assay that 
reconstitutes ER to Golgi transport of temperature-sensitive vesicular stomatitus 
virus glycoprotein (VSVG) in scrape-permeabilized NRK cells (25).  As shown in 
Figure 11A and quantified in Figure 11B, addition of either anti-rsly1 or 18C8 Fab 
fragments to transport reactions potently and specifically inhibited transport 
relative to control antibodies.  Supplementation of a partially inhibitory dose of α-
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rsly1 antibody with a ~100-fold excess of purified, recombinant rsly1 significantly 
protected against inhibition by the antibody, demonstrating that it was rsly1-
reactive antibody molecules that caused the inhibition (Figure 11B, right).  The 
results of Figure 11A&B establish that rsly1 is directly involved in ER to Golgi 
transport, since abrupt neutralization of rsly1 with the Fab blocks transport.  
Furthermore, that 18C8 inhibits transport implies that functionally relevant 
syntaxin 5 SNARE motif is available during at least part of the transport 
incubation.  This is in agreement with the microscopy figures and argues that the 
pool of syntaxin 5 immunostained by 18C8 is in fact functionally important.  
 Since rsly1 is a hydrophilic protein that can be added exogenously to 
permeabilized cells, we had the opportunity to test whether soluble rsly1 could 
complement the function of antibody-neutralized membrane-bound rsly1.  If rsly1 
need not be bound to syntaxin 5 to perform its essential function, for example if it 
bound to syntaxin 5 only to concentrate at the site of membrane fusion where it 
performed a non-SNARE-related function, then pre-neutralization of the 
membrane-bound rsly1 pool at low temperature followed by washout of unbound 
antibody should be complemented by addition of excess soluble rsly1 during a 
transport incubation.  On the other hand, if only the syntaxin-bound rsly1 can 
perform its essential function, then pre-neutralization of the membrane-bound 
pool would prevent the function of even a large excess of exogenous rsly1 added 
later (assuming essentially irreversible rsly1 and antibody binding).  The anti-
rsly1 pre-neutralization incubation was carried out on ice to inhibit transport-
related events that might, in the absence of rsly1 function, result in irreversible 
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dead-end intermediates.  As shown in Figure 11C, 6th bar, inclusion of anti-rsly1 
during both the pre-neutralization as well as the transport incubation resulted in 
virtually complete inhibition of transport.  The 7th bar demonstrates, strikingly, that 
inclusion of anti-rsly1 only during the pre-neutralization step still resulted in 
almost complete inhibition of transport, even though fresh transport cocktail 
containing the regular amount of cytosolic rsly1 was provided during the transport 
reaction.  This indicated that soluble rsly1 at the regular concentration could not 
function in transport nor readily replace the membrane-bound inactivated pool.  
To test whether a higher concentration of fresh soluble rsly1 could restore at 
least some rsly1 function, we prepared purified soluble recombinant rsly1 and 
partially purified native rat liver rsly1.  As shown in Figure 11D, regular transport 
reactions contain about one-third soluble and two-thirds membrane-bound rsly1.  
Supplementation of transport cocktails with recombinant rsly1 increased the total 
rsly1 in transport reactions by about 100-fold, whereas the liver rsly1 represented 
about a 10-fold  excess over normal levels.  Figure 11C, 8th and 9th bars 
demonstrate that the addition of the ~100-fold excess of soluble recombinant 
rsly1, or the 10-fold excess of partially purified native rat liver rsly1, respectively, 
did not significantly restore transport after pre-neutralization with anti-rsly1.  
Thus, it appears that rsly1 requires interaction with its membrane receptor, 
presumably syntaxin 5, to provide its essential function.  The first 4 bars 
demonstrate that neither the recombinant nor liver rsly1 preparations contain 
major inhibitors of transport, and the 5th bar shows that the preincubation on ice 
and washing steps themselves do not account for the irreversible loss of 
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transport activity.  The possibility that residual anti-rsly1 antibody in the 
permeabilized cells inhibited the function of the fresh soluble rsly1 is rendered 
very unlikely by the excess of rsly1 additions, as this was shown to neutralize the 
antibody inhibition (Figure 11B).  Together, the experiments of Figure 11 suggest 
that rsly1 function can only be provided when stoichiometrically bound to a 
particular membrane receptor present in limiting quantities.  Although the 
transfection experiments of Figures 7-9 and previous immunoprecipitation results 
(14) suggest that syntaxin 5 is the membrane receptor, other critical membrane 
site(s) are also consistent with Figure 11. 
 To further address whether syntaxin 5 binding, per se, was critical for the 
direct function of rsly1 in ER to Golgi transport, we added competitor peptides 
corresponding to the rsly1 binding site on syntaxin 5.  Syntaxin 5 residues 1-43 
were expressed as a GST fusion protein in bacteria, cleaved free of GST, and 
tested in transport incubations relative to GST as a control.  As shown in Figure 
12A, the preparation containing the peptide specifically inhibited ER to Golgi 
transport, albeit not to as great an extent as anti-rsly1 antibodies had in Figure 
11.  We speculate that complete removal of all rsly1 from its syntaxin 5 binding 
site may require very high local concentrations of peptide, perhaps implying the 
existence of two functional pools of rsly1, one easier to compete off than the 
other.  To evaluate whether the inhibition we observed was in fact a result of 
blocked rsly1-syntaxin 5 interactions, we further correlated the inhibition with 
known requirements for rsly1 binding.  As shown in Figure 12B, a synthetic 
peptide, UM-1, representing the minimal 27 amino acids for rsly1 binding 
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identified by Yamaguchi et al, inhibited transport as well, although requiring even 
higher concentrations.  That this inhibition is due to its rsly1 binding rather than 
general biophysical properties is supported by the observation that a control 
peptide, UM-2, mutated at two amino acids found to be important for rsly1 
binding (30), caused significantly less inhibition of transport.  In conclusion, the 
results of Figure 11 and 12 together form a strong argument that rsly1 binding to 
syntaxin 5 is in fact an active and critical feature of its required role in transport.  
Thus, although our 18C8 microscopy work argues that rsly1 functions 
downstream of the production or maintenance of SNARE motif accessibility, our 
in vitro transport experiments indicate that rsly1 function is intimately intertwined 





 Despite ten years of scrutiny, the mechanism of action of SM proteins 
continues to elude cell biologists. Several potential positive mechanisms of action 
of rsly1 are summarized schematically in Figure 13. These potential roles can be 
grouped into those that act early in the SNARE cycle to provide or protect 
available syntaxin 5 (“opener roles”, Figure 13A), and those that act late to 
promote trans-SNARE associations, four-helix bundle zippering or multi-complex 
organization (“late-stage roles”, Figure 13B). We have exploited a conformation-
specific antibody to examine the relationship between rsly1-syntaxin 5 protein 
interactions and syntaxin 5 conformation. Our results argue strongly against 
opener models of rsly1 function whereby this SM protein promotes or maintains 
an available population of syntaxin 5 molecules. Instead, our results are 
consistent with rsly1-syntaxin 5 interactions being critical at a later stage of 
SNARE complex formation or function such as trans complex formation, helix 
bundle zippering, or the organization of multipe SNARE complexes around a 
fusion site (see Figure 13 legend for more explanation).  
 A difficulty in the interpretation of our data stems from not knowing 
precisely which conformational states exist for syntaxin 5 in vivo, and which of 
those states are available to 18C8.  For example, we cannot be certain that an 
Habc-closed state exists for syntaxin 5 in vivo, or that 18C8 can discriminate that 
state from an open state under our immunostaining conditions.  We have 
demonstrated that the syntaxin 5 Habc domain interacts robustly with the 
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syntaxin 5 SNARE motif (Figure 3), and that the presence of Habc in the syntaxin 
5 molecule hinders the rate of ER/Golgi SNARE complex formation by at least an 
order of magnitude (29).  Thus, it seems likely that syntaxin 5, like exocytic 
syntaxins, forms a closed conformation that plays an autoinhibitory role in vivo.  
However, although 18C8 binding is incompatible with a closed conformation 
(Figure 3), it is still possible that the four-helix bundle formed during a closed 
conformation is more dynamic, even in aldehyde-fixed cells, than a SNARE motif 
four-helix bundle, and therefore less able to exclude 18C8 from binding during 
staining experiments.  Nonetheless, even lacking these conformational details, 
our 18C8 immunostaining assay provides at least an operational measure of 
SNARE motif availability for experiments in fixed cells.  And since, based upon 
the NEM experiments, it seems quite certain that 18C8 immunostains the 
monomeric but not cis-SNARE complexed syntaxin 5, our data would at least 
seem to exclude models where rsly1 promotes new SNARE complex formation 
by preventing newly-available syntaxin 5 from falling back into cis-SNARE 
complexes (see Figure 13A).  Although it has been possible in the past to 
quantify total immunoprecipitable SNARE complexes in cell extracts, our 
experiments represent the first opportunity to directly assess the level of free 
syntaxin in cells. 
 Another potential limitation in our interpretations is the nonspecific nature 
of NEM inhibition as a means of shifting the balance of free and SNARE-
complexed syntaxin 5.  We cannot eliminate the possibility that NEM treatment 
may have effected syntaxin 5 staining in ways other then inhibiting NSF activity.  
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In support of a somewhat more complex explanation, we were unable to restore 
18C8 staining to NEM-inhibited permeabilized cells merely by addition of purified 
NSF, α-SNAP and MgATP on ice (not shown).  However, several observations 
argue that the effect was due to a bona fide change in syntaxin 5 conformation 
and not a trivial or direct affect of NEM on immunostaining.  First, the SNARE 
motif is not a substrate for NEM, as it lacks a cysteine.  Second, the 18C8 
epitope was fully reactive by Western blot after NEM treatment (Figure 4G), 
indicating that it was only its availability that was altered by NEM.  Third, NEM 
treatment at low temperature did not alter 18C8 staining; however, after removal 
of NEM, 18C8 staining decreased in a time-dependent fashion on incubation of 
cells at 37 °C (Figure 4E and F).  This is consistent with a requirement for 
ongoing vesicle docking and fusion reactions to consume free syntaxin 5 before 
the effect on 18C8 staining occurs.  Finally, we found that in permeabilized cells, 
purified NSF, α-SNAP and MgATP caused a significant increase in the 18C8 
staining intensity (Figure 9A).  All of these observations are consistent with 18C8 
staining being dependent upon free syntaxin 5 molecules. 
 A striking finding of this study was that available syntaxin 5 was non-
uniformly distributed in the Golgi region, and was present in foci of high 
concentration relative to total syntaxin 5.  At this time we do not know what these 
syntaxin 5 “hotspots” represent and what factors and signals initiate them.  
Functionally, they could represent active sites for membrane fusion between 
incoming VTCs and the Golgi.  One possibility is that microtubules pass through 
the Golgi area near these sites, causing nearby Golgi membranes to sustain a 
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higher load of membrane fusion and consequent recruitment of SNARE 
regulatory factors.  They could also represent Golgi cisternal rims, where intra-
Golgi transport vesicles may be tethered on string-like attachments that restrain 
their diffusion and fusion to within a fixed distance (21).  What regulatory 
machinery maintains the available syntaxin 5?  NSF is responsible for 
dissociating used SNARE complexes, but little is known about factors that 
maintain SNAREs in an active state once dissociated, if such factors are indeed 
necessary.  Our study does not shed light upon the identity of those factors other 
than to argue strongly that rsly1 is not one of them.  If rsly1 binding to syntaxin 5 
were required for maintenance of a free population of syntaxin 5, then a 
significant decrease in 18C8-availailable syntaxin 5 would have been expected to 
result from disruption of rsly1-syntaxin 5 interactions (Figure 9B).  The 
mechanisms underlying the available syntaxin 5 foci, as well as their precise 
ultrastructure, are interesting topics for future studies. 
 Significant disruption of rsly1-syntaxin 5 interactions caused unexpectedly 
little change in the 18C8:syntaxin 5 staining ratio, however, it did result in a small 
but statistically significant increase in this ratio (Figure 9B).  There are several 
ways that this effect could be interpreted: Firstly, since the effect is relatively 
small, it is possible that the effect was due to a change in the degree of co-
localization of 18C8 and anti-syntaxin 5 staining, rather than to a change in the 
staining intensities.  This effect is possible since we used 18C8 staining to select 
the precise regions of the cell to include for quantification of both color channels.  
Hence, if a manipulation were to cause a slight decrease in colocalization of the 
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two staining patterns, this could cause a slight increase in the 18C8 staining 
index.  We did not notice such a change by eye, however, this does not exclude 
the possibility.  Secondly, since disruption of rsly1-syntaxin 5 interactions caused 
a significant decrease in total syntaxin 5 molecules in the cell (Figures 7 and 8, 
arrowheads vs. arrows), it is possible that a compensatory regulatory mechanism 
resulted in a higher proportion of syntaxin 5 molecules residing in an available 
state, and thus an increase in the 18C8:syntaxin 5 staining ratio.  Thirdly, the 
slight increase in the 18C8:syntaxin 5 staining ratio could have been caused by 
an indirect effect on SNARE complex formation or stability resulting from a later 
block in membrane fusion—assuming that SNARE complex formation is a readily 
reversible process when full membrane fusion, and hence full SNARE zippering, 
is inhibited. Fourthly and finally, the simplest interpretation is that rsly1 is in fact 
positively involved in syntaxin 5 SNARE complex formation.  However, it would 
have to promote SNARE complex formation via a mechanism that does not 
increase available SNARE motif.  For example, it could act to stabilize 
intermediates in the trans-complex assembly process, the completion of 
zippering or the supra-molecular arrangement of multiple forming SNARE 
complexes around a fusion site (see schematic, Figure 13B).  Although the slight 
staining ratio increase is also compatible with rsly1 stabilizing the closed, rather 
than the open, conformation of syntaxin 5, this interpretation seems very unlikely 
since it would not predict the potent inhibition of transport by anti-rsly1 
antibodies, nor would it be compatible with previous work that found a Sly1p-
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 At the time of this manuscript the prevailing theme revolved around a lack 
of understanding of the precise mechanism of action of SM proteins in terms of 
their potential regulation of SNAREs. Past models of SM protein function held 
that these proteins assume a regulatory role responsible for maintaining an 
available open and/or monomeric pool of syntaxin molecules for SNARE complex 
formation. But the exploration of the interactions of SM proteins with syntaxins 
and their functional consequences in vivo within several eukaryotes has led to a 
reconsideration of the long-standing assumption that SM proteins fulfill their 
regulatory role by binding to syntaxins. 
 By addressing the functional relationship of the mammalian ER/Golgi SM 
protein rsly1 and its SNARE binding partner syntaxin5, we were able to 
demonstrate that rsly1-syntaxin5 interactions are critical at a later stage of 
SNARE complex formation or function such as trans complex formation, helix 
bundle zippering, or the organization of multiple SNARE complexes around a 
fusion site (see Figure 13 legend for more explanation). These results are 
consistent with the emerging picture unifying connections between individual 
SM/syntaxin interactions and one complete functional model for SM/SNARE 
protein-protein interactions, whereby each of the interactions observed in vitro 
represent intermediate stages of a SM protein-controlled molecular pathway of 
specific SNARE complex assembly that results in membrane fusion. However, 
much still remains uncovered. First, why does Munc18-1 bind syntaxin1A in a 
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closed conformation? Second, if this closed conformation is the first step in a 
series of SM protein-mediated steps toward SNARE complex formation, how and 
when does the SM/closed syntaxin dimer transit to the SM protein/SNARE 
complex: does it truly involve an intermediate where the SM protein is bound to 
the amino-terminus of syntaxin or is the association of the SM protein to SNARE 
complexes preceded by complete dissociation of the SM protein followed by re-
binding? Third, do all SM proteins undergo all three modes of binding? Finally, is 
there another uncovered SM/syntaxin binding mode? 
 Current research aimed at addressing these questions have employed 
Fluorescence Resonance Energy Transfer (FRET) microscopy to take a deeper 
look at the protein-protein interactions involved in SM protein/SNARE-mediated 
vesicle fusion. The use of this technique permits an analysis of the interactions 
between native participating proteins in single living or fixed cells. In this way 
false results, positive or negative, that could be produced by the interference of 
outside elements are eliminated. Using confocal microscopy, FRET is able to 
capture weak and transient interactions through fluorescent signals that indicate 
direct interactions. In vivo FRET analysis of SM protein/syntaxin interactions 
should promote further understanding of the precise timing at which these 
complexes assemble and function within the seretory pathway and how these 
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Figure 2.1.  A set of monoclonal antibodies directed against the syntaxin 5 
SNARE motif.  Antibodies from tissue culture supernatants from the indicated 
hybridomas (above) were purified by protein A or protein G-Sepharose and 
utilized to immunoblot identical lanes of crude rat brain membranes separated by 
SDS-PAGE and transferred to nitrocellulose.  The migration of molecular weight 
marker proteins are shown (left), as are the positions of the 42 kD (syn 5 42) and 
34 kD (syn 5 34) endogenous syntaxin 5 isoforms and a commonly seen syntaxin 
































Figure 2.2.  18C8 binds to the syntaxin 5 SNARE motif mutually exclusively 
with ER/Golgi SNAREs.  A,  Purified bacterially expressed GST or GST-
membrin was immobilized on glutathione beads and mixed with soluble syntaxin 
5 SNARE motif and rbet1 cytoplasmic domain.  Shown is a quantification of 
syntaxin 5 bound to the GST and GST-membrin beads after washing with buffer 
and immunoblotting.  GST and GST-membrin beads were reacted either in the 
absence of monoclonal antibody (filled bars) or the presence of equal 
concentrations of the indicated monoclonal antibody (open bars).  B,  ER/Golgi 
quaternary complexes were formed from syntaxin 5 SNARE motif, membrin, 
rbet1 and sec22b in solution and purified by gel filtration as described previously 
(29).  Purified ER/Golgi quaternary complex (open bars), or a lesser amount of 
syntaxin 5 SNARE motif in isolation (filled bars), were subjected to 
immunoprecipitation with 18C8 and protein A-Sepharose beads at the indicated 
antibody concentrations, and syntaxin 5 in the immunoprecipitated pellets was 
quantified by immunoblotting following SDS-PAGE and transfer to nitrocellulose.  
C,  Autoradiogram of the blot that was quantified to produce part B.  Shown are 




Figure 2.3.  18C8 inhibits binding between the syntaxin 5 SNARE motif and 
Habc domain.   A,  Purified bacterially expressed GST (open symbols) or GST-
syntaxin 5 Habc domain (filled symbols) was immobilized on glutathione beads 
and mixed with soluble syntaxin 5 SNARE motif at the indicated concentrations.  
SNARE motif bound to the beads after buffer washes was quantified by 
immunoblotting.   B,  Autoradiogram of the blot that was quantified to produce 
part A.   C,  Ponceau stain of the immunoblot lanes to which no soluble SNARE 
motif was added; a high proportion of the protein in the GST-Habc preparation 
was GST.   D,  Purified bacterially expressed GST-syntaxin 5 Habc domain was 
immobilized on glutathione beads and mixed with soluble syntaxin 5 SNARE 
motif at the highest concentration on the curve in part A, in the presence of 
increasing concentrations of purified 18C8 (open symbols) or 10A1 (closed 
symbols).  SNARE motif bound to the beads after buffer washes was quantified 
by immunoblotting following SDS-PAGE and transfer to nitrocellulose.   E,   






































Figure 2.4.  18C8 stains only free, uncomplexed syntaxin 5 in fixed NRK 
cells.  A-D, NRK cells were either incubated in control medium (A, B) or in 
medium containing 50 µM NEM (C, D) for 5 minutes at 37 °C in a CO2 incubator 
prior to fixation with paraformaldehyde and immunostaining with 18C8 and 
polyclonal anti-syntaxin 5 as described in the methods section. E, F,  NRK cells 
were incubated in medium containing 100 µM NEM for 5 minutes on ice, then 
washed several times with NEM-free medium and either fixed on ice (E), or 
incubated at 37 °C for 5 min and then fixed on ice (F).  After fixation, the cells 
were immunostained with purified 18C8.  G,  Cells that had undergone control or 
NEM incubations were placed on ice, lysed, separated by SDS-PAGE and 
immunoblotted using 18C8 or polyclonal anti-syntaxin 5 antisera. 
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Figure 2.5.  18C8-available syntaxin 5 is nonuniformly and focally localized.  
Fixed NRK cells were double-stained with 18C8 and polyclonal anti-syntaxin 5 
antibodies using FITC- and Texas Red-labeled secondary antibodies, 
respectively.  Images were collected for both filter sets every 0.2 microns through 
the cell, and the image stacks were optically deconvolved using an algorithm that 
removes no light from the stack and involves no arbitrary user inputs.  Single 
optical sections of three Golgi regions, from three different cells are shown for the 








Figure 2.6.  rsly1 is localized to the Golgi region independently of the 
oligomeric state of syntaxin 5.  Fixed NRK cells were immunostained using an 
affinity-purified anti-rsly1 antiserum under control conditions (A, C), after 50 µM 
NEM treatment as in Figure 4 (D), or in the presence of an excess of purified 
bacterially produced GST-rsly1 (B).  A and B are from a separate experiment 




Figure 2.7.  Expression of syntaxin 5 (1-43)-GFP dissociates Golgi rsly1 
staining from that of 18C8.  NRK cells were transfected with syntaxin 5 (1-43)-
GFP, fixed, and immunostained with the indicated primary antibodies followed by 
cy3- and cy5-labeled secondary antibodies.  Images shown employed filter sets 
for GFP (A, G), cy3 (B, D, H) and cy5 (C, E, I) or a merge of cy3 and cy5 (F).  
Panel D, E, and F are magnified views of the boxed region in B and C.  






Figure 2.8.  Expression of syntaxin 5 (1-43)-GFP does not significantly alter 
18C8 staining intensity relative to polyclonal anti-syntaxin 5 staining.  NRK 
cells were transfected with -syntaxin 5 (1-43)-GFP, fixed, and immunostained 
with 18C8 or polyclonal anti-syntaxin 5 antibodies followed by cy3- and cy5 -
labeled secondary antibodies, respectively.  Images shown employed filter sets 
for GFP (A), cy3 (B, D) and cy5 (C, E).  Panels D and E are magnified views of 
the boxed region in B and C.  Arrowheads demonstrate staining in 
nontransfected cells, short arrows demonstrate staining in low expressing cells 






Figure 2.9.  Quantitation of 18C8 staining intensities reveals that 
dissociation of rsly1-syntaxin 5 interactions causes a modest increase in 
18C8 accessibility.  A,  Demonstration of ratiometric quantitation of 18C8 
staining intensity relative to rsly1 staining (left) and polyclonal anti-syntaxin 5 
staining (right).  Digitonin-permeabilized cells were fixed and stained after 
incubation on ice with buffer (open bars), with buffer containing purified NSF, α-
SNAP and MgATP (gray bars), or following a 37 °C NEM treatment as in Figure 4 
(filled bars).  Plotted is the ratio of Golgi-area 18C8 staining intensity to that of 
anti-rsly1 or anti-syntaxin 5, averaged over approximately 120 cells per condition 
as described in the Materials and Methods section.  B,  Ratiometric quantitation 
of 18C8 staining intensity relative to rsly1 staining (left) and polyclonal anti-
syntaxin 5 staining (right) in untransfected (open bars) and syntaxin 5 (1-43)-
GFP-transfected cells (solid bars).  Nontransfected and transfected cells were 
from the same coverslips.  For both panels A and B, the means are plotted plus 
or minus standard error. 
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Figure 2.10.  Overexpression of myc-rsly1 does not significantly change 
18C8 accessibility of syntaxin 5.  NRK cells were transfected with myc-rsly1, 
fixed and immunostained with anti-myc (A, C, E), anti-rsly1 (B), or 18C8 (D, F) 
antibodies.  Overexpressing cells (arrows) displayed similar 18C8 staining to that 





Figure 2.11.  rsly1 must bind stoichiometrically to a fillable membrane site 
to function in ER to Golgi transport.  A,  Endoglycosidase H analysis of VSVG 
ts045 protein in permeabilized NRK cells after transport incubations containing 
the indicated concentrations of the indicated control (mouse, rabbit) or immune 
(α-rsly1, 18C8) Fab fragments.  Endo H-resistant (HR) and –sensitive (HS)  bands 
are indicated (arrows).  Control reactions lacking any Fabs are shown above.  B,  
Quantitation of the experiment from part A (main axis) and also a separate 
experiment (histogram) in which a partially inhibitory concentration of α-rsly1 
intact IgG was tested in the absence (left bar) or presence (right bar) of excess 
purified GST and rsly1.  C,  Permeabilized NRK cells were either preincubated 
on ice with or without anti-rsly1 antibodies (bars 5-9) or else incubated at 32 °C 
immediately (bars 2-4) with regular transport cocktail (reg.) or cocktail 
supplemented with a 100-fold excess of soluble purified recombinant rsly1 (rec. 
rsly1) or a 10-fold excess of partially purified native liver rsly1 (liv. rsly1).  The 
preincubated cells (bars 5-9) were subsequently washed twice and resuspended 
in regular transport cocktail (reg.) or cocktail supplemented with α-rsly1 
antibodies (+Ab) or excess rsly1-containing cocktails (rec. rsly1 & liv. rsly1).  VSV 
G transport was quantified after 90 minutes at 32 °C as in part B.  Plotted values 
are means of duplicate reactions plus or minus standard error.  D,  Immunoblots 
demonstrating the quantity of rsly1 present in washed, permeabilized NRK cells 
used for transport, the normal rat liver cytosol used for transport, and the 
indicated dilutions of the purified recombinant and partially purified cytosolic rsly1 
















Figure 2.12.  Syntaxin 5 binding is essential for rsly1 function in ER to 
Golgi transport.  A,  VSVG transport was monitored in the presence of the 
indicated concentrations of GST (filled circles) or thrombin-cleaved GST-syntaxin 
5 (1-43) (open circles).  B,  Transport was monitored under control conditions 
(open bars) or in the presence of the indicated concentrations of synthetic 
peptides corresponding to syntaxin 5 amino acids 1-27 (UM-1, solid bars) or the 
same peptide containing T7A and F10A mutations (UM-2, gray bars).  Plotted are 






Figure 2.13.  Schematic of possible mechanisms of action of SM proteins in 
the SNARE cycle and membrane fusion.  Known or hypothetical steps in the 
SNARE cycle are represented with black arrows.  Potential SM protein roles that 
are consistent with our data are indicated with red arrows and roles that are 
inconsistent or less consistent with our data are indicated with gray arrows.  
Potential SM protein roles are grouped for illustration purposes into Opener 
Roles  (A), and Late Stage Roles (B).  The opener roles are inconsistent with our 
staining experiments (e.g. Figures 9 and 10), since they would predict a 
decrease in available syntaxin 5 SNARE motif when syntaxin 5/rsly1 interactions 
were blocked, and an increase when rsly1 was overexpressed.  Among the 
potential late-stage roles, a role in promotion of fusion pore expansion or other 
lipidic events is less consistent with our data than the other illustrated roles, since 
they would not necessarily require syntaxin 5/rsly1 interactions, whereas our 
transport experiments (Figures 11 and 12) demonstrated this requirement for 
rsly1 function.  The role indicated by “multi-complex organization” is not explicitly 
illustrated since very little is known about what this may entail; one suggestion 
would be arrangement of multiple SNARE complexes around a central fusion 
site.  We illustrate only potentially required, positive roles.  Negative roles such 
as stabilization of closed syntaxin would not predict the strict requirement for 
rsly1 in ER/Golgi transport (Figure 11).  Note that rsly1 could potentially perform 
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A few peroxisomal matrix enzymes contain a PTS2 nonapeptide sequence 
with the consensus R-(L/V/I/Q)-X5-(H/Q)-(L/A), located within the amino terminus 
of the protein. In plants and mammals, these enzymes are imported as precursor 
proteins that are processed to their mature forms subsequent to matrix entry. 
Bioinformatic analysis of the Arabidopsis genome revealed nine candidate 
proteases predicted to be in peroxisomes; among them was a 76 kDa DEG 
protease. Seeds from plants with a T-DNA insertion in AtDEG15, the Deg15 
protease homolog in Arabidopsis (At1g28320), required sucrose for germination. 
Western blot analysis of whole plant extracts from these atdeg15 knockout 
mutants reveals that only the unprocessed precursor form of the PTS2 protein 
thiolase (THL) was present. In vitro peroxisome import assays show that 
AtDEG15 imported into the peroxisome matrix. Purified recombinant AtDEG15 
specifically processed the PTS2 proteins THL and aspartate aminotransferase 3 
(ASP3) in vitro; the PTS1 proteins glycolate oxidase (GLO) and isocitrate lyase 
(IL) were not cleaved. In plants and mammals, a cysteine located downstream of 
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PTS2 sequences is required for processing of precursor forms of all PTS2 
proteins identified so far. An engineered mutation to glycine prevented AtDEG15-
mediated cleavage of THL, although its in vitro import was not impeded. 
Moreover, mutations of the PTS2 signal that resulted in decreased import of THL 
and ASP3 did not prevent the proteolytic processing of their precursor forms by 
AtDEG15. Taken together, these results indicate that AtDEG15 is a novel, PTS2-





 Though the mechanisms of PTS2 protein import appear to be conserved 
among most species, one difference concerns the fate of PTS2 proteins following 
import into the matrix of peroxisomes in plants and mammals. In these 
eukaryotes, the PTS2 import signal is cleaved off subsequent to matrix protein 
import (11, 12, 15, 18, 20, 31, 33, 41). A completely conserved cysteine residue 
35 to 45 amino acids downstream of the PTS2 has been suggested for the 
cleavage site of PTS2-containing precursor proteins (11, 12, 15, 18) (Table 1).  
 Although many attempts have been made to establish its identity, little is 
known about the enzyme responsible for PTS2 processing. Likely candidates 
must fulfill certain criteria: 1) since PTS1 import defects result in a lack of 
processing of PTS2 proteins and mutations that result in a lack of PTS2 import 
result in the accumulation of precursor protein in the cytosol, potential proteases 
must possess a PTS1 signal for peroxisome matrix localization (2, 15); 2) 
because yeast do not have proteolytically processed PTS2 proteins, potential 
candidates are not expected to have functional homologs in yeast (28); and 3) 
finally, the candidate protein must contain a proteolytic domain within its amino 
acid structure.  
 An insulin-degrading enzyme of the metalloproteinase family was localized 
to peroxisomes in mammalian fibroblasts cells (1). Although this protease, 
renamed PP110 for peroxisomal protease of 110kDa, was capable of degrading 
a synthetic presequence of thiolase, it failed to process full-length thiolase in vitro 
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(1).  In plants, a 35kDa cysteine endopeptidase was isolated from the 
glyoxysomes of germinating castor bean endosperm via its capacity to 
specifically process the precursor form of the PTS2 protein malate 
dehydrogenase in vivo; the same endopetidase was unable to cleave thiolase at 
the proper processing site in vitro (9). Moreover, the castor bean protease was 
not peroxisomally localized, but rather it was localized to ricinosomes, which are 
ER-derived organelles that develop in senescing endosperm cells of plants, 
concomitant with nuclear DNA fragmentation (10). An ATP-dependent Lon 
protease, distinct from the mitochondrial isoform, was identified in rat liver 
peroxisomes (19). Like its bacterial and mitochondrial homologs, however, this 
protease is likely to function as a chaperone, degrading unfolded proteins (19).  
 Recently, more promising candidates for processing the PTS2-containing 
propeptide have been recognized. A novel PTS1-targeted protein called Tysnd1 
(trypsin-domain-containing protein 1) was identified in mammalian peroxisomes. 
This protein was demonstrated to be responsible for both the removal of PTS2-
containing leader peptide from prethiolase and for processing of PTS1 proteins 
involved in the peroxisomal β-oxidation pathway of fatty acids in mammals (20). 
Using a cell-based assay, these authors show that Tysnd1 overexpression led to 
the in vitro processing of the peroxisomal enzymes to fragments identical to the 
sizes described for their endogenous forms (20). Moreover, Tysnd1 itself is 
reported to undergo processing in a cysteine-dependent manner similar to its 
substrates, perhaps as an auto-activating mechanism (20). 
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 The plant Tysnd1 homolog belongs to a group of ATP-independent 
trypsin-like serine proteases (12). This protease, referred to as Deg15, has been 
partially purified from the fat-storing cotyledons of watermelon (Citrullus vulgaris) 
and examined for its ability to act as a glyoxysomal processing protease (GPP) 
(12). In watermelon, Deg15 functions in two forms, a 72 kDa monomer and a 144 
kDa dimer, whose equilibrium can be shifted in the presence of Ca2+ in favor of 
the dimeric GPP/Deg15 form, reportedly responsible for cleavage of the PTS2 
presequence of malate dehydrogenase at the proper, cysteine-containing 
location (12). The monomer, on the other hand, acts as a general peptidase that 
cleaves denatured peroxisome matrix proteins (12).  
 In Arabidopsis, a knockout mutation in DEG15 prevents processing of 
glyoxysomal malate dehydrogenase (gMDH) to its mature form (12). Although 
the presence of unprocessed malate dehydrogenase in deg15 mutants provides 
evidence that DEG15 may be the PTS2-processing protease in plants, its 
peroxisomal localization and specific cleavage of PTS2 proteins in vitro have not 
yet been experimentally defined. 
 Using RT-PCR we isolated and cloned DEG15 (At1g28320) from wild-type 
Arabidopsis plants. Only the unprocessed, precursor form of the PTS2 protein 
thiolase (THL) was present in atdeg15 knockout mutants, consistent with the lack 
of processing of malate dehydrogenase previously described (12). Our results 
from in vitro peroxisome import, protease assays and mutagenic analysis 
indicate that AtDEG15 is a peroxisomal protease that specifically processes 
PTS2 proteins in Arabidopsis. 
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MATERIALS AND METHODS 
 
DNA constructs. Plasmids containing the full-length cDNA inserts for isocitrate 
lyase (IL) from Brassica napus, spinach (Spinacia oleracea) glycolate oxidase 
(GLO), and thiolase (THL) from Arabidopsis were previously described (3, 4, 14). 
The plasmid (pASP3) containing the full-length cDNA insert coding for aspartate 
aminotransferase 3, in the pZL1 expression vector, was obtained from the 
Arabidopsis Biological Resource Center at Ohio State University (Columbus; 
EST stock 136A4T7; GenBank accession no. P46644; Arabidopsis Genome 
Initiative locus At5g11520). Mutants for THL and ASP3 constructs in the pZL1 
expression vector were obtained using the Site-Directed Mutagenesis (SDM) kit 
(Statagene); mutations and primers are shown in Table 2.  
 To obtain the full-length cDNA of AtDEG15 (At1g28320), the cDNA 
product from RT-PCR using RNA extracted from the leaves of wild-type plants 
was cloned into the in vitro expression vector pCRII-TOPO (Invitrogen). 
Additionallly, a bacterial expression construct encoding an amino-terminal 
maltose binding protein (MBP) fused to AtDEG15 was prepared by subcloning 
the full-length AtDEG15 gene into the pMalC2 vector (New England Biolabs).  
Transformants were screened by PCR amplification using AtDEG15 gene-
specific primers (forward: 5’ GTC GAC ATG GAT GTG TCT AAA GTT GTC 3’ 
and reverse: 5’ CTC GAG GGC ACA AAT TAT GCA AAG AAG 3’) and a primer 
specific to the MalE gene located within the vector pMalC2 (5’ GCG GTC GTC 
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AGA CTG TCG ATG AAG CC 3’). DNA sequencing confirmed all DNA 
constructs. 
 
Protein expression and purification. To synthesize radiolabeled GLO, IL, THL, 
ASP3, and AtDEG15 proteins all DNA templates were linearized with an 
appropriate restriction enzyme such that a single cleavage occurred 3' (RNA 
sense) to the coding region to be transcribed/translated (GLO, HindIII; IL, SphI; 
THL and ASP3, NotI or XbaI; AtDEG15, SacI). Transcription of the linearized 
DNA with SP6 RNA polymerase for pGLO and IL, T7 RNA polymerase for all 
others, was performed as described previously (24, 32). Radiolabeled proteins 
were synthesized in a cell-free wheat germ lysate system in the presence of 
[35S]- L- methionine, (specific activity 43.3 TBq/mmol) purchased from MP 
Biomedicals, Inc. (Irvine, CA). The efficiency of translation was assessed by 
trichloroacetic acid precipitation onto glass fiber filters, followed by ethanol 
washes and quantitation in a liquid scintillation counter (model LS 6800, 
Beckman Coulter, Fullerton, CA). Radiolabeled THL and ASP3 were synthesized 
in their full-length precursor protein forms.  
 Full-length MBP-AtDEG15 was expressed in E. coli BL21 induced with 
isopropyl β-D-1-thiogalactopyranoside (IPTG) to a final concentration of 0.3 mM 
at 37°C for 4 hours. MBP-AtDEG15 was purified by affinity chromatography on 
amylose resin as described in the manufacturer’s instructions (New England 
Biolabs). Following purification, protein concentration was determined by the 
Bradford protein assay (BioRad).  Purified recombinant MBP-AtDEG15 was 
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resolved by 10% SDS-PAGE and assayed by Western blotting with anti-MBP 
(New England Biolabs) and anti-SKL antibodies (see below).  
 
Isolation of pumpkin glyoxysomes. Pumpkin seeds (Cucurbita pepo var 
Connecticut Fields) purchased from Siegers Seed Co. (Zeeland, MI) seedlings 
were grown in moist vermiculite for 5 to 7 days in the dark at 25°C. 
Approximately 25-40 g cotyledons were harvested manually in dim light and 
glyoxysomes were isolated by slight modification of the procedure described 
previously (3). Initial homogenization occurred with three 3-second bursts using a 
Waring blender. Filtration was performed through one layer of Miracloth 
(Calbiochem). The final glyoxysomal pellet was resuspended in isolation buffer to 
a final concentration of 20 mg/ml total protein. 
 
In vitro import assays. Standard in vitro import reactions were initiated by the 
addition of 200 µg glyoxysomes to 500,000 cpm trichloroacetic-acid-precipitable, 
radiolabeled protein in the presence of import buffer (25 mm MES-KOH, pH 6, 
500 mM sucrose, 10 mM KCl, 1 mM MgCl2 and 5 mM MgATP) in a final volume 
of 200 µl. All import reactions were performed at 26°C for 1 hour unless 
otherwise noted. Following incubation, the import reactions were treated with 
thermolysin (freshly dissolved in import buffer containing 5 mM CaCl2) using the 
following concentrations: GLO, 100 µg/ml; THL, 250 µg/ml; ASP3, 500 µg/ml; 
DEG15 100 µg/ml, to completely digest proteins that were not imported. Protease 
treatments were incubated for 30 min. on ice; reactions were stopped by the 
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addition of EDTA (25 mM final concentration) to inhibit the thermolysin. After 
protease treatment, the glyoxysomes were repurified on a 0.7 M sucrose 
cushion, solubilized in 1X (Laemmli) sample buffer, subjected to 10% SDS-PAGE 
and visualized by autoradiography after 12-16 hour overnight exposure at -70°C. 
Some samples (indicated in the figures) were incubated at either 4°C or -20°C 
during import to provide negative import controls. Note that the protein from 
these samples was fully digested after treatment with thermolysin and no longer 
detectable subsequent to repurification of glyoxysomes on sucrose. Each of the 
proteins used in these experiments contain roughly the same number of 
methionine residues (GLO, 13 Met residues; precursor THL and ASP3, as well 
as all associated SDM mutants have 12 Met residues). Therefore, equal counts 
of radioactive protein represent nearly equal amounts of protein presented for 
import. 
 
Genotypic analysis.  Seeds for the T-DNA insertion line Salk_007184, with a 
potential mutation in AtDEG15, were purchased from the Arabidopsis Biological 
Resource Center at Ohio State University. Seedlings were germinated on 
Murashige-Skoog media (Sigma-Aldrich) supplemented with 1% sucrose under 
16-hour light/ 8-hour dark conditions at 22°C. DNA was extracted from the leaves 
of 2-week old seedlings. Leaf tissue was homogenized (200 mM Tris-HCl, pH 
7.5, 250 mM NaCl, 25 mM EDTA and 0.5% SDS), vortexed, and immediately 
placed on ice. Following centrifugation in a microcentrifuge at maximum speed 
for 5 min., the supernatant was transferred to fresh tubes and the DNA was 
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precipitated with an equal volume of isopropanol for 2 min. at room temperature. 
The resulting DNA pellet was washed in 70% ethanol, air-dried and dissolved in 
15-20 µl glass-distilled water. T-DNA insertions were detected by PCR with gene-
specific primers (forward- 5’ CGC TAG TGT AGC CAT AAT TCA CCT G 3’; 
reverse- 5’ TGC GTA TTC TTT TCA GGG TCA GC 3’) and the LBc1 primer (5’ 
GCC GAT TTC GGA AGG AGG ATC 3’) using conditions of 52°C annealing for 
30 seconds and 1 minute 72°C extension for 25 cycles.  
 At 4 weeks, plants were transferred to fertilized soil and maintained under 
16-hour light/ 8-hour dark conditions at 22°C for subsequent phenotypic analysis. 
 
RT-PCR. Total RNA was extracted from the leaves of 2-week old wild-type and 
deg15 mutant seedlings using the RNeasy Plant Mini kit (Qiagen) with column 
DNase I digestion, according to the manufacturer’s directions. RNA was eluted 
with 30µl RNase-free water and quantitated by spectrophotometry at 260 nm. 
RT-PCR was performed using the Access RT-PCR System (Promega); PCR 
conditions of 52°C annealing for 30 seconds and 2.5 minute 72°C extension for 
30 cycles.  Each RT-PCR reaction contained 150 ng of RNA template and 100 
ng each of either AtDEG15 gene-specific primers (forward: 5’ GTC GAC ATG 
GAT GTG TCT AAA GTT GTC 3’ and reverse: 5’ CTC GAG GGC ACA AAT TAT 
GCA AAG AAG 3’), or β-tubulin gene-specific primers (forward: 5’ ATA CAG AAC 
AAG AAC TCG TCT TAC 3’ and reverse: 5’ CTC TTC TTC TTC AAC ATC ATA 




Western blot analysis. Whole plant extracts were prepared from 2-week old 
wild-type, atlon2-3 and deg15 seedlings by homogenization in 2X (Laemmli) 
sample buffer using 200 µl/100 µg plant tissue and boiled for 5 min. at 100°C. 
The extract (0.5 µg) was separated by 10% SDS-PAGE and blotted onto an 
Immobilon-P PVDF membrane (Millipore). The blot was probed with plant anti-
THL (PED1) polyclonal antibodies to detect the presence of precursor and 
mature forms of thiolase. Secondary antibody detection was performed with goat 
anti-rabbit IgG secondary antibody conjugated to horseradish peroxidase 
(BioRad). 
 
In vitro protease assays. Purified recombinant MBP-AtDEG15 or thermolysin 
(in 5 mM CaCl2) was added in excess of 10X the amount of radiolabeled 
substrate (GLO, THL, ASP3, and all SDM mutants) in 50 mM Hepes, pH 8.0, 115 
mM NaCl and 0.2 mM DTT at 37°C for 4 hours. Reactions were stopped by the 
addition of an equal volume of 2X (Laemmli) sample buffer, followed by boiling 
for 5 min. at 100°C. 10µl of each reaction product was separated by 10% SDS-
PAGE and visualized by autoradiography following 12-16 overnight exposure at -
70°C. The concentration of each radiolabelled protein used in these experiments 
was based on a calculation that considered the following: counts of radioactivity 
(in cpm) present in each in vitro translation reaction, divided by the specific 
activity of 35S/ molecule of methionine (in cpm), divided by the number of 
molecules of methionine present in each molecule of protein, divided by the 
specific number of molecules found in a mole of protein (6.02 x 1023 molecules), 
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multiplied by the molecular weight of each protein (in g/mole).  For example, if 
protein A has 10 methionines, 5 x 105cpm/µl, and a molecular weight of 
50000g/mole, then it’s concentration would be determined as follows: (5 x 
104cpm/µl) X (1 met/4.33x10-7cpm) X 1 molecule protein/10 met) X (1 mole/6.02 
x 1023) X (50000g/mole)= 959 x 10-12g/µl = .959ng/µl 
 
Other reagents. Seeds for the T-DNA insertion line Salk_043857, with a 
potential mutation in the protease AtLON2, were purchased from the Arabidopsis 
Biological Resource Center at Ohio State University. T-DNA insertion mutants 
(atlon2-3) were identified by PCR amplification of DNA extracted from the leaves 
of germinated seedlings and confirmed by sequencing (Johnson and Olsen, 
unpublished data, not shown). Anti-THL (PED1) crude serum was a kind gift of 
Dr. Bonnie Bartel (Rice University, Houston Texas). The antibody was raised in 
rabbit against a fusion protein produced in pGEX-4T that included the carboxyl 
terminal 350 amino acid residues of AtTHL. Dr. Stanley R. Terlecky (Wayne 
State University, Detroit Michigan) generously donated the anti-SKL antiserum 
used to detect purified recombinant AtDEG15. For Western blots, anti-PED1 and 
anti-SKL antibodies were used at a 1:10,000 dilution in 1X phosphate-buffered 
saline (PBS) containing 0.05% Tween-20 and 5% nonfat dry milk (PBST). Anti-
MBP was purchased from New England Biolabs (Ipswich, MA) and diluted 1: 
75,000 in PBST for immunoblot analysis. Goat anti-rabbit IgG secondary 
antibody conjugated to horseradish peroxidase was purchased from BioRad 





AtDEG15 imports into the isolated glyoxysomes of pumpkins (Cucurbita 
pepo) in vitro. Using RT-PCR we isolated and cloned DEG15 from Arabidopsis. 
In vitro transcription, followed by in vitro translation of [35S]-radiolabeled protein 
resulted in a 70kDa protein product (Figure 1A, left). Western blot analysis using 
an anti-SKL antibody immunologically recognized the 70 kDa band (Figure 1A, 
right).  
 To confirm the peroxisome localization of AtDEG15, suggested by the 
PTS1 sequence, –SKL, present at its carboxyl terminus, in vitro peroxisomal 
protein import assays were performed using glyoxysomes isolated from pumpkin 
cotyledons and protease resistance as the hallmark of protein import into 
glyoxysomes (i.e. proteins protected by the glyoxysomal membrane are not 
degraded by subsequent protease digestion). In each import experiment, all 
protease-protected protein was considered as imported. The results of a typical 
import experiment are shown in Figure 1B. The pattern of AtDEG15 import into 
peroxisomes was similar to that of the control peroxisomal protein glycolate 
oxidase (GLO), a PTS1 photorespiration enzyme whose import has been 
previously characterized (Brickner et al., 1997; Brickner and Olsen, 1998). Lane 
1 represents all protein bound to the membrane or imported into the organelle. 
Protease was added to the samples shown in lane 2 to degrade proteins not 
protected by the peroxisome membrane, leaving only protease-protected, 
imported proteins. The import reaction was also performed at 4°C (lane 3) to 
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demonstrate that under conditions not conducive to import, the amount of 
protease added to the samples is enough to completely degrade unprotected, not 
imported, protein. From these results it is clear that AtDEG15 imports into 
peroxisomes (Figure 1).  
 
Thiolase (THL) is not processed in deg15 knockout mutants in Arabidopsis. 
To assess the physiological role of AtDEG15, a T-DNA insertion mutant line was 
purchased from the ABRC stock center: Salk_007184. Genotypic analysis of 
plants revealed a DNA product consistent with a T-DNA insertion in the fourth 
intron of AtDEG15 (At1g28320). PCR amplification of genomic DNA extracted 
from the leaves of two-week-old mutant plants with either gene-specific left or 
right primers and the T-DNA specific primer yielded 600 bp and 800 bp products 
(Figure 2A, panel 2), whereas PCR analysis of genomic DNA extracted from the 
wild-type tissue resulted in a single product of 1000bp (Figure 2A, panel 1). RT-
PCR confirmed that AtDEG15 was not expressed in these mutants (Figure 2B, 
lane 4). Immunoblot analysis performed with anti-THL antibodies revealed that 
THL was not processed to its mature form in these atdeg15 knockout plants 
(Figure 2C). Interestingly, these seeds appear to have sucrose-dependent 
germination; only 25% of mutant seedlings planted on sucrose germinated as 
compared to the 94% wild-type seedlings germinated at the same time and under 
the same conditions (Figure 3). By 4-8 weeks, no detectable differences between 




AtDEG15 directly processes thiolase in vitro. Full-length MBP- AtDEG15 was 
expressed in E. coli. Purified recombinant MBP-AtDEG15 was resolved by 10% 
SDS-PAGE and assayed by Western blotting with anti-MBP and anti-SKL 
antibodies. A 119 kDa band was detected with both antibodies, consistent with 
the calculated size expected for an amino-terminal tagged MBP-AtDEG15 fusion 
protein product (Figure 4A). To assess the in vitro proteolytic activity of AtDEG15 
with PTS2 proteins, purified, recombinant MBP- AtDEG15 was incubated with the 
radiolabeled substrates GLO (PTS1), IL (PTS1), and precursor THL (PTS2). 
Upon incubation with AtDEG15, THL was proteolytically cleaved, as evidenced 
by the appearance of a distinct lower molecular weight band migrating at 47kDa, 
the size reported for the endogenous mature form found in Arabidopsis (Figure 
4B, THL panel, lane 3). AtDEG15 showed no proteolytic activity when incubated 
with the PTS1 proteins GLO and IL (Figure 4B, GLO and IL panels, lane 3). Total 
proteolytic digestion was obtained when incubating each protein in the presence 
of the nonspecific metalloproteinase thermolysin (Figure 4B, lane 4).  
 In vivo processing of precursor PTS2 proteins occurs at a conserved 
cysteine residue located at the carboxyl terminal end of their presequences 
(Table 1).  Site-directed mutagenesis studies indicate that changing this 
conserved residue to glycine or phenylalanine results in the inhibition of 
processing of chimeric proteins, possessing the amino-terminal presequence of 
glyoxysomal citrate synthase (gCS) fused to β-glucuronidase (GUS), subsequent 
to their import into microbodies in transgenic plants (15, 16, 18). To test the 
importance of this conserved cysteine residue for AtDEG15 specific cleavage of 
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thiolase, site-directed mutagenesis was performed to change the cysteine (C34), 
located 19 amino acids downstream of the PTS2 sequence, to glycine. As a 
direct result of this mutation, proteolytic processing of thiolase by AtDEG15 in 
vitro was hindered (Figure 4B, bottom panel lane 3). These results suggest that 
AtDEG15 is the processing protease for THL in Arabidopsis.  
 
Aspartate Aminotransferase 3 (ASP3) is a PTS2 dependent peroxisome 
matrix enzyme that is processed by AtDEG15 in vitro. Aspartate 
aminotransferase (EC 2.6.1.1; AspAT) catalyzes the reversible reaction: 
aspartate + α-ketoglutarate  oxaloacetate + glutamate. In plants, AspAT 
exists as multiple isozymes localized to different subcellular compartments. For 
example, in maize and cucumber (13, 23, 38), specific AspAT isozymes have 
been associated with the mitochondrion, chloroplast, glyoxysome and cytosol.  In 
Arabidopsis, 5 AspAT isozymes have been identified that are targeted to different 
subcellular compartments (Figure 5A): ASP1 (mitochondrial), ASP2 and ASP4 
(cytosolic), ASP5 (chloroplastic). ASP3 is predicted to encode either a plastid or 
peroxisomal enzyme based on analysis of its putative transit peptide sequences 
(5).  Analysis of the amino terminus of ASP3 reveals an obvious nonapeptide 
sequence, -RIGALLRHL- (Figure 5B), consistent with that of PTS2 sequences 
currently identified in plants (36). To investigate the import of ASP3 into 
peroxisomes, in vitro import assays were performed. The results indicate that 
ASP3 imports into peroxisomes in a manner similar to the previously 
characterized PTS2 protein THL (14) (Figure 5C). Radiolabeled ASP3 becomes 
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protease-protected after incubation with isolated pumpkin glyoxysomes and 
subsequent protease treatment (Figure 5C, bottom panel lane 2).  In our import 
experiments, there was not always an observed distinction between precursor 
and processed forms of imported PTS2 proteins although this difference is clear, 
at least for thiolase, in the representative gel of the import shown here. This is 
possibly because processing of PTS2 proteins can occur at any time after import 
and although there is much evidence that the processing of PTS2 proteins 
occurs in vivo, the temporal sequence of proteolytic cleavage and intracellular 
import has yet to be determined.  
 In plants, the first three of the four residues of the original PTS2 
nonapeptide consensus sequence are highly conserved; positions 1, 8 and 9 are 
R, H, and L, respectively (36). To determine whether the putative PTS2 signal for 
ASP3 is functional, the R in the first position of the nonapeptide was changed to 
an A using site-directed mutagenesis. As a control for PTS2-dependent import, 
the R in the first position in the PST2 sequence of THL was also mutated to an A. 
These mutations resulted in loss of import for both THL and ASP3 (Figure 5C, 
bottom panel, lane 5), indicating that ASP3 is a PTS2-dependent peroxisome 
matrix enzyme.  
 The amino acid sequence of ASP3 does not contain a conserved cysteine 
residue near the carboxyl terminus of its PTS2 presequence (Figure 5B). Since 
this is the first time, to our knowledge, that ASP3 peroxisomal import has been 
characterized, it remains to be determined whether ASP3 is cleaved following 
import. While we have observed protease-protected ASP3 migrating at a lower 
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molecular weight in our in vitro assays (data not shown), we cannot conclude that 
this shift in mobility is necessarily due to a processing event because the 
observation of precursor and processed forms of imported PTS2 proteins in our 
in vitro assays remains unpredictable (14). To address the question of whether 
ASP3 is processed, we examined the proteolytic activity AtDEG15 in the context 
of its ability to cleave ASP3 in vitro. Incubation of purified recombinant MBP- 
AtDEG15 resulted in the cleavage of ASP3. Visualization of the cleavage product 
by autoradiography revealed a lower molecular weight band, migrating at 43kDa, 
after direct incubation with AtDEG15 (Figure 5D, WT panel, lane 2).  
 To investigate the specificity of the AtDEG15 cleavage recognition site in 
ASP3, site-directed mutagenesis was used to create three different mutagenic 
constructs in the pZL1 expression vector containing the full-length cDNA for 
ASP3: S41 to G41, S47 to G47, and C148 to G148. Each of the three mutations 
represented potential sites for the cleavage of precursor ASP3 into its mature 
form (Figure 5D). Subsequent to incubation with purified recombinant MBP- 
AtDEG15, all of the potential cleavage site mutants were processed in vitro 
(Figure 5D, lanes 4,6, and 8). Although it is clear from our results that ASP3 was 
processed to its mature form, this AtDEG15-mediated cleavage does not occur at 
any of the cleavage sites we predicted.  
 
In vitro AtDEG15-mediated processing of PTS2 proteins occurs 
independently from their targeting to glyoxysomes. To investigate the extent 
to which the PTS2 sequence plays a role in the recognition and subsequent 
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cleavage of PTS2 proteins by AtDEG15, the loss-of-import R-to-A variants from 
THL and ASP3 were each incubated with purified recombinant AtDEG15. Figure 
6 shows that AtDEG15 is capable of processing these variants equally as well as 
their import competent partners. As expected, the cleavage mutants of both THL 
and ASP3 show import competency when assayed in our in vitro import system 
(data not shown). These results indicate that AtDEG15 processing of PTS2 







 Proteins are targeted to the peroxisome by a PTS2 less frequently than by 
its predominant counterpart, the PTS1.  Plant PTS2-containing proteins account 
for about 10% of all proteins targeted to the peroxisome matrix (36). In plants and 
mammals, PTS2 proteins are synthesized and imported as precursors with larger 
molecular weight masses than those of the mature proteins (11, 12, 17, 18, 20, 
21, 31, 33, 41).  
 Using RT-PCR, we isolated a 76kDa peroxisomal member of the DegP 
protease family in Arabidopsis, AtDEG15 (At1g28320), which directly processed 
PTS2 proteins in vitro. In addition to a trypsin-like serine protease domain, 
AtDEG15 contains a clearly defined, extreme carboxyl terminal PTS1 sequence, 
SKL, and was imported to glyoxysomes in vitro (Figure 1). AtDEG15 is involved 
in specifically processing PTS2 proteins. Consistent with previously published 
evidence concerning the processing of the PTS2 protein gMDH (12, 20), a 
knockout mutation resulting in the lack of expression of AtDEG15 also prevents 
processing of the classic PTS2-containing protein thiolase to its mature form 
(Figure 2). In addition, we demonstrate direct proteolytic activity in vitro, where 
incubation of recombinant purified AtDEG15 with thiolase resulted in the direct 
processing of this enzyme to a lower molecular weight consistent with the size 
reported for its endogenous, mature form (Figure 3). Furthermore, this AtDEG15-
mediated processing of thiolase was dependent on the cysteine residue located 
at amino acid position 34, immediately downstream of its PTS2; the exact 
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processing site for reported thiolase in Arabidopsis (16). Our results are partially 
consistent with those reported for the AtDEG15 mammalian homolog, Tysnd1 
(20). These authors demonstrated that Tysnd1 was directly responsible for both 
the cysteine-dependent removal of the PTS2-containing leader peptide from 
prethiolase and for specific processing of all PTS1 proteins involved in the 
peroxisomal β-oxidation pathway of fatty acids in mammals (20).  
 The third isozyme of aspartate aminotransferase (ASP3) was shown to be 
a bona fide PTS2-dependent peroxisome enzyme in Arabidopsis (Figure 5C). 
AtDEG15 was also able to process ASP3 to a lower molecular weight form 
(Figure 5D) although the identity of the precise cleavage recognition site in ASP3 
has yet to be determined. An alignment of the 5 aspartate aminotransferase 
(ASPAT) isozymes identified in Arabidopsis, specifically focusing on those that 
are targeted to organelles, reveals a 65% sequence conservation in the region 
downstream of the known amino-terminal presequence cleavage sites for 
ASPATs targeted to the chloroplast (ASP5) and mitochondria (ASP1) (Figure 7). 
In addition, alignment of this same region amongst the ASP3 homologs found in 
Arabidopsis, rice, and soybean shows 97% sequence conservation (Figure 8). 
Therefore, it is reasonable to predict that the AtDEG15 cleavage recognition site 
is probably located within the seventeen amino acid residues immediately 
downstream of the PTS2 sequence because elimination of these non-conserved 
amino acids would likely not change any conserved domain structure between 
the ASPATs that also possibly contribute to conserved function.  
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  The physiological relevance of processing of PTS2-containing proteins in 
the peroxisomes of plants and mammals is not yet understood. One theory is that 
processing is a necessary mechanism for the activation of PTS2 enzymes within 
the matrix of peroxisomes. Indeed, in this study, we observed that AtDEG15 
knockout mutants in Arabidopsis have a sucrose-dependent germination 
phenotype (Figure 3), similar to other PTS2 import defective mutants (43). 
Whereas the latter phenotype is due to an import deficiency that results in a lack 
of resident PTS2 proteins in the matrix, the former would imply a lack of enzyme 
function, since it is clear that PTS2 import is normal in atdeg15 knockout 
mutants. However, recombinant proteins from both the full-length cDNA of the 
glyoxysomal thiolase from Brassica napus and the truncated version, lacking the 
amino-terminal targeting signal, have comparable activity when expressed in E. 
coli (30). Also, processing events are not present in yeast, yet yeast PTS2 
proteins are fully functional. Therefore, it is likely that PTS2 enzyme function is 
not a consequence of processing.  
 PTS2 protein import is characterized by the binding of the PTS2 sequence 
to the PTS2 receptor PEX7, which facilitates PTS2 protein entry and 
translocation into the peroxisome matrix followed by the recycling of the import 
receptor back out into the cytosol for further rounds of PTS2 import (21, 29). 
Although PEX7 function requires the assistance of several species-specific 
auxiliary proteins (21, 25, 34, 35, 39, 40, 42, 43), PEX7 binding alone is essential 
for PTS2 recognition and delivery of proteins into the peroxisome matrix. 
Perhaps, the subsequent processing of PTS2 presequences could aid in the 
 
 151 
dissociation of PEX7 from its cargo on the matrix side of the peroxisome 
membrane to liberate PEX7 for recycling. A caveat to this theory comes from 
PTS2 import in yeast: evidence of recycling of PEX7 is reported within these 
species (6), although no apparent PTS2 protein processing mechanism exists.   
 One final consideration for the physiological relevance of PTS2 protein 
processing concerns the preservation of evolutionarily conserved roles for 
proteins that have evolved to require different modes of import. Both targeting 
pathways have been identified in highly divergent eukaryotes - from 
trypanosomes, to yeasts, plants and mammals. Surprisingly, not all peroxisome 
enzymes have maintained the same mechanism of targeting throughout 
evolution. In fact, examination of the same peroxisomal proteins from species to 
species shows evidence for target signal switching of PTS1 and PTS2 proteins 
(27). For example, plant PTS2 proteins malate dehydrogenase and citrate 
synthase have clearly defined, experimentally validated PTS1s in S. cerevisiae 
(22, 26). Likewise, acyl-CoA-oxidase is targeted to the peroxisome by a PTS1 
signal in both P. pastoris and mammals, but it is a PTS2 protein in plants (7). The 
most dramatic example of target switching lies within the species C. elegans. 
Orthologs of proteins required in the PTS2 import pathway are absent from the 
genome of C. elegans (27). In fact, the entire PTS2 targeting pathway is absent 
in this species (27). Not surprising, every PTS2-containing protein found in other 
species has PTS1-containing homologs in C. elegans. In light of target switching, 
it is reasonable to propose that PTS2 protein processing could serve as a 
mechanism to maintain identical enzyme-substrate interactions and multiple 
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enzyme complex formations responsible for mediating the same functions 
regardless of the position of the signal sequence from species to species. As a 
result of cleavage, PTS2 proteins from one species would maintain the same 
contact surfaces at their amino terminus as their PTS1 orthologs present in other 
species.  
 Regardless of the hypothesized physiological role of processing for PTS2-
containing peroxisome matrix proteins in plants and mammals, the first step 
towards understanding its purpose comes from identifying and characterizing the 
protein responsible. In this study we have cloned, purified, and examined the 
direct PTS2-specific proteolytic activity of AtDEG15 in Arabidopsis. Our studies 





 Subsequent to our initial identification and characterization of AtDEG15 as 
the PTS2 processing protease, is a full examination of the factors that influence 
this cleavage. First, a conserved cysteine residue 35 to 45 amino acids 
downstream of the PTS2 has been suggested for the cleavage site of PTS2-
containing precursor proteins (11, 12, 15, 18). But what other factors does 
AtDEG15 require that determines the protein-protein interaction required for 
recognition and specific cleavage of PTS2-containing precursor proteins? Using 
deletion constructs, mutagenic analyses, and protease assays, the functional 
organization of both AtDEG15 and the amino terminus of PTS2-containing 
proteins can be elucidated.  
 Second, the watermelon homolog of AtDEG15 was partially purified and 
identified as a glyoxysomal processing protease (GPP) (12). Consistent with our 
findings, these authors also attribute the specific cleavage of PTS2-carrying 
proteins to this DegP protease. However, in watermelon, DegP15 is proposed to 
function in two forms, a 72kDa monomer and a 114kDa dimer whose equilibrium 
can be shifted in the presence of Ca2+ in favor of the dimeric GPP/DEGP15 form, 
reportedly responsible for cleavage of the PTS2 presequence of malate 
dehydrogenase at the proper, cysteine-containing location (12). The monomer, 
on the other hand, acts as a general peptidase that cleaves denatured 
peroxisome matrix proteins (12). With our in vitro protease assays, we 
demonstrated AtDEG15 cleavage of PTS2 leader peptide sequences in the 
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absence of calcium. Although these results suggest that AtDEG15 is able to 
specifically process PTS2 proteins in the absence of calcium, AtDEG15-
dependent processing may be increased by the addition of calcium. Indeed when 
calcium is added to import of PTS2 proteins (THL and ASP3) in vitro, there is an 
increase of protease-protected, imported protein that migrates at the lower 
molecular weight consistent with processed, mature forms (Williams and Olsen, 
unpublished data).  
 Third, the mammalian homolog of AtDEG15, Tysnd1, is reported to 
undergo intracellular amino-terminal processing in a transient overexpression 
assay (20). This cleavage event resulted in the generation of a smaller molecular 
weight, catalytically active form.  This suggests that Tysnd1 could be synthesized 
in the cytosol as an inactive precursor that is cleaved to an active form upon 
entry into the peroxisome matrix. These results are consistent with the idea that 
the PTS2 processing protease may undergo catalytic autoactivation; a common 
mechanism found among serine proteases (8). It may be interesting to examine 
whether or not AtDEG15 undergoes this catalytic activation both in vitro and in 
vivo, whether an additional enzyme present within the peroxisome matrix or self-
catalysis mediates this cleavage and further, to determine if this potential 
catalytic cleavage is necessary to promote AtDEG15 cleavage of PTS2 proteins. 
   Finally, what is the identity of the protein responsible for proteolytic 
degradation of the precursor sequence subsequent to its liberation from the 
amino terminus of the mature PTS2 protein by AtDEG15? Given the amount of 
precursor protein that must be processed after PTS2 import, it is conceivable that 
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digestion of the precursor sequence is absolutely required to prevent an 
accumulation that may be toxic to the peroxisome matrix environment.  An 
answer to this question, however, depends on knowing more about the identity of 
the degradation activity that occurs within peroxisomes. In chloroplasts, a novel 
activity, separate from the stromal processing protease has been shown (37). 
Perhaps a likely candidate for this activity will be uncovered as the proteomic 
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Plants and mammals 
 
Enzyme 
Species  PTS2 sequence (cleavage recognition site*)  Mature subunit 
___________________________________________________________________________________________ 
Malate dehydrogenase 
Watermelon   QRIARISAHLHPPKSQMEESSALRRANCR*   AKGGAPGFKVAI 
Pumpkin   ERIARISAHLPPKSQMEEGSVLRRANCR*    AKGGAPGFRVAI 
Alfalfa    SRITRIASHLNPPNLKMNEHGGSSLTNVHCR*   AKGGTPGFKVAI 
Rice    RRMERLASHLRPPASQMEESPLLRGSNCR*   AKGAAPGFKVAI 
Rapeseed   KRIAMISAHLQPSFTPQMEAKNSVMGLESCR*  AKGGNPGFKVAI 
Arabidopsis (At5g09660)  
QRIARISAHLTPQMEAKNSVIGRENCR*   AKGGNPGFKVAI 
Arabidopsis (At2g22780)  
            QRIARISAHLNPPNLHNQIADGSGLNRVACR*   AKGGSPGFKVAI 
Citrate synthase 
Pumpkin                        RHRLAVLAAHLSAASLEPPVMASSLEAHCV*   SAQTMVAPPEL 
Arabidopsis (At2g42790)   
             RARLAVLSGHLSEGKQDSPAIERWCT*   SADTSVAPLGS 
Arabidopsis (At3g58740)  
             RARLAVLNAHLTVSEPNQVLPAIEPWCT*   SAHITAAPHGS 
Acyl CoA oxidase 
Pumpkin    RRIERLSLHLTPIPLDDSQGVEMETC*    AAGKAKAKIEVD 
Arabidopsis (At5g65110)  
RRIQRLSLHLSPSLTLSPSLPLVQTETC*   SARSKKLDVNGE 
3-keto-acyl-CoA thiolase 
Cucumber   NRQSILLHHLRPSSSAYTNESSLSASVC*   AAGDSASY 
Pumpkin   NRQSILLHHLRPSSSAYSHESSLSASVC*   AAGDSASY 
Mango    NRQSILLHHLRPSNSSSHNYESALAASVC*   AAGDSAAY 
Rapeseed   ERQRVLLEHLRPSSSSSHSFEGSLSASAC*   LAGDSAAY 
Arabidopsis (At5g48880)  
ERQRVLLEHLRPSSSSSHNYEASLSASAC*   LAGDSAAY 
Rat    HRLQVVLGHLAGRPESSSALQAAPC*    SAGFPQAS 
Human   QRLQVVLGHLRGPADSGWMPQAAPC*    LSGAPQAS 
 
 
Table 3.1. Consensus sequences of known PTS2 matrix proteins in 
mammals and plants. The PTS2 is underlined and indicated in bold. The 
conserved Cys near the cleavage site for recognition by the peroxisomal 
processing peptidase in plants and mammals is indicated in bold. Adapted from 
Helm (2007).  
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Primer pairs used Protein Mutation 
FORWARD REVERSE 
R7A 5’ GAG AAA GCG ATC GAG 
GCA CAA CGC GTT CTT C 
3’ 
5’ GAA GAA CGC GTT 
GTG CCT CGA TCG CTT 
TCT C 3’ 
THL 
C34G 5’ CTA TCT GCT TCT GCT 
GGC TTG GCT GGG GAC 
3’ 
5’ GTC CCC AGC CAA 
GCC AGC AGA AGC AGA 
TAG 3’ 
 
R15A 5’ TCT TCT TCT TCC GAT 
CGC GCT ATC GGT GCT 
CTG CTC C 3’ 
5’ GGA GCA GAG CAC 
CGA TAG CGC GAT CGG 
AAG AAG AAG A3’ 
S41G 5’ CTT TAT GCA TCT CCG 
ACA GGC GGA GGC ACC 
GGT GGT TCT G 3’ 
5’ CAG AAC CAC CGG 
TGC CTC CGC CTG TCG 
GAG ATG CAT AAA G 3’ 
S47G 5’ CAT CGG GAG GCA 
CCG GTG GTG GAG TTT 
TCT CTC ATC TTG TTC 3’ 
5’GAA CAA GAT GAG AGA 
AAA CTC CAC CAC CGG 
TGC CTC CCG ATG 3’ 
ASP3 
C148G 5’ CGG ATT ACC ACC GTG 
GAG GGA TTG TCT GGT 
ACT GGT TCT C 3’ 
5’ GAG AAC CAG TAC 
CAG ACA ATC CCT CCA 
CGG TGG TAA TCC G 3’ 
 
 











Figure 3.1. AtDEG15 imports into isolated pumpkin glyoxysomes in vitro. A) 
RT-PCR was used to clone AtDEG15 into TOPO vector pCRII. In vitro 
transcription with T7 polymerase followed by in vitro translation produced [35S-
met]-radiolabeled AtDEG15 protein. Samples were analyzed by SDS-PAGE and 
visualized by autoradiography (left) and immunologically identified by Western 
blot analysis (right) using an anti-SKL antibody. B) Isolated glyoxysomes were 
incubated with the radiolabeled proteins AtDEG15 and GLO (glycolate oxidase) 
under standard import conditions, as described in Materials and Methods. 
Following import, some samples were incubated with the protease thermolysin. 
Intact glyoxysomes were reisolated and samples were prepared for analysis by 
SDS-PAGE. A typical autoradiograph is shown. These results are from a 
representative experiment that was repeated at least 3 times. Both proteins were 





Figure 3.2. Thiolase is not processed in plants from a homozygous T-DNA 
knockout mutation (7184A) in the AtDEG15 gene. A) Genotypic analysis was 
performed on wild-type (Col-0) and mutant (7184A) plant DNA with primers 
specific to AtDEG15 (RP/LP) and the T-DNA insertion (LB). The results from the 
PCR amplification of DNA extracted from both the wild-type and the T-DNA 
insertion mutant are shown. B) Results from reverse transcription followed by 
PCR of RNA extracted from the leaves of wild-type and the T-DNA insertion 
mutant is shown. Primers specific to AtDEG15 and β-tubulin are indicated as 15 
and tub, respectively. C) Western blot analysis of protein extracts from wild-type 






Figure 3.3. Plants with a homozygous mutation in AtDEG15 germinate 
poorly and require sucrose to germinate.  Seeds from wild type (Col-0) and 
homozygous mutants were germinated on 1% sucrose-supplemented growth 
media. Seeds were incubated under 16-hour light/ 8-hour dark conditions at 
22°C. After 2 weeks, seedlings germinated on sucrose-supplemented media 
were transferred to fertilized soil and incubated under 16-hour light/ 8-hour dark 







Figure 3.4. Recombinant AtDEG15 processes thiolase (THL), but not PTS1 
proteins GLO and IL in vitro. A) Full-length AtDEG15 fused to an amino 
terminal MBP tag was expressed in E. coli. MBP-AtDEG15 was purified by 
affinity chromatography on amylose resin and resolved by SDS-PAGE. The 
indicated samples were analyzed by Western blot analysis with anti-SKL 
antibodies. B) Top three panels: radiolabeled proteins IL (isocitrate lyase; 
PTS1), GLO (glycolate oxidase; PTS1) and THL (thiolase; PTS2) were incubated 
without and with protease (either AtDEG15 or the protease thermolysin). Bottom 
panel: the highly conserved cysteine residue at the cleavage site in thiolase 
(amino acid position 34) was changed by site-directed mutagenesis to a glycine 
residue. Radiolabeled protein from the C34G mutant was incubated without and 
with protease (either AtDEG15 or the protease thermolysin). All samples were 
prepared for analysis by SDS-PAGE. A typical autoradiograph is shown. These 
results are from a representative experiment that was repeated at least 3 times. 
TR, in vitro translated, radiolabeled protein; “-“, no protease added; DEG15, 





Figure 3.5. The PTS2-dependent peroxisome protein AtASP3 is also 
processed by AtDEG15 in vitro. A) The five ASPAT isozymes from 
Arabidopsis, the gene locus, and intracellular protein locations are shown. The 
putative peroxisome enzyme encoded by At5g11520, ASP3, is indicated in red. 
B) The complete amino acid sequence for AtASP3. The amino-terminal PTS2 
sequence is shown in bold and underlined. The amino acid residues at the 
potential cleavage sites of ASP3 are indicated in bold red. C) Isolated 
glyoxysomes were incubated with the radiolabeled proteins THL, ASP3, or their 
respective PTS2 mutants (RA) under standard import conditions, as described in 
Materials and Methods. Following import, all samples were incubated with the 
protease thermolysin. Intact glyoxysomes were reisolated and samples were 
analyzed by SDS-PAGE. Note that placing an alanine residue in the first position 
of the signal sequence abolished the PTS2-directed targeting and that there is no 
protease-protected mutant protein for either THLRA or ASP3RA (lane 5).  Only 
wild-type proteins with their PTS2 fully intact were protease protected (lane 2), 
consistent with peroxisome localization. D) Site-directed mutagenesis was used 
to change each putative cleavage site (S41, S47 and C148) to a glycine residue.  
Radiolabeled protein was synthesized from wild-type ASP3 and each mutant 
(S41G, S47G and C148G). Each radiolabeled protein was incubated without and 
with protease (either purified, recombinant AtDEG15 or the general protease 
thermolysin). Samples were analyzed by SDS-PAGE. A typical autoradiograph is 
shown. These results are from a  representative experiment repeated at least 3 
times. TR, translated protein; “-“, no protease added; DEG15, AtDEG15 added; 
THER, thermolysin added 
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Figure 3.6. Mutants lacking a functional PTS2 are still processed by 
AtDEG15 in vitro. Radiolabeled proteins from THL, ASP3, and the RA import 
mutants were each incubated without and with protease (either purified, 
recombinant AtDEG15 or the protease thermolysin). Samples were prepared for 
analysis by SDS-PAGE. A typical autoradiograph is shown. These results are 
from a representative experiment repeated at least 3 times. The PTS2 sequence 
of each protein is shown; mutated residues are red. WT, wild type; RA, PTS2 







Figure 3.7. Sequence alignment of the ASPAT isozymes found in 
Arabidopsis. The amino terminal sequences of the ASPAT isozymes found in 
Arabidopsis are shown. Black, green, blue, and red names indicate cytosolic, 
plastidic, mitochondrial, and peroxisomal localizations, respectively. Asterisks 
indicate the cleavage recognition sites for plastid and mitochondrial ASPATs. 
The PTS2 sequence for the peroxisomal ASPAT, ASP3, is bold, underlined, and 
shown in red. Blue-shaded boxes indicate areas of sequence conservation. Data 
were obtained using ClustalW, a web-based EBI server for multiple sequence 








Figure 3.8. Sequence alignment of some plant ASP3 homologs. The amino 
terminal sequences of the ASP3 homologs from Arabidopsis, rice, and soybean 
are shown. The PTS2 sequences are bold, underlined, and shown in red. Lilac 
shading indicates areas of non-conserved amino acid sequence, and blue 
shading indicates areas of high sequence conservation. Data were obtained 
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Peroxisome matrix protein import: the study of putative dual-signaled 





 To date, all models of peroxisome matrix protein import agree that each 
respective receptor PEX5 or PEX7 binds to a distinct, newly synthesized protein 
in the cytosol bearing either a Peroxisome Targeting Signal (PTS) 1 protein or 
PTS2, respectively. The receptor/cargo complex follows a distinct pathway that 
converges at the docking site on the peroxisome membrane, after which the 
cargo is translocated into the matrix and the receptor is recycled to the cytosol for 
further rounds of import. Two proteins found in Arabidopsis thaliana have been 
identified that possess both a putative PTS1 and a PTS2: long-chain acyl-CoA 
synthetase 7 (LACS7) and alpha-crystallin domain-containing protein 31.2 
(ACD31.2). While both proteins have been localized to peroxisomes, the PTS 
responsible for their localization remains unclear. Using mutagenic analysis and 
a standard in vitro protein import assay, the import of each protein and the role 
that each of its putative PTSs plays in this subcellular localization was 
characterized. For both proteins ACD31.2 or LACS7, either the PTS1 or PTS2 
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alone was sufficient to direct import into the peroxisome matrix.  Removal of both 






 Peroxisomal matrix protein import is accomplished when a single targeting 
sequence, present on newly synthesized peroxisome matrix proteins is bound by 
a specific receptor in the cytosol that facilitates import. In the case of PTS2 
protein import, additional interactions between the PTS2 receptor PEX7 and 
other co-factors are required to complete the PTS2-dependent import process 
(27). Nevertheless, it remains clear that most peroxisome matrix protein import is 
directed by an independent interaction between one targeting signal (PTS1 or 
PTS2) and its specific targeting pathway receptor (PEX5 or PEX7, respectively) 
(2, 5, 9, 14, 22, 31, 33).  Interestingly, a few unique enzymes predicted to be 
associated with peroxisomes have been identified that contain both a putative 
PTS1 and PTS2.  
 PEX8, the yeast importomer complex linker protein, contains both a PTS1 
and a PTS2 sequence (23, 29, 30).  Studies involving PEX8 from Hansenula 
polymorpha first revealed that both the PTS1 and its interaction with PEX5 are 
required for targeting of PEX8 (34). Also, deletion of the PTS2 motif on PEX8 
results in PEX5-directed PTS1 import (34).  Similarly, PEX8 lacking its PTS1 
sequence is imported via the PTS2 pathway. In this case, the targeting depends 
on both PEX7 and its auxillary protein PEX20 (15, 28, 34).  
 Two proteins identified in Saccharomyces cerevisiae, Dci1 and Eci1, 
belong to the isomerase/hydratase family and share 50% sequence identity. Both 
of these proteins are localized to peroxisomes, and both contain sequences at 
 
 174 
their carboxyl and amino-termini that resemble PTS1 and PTS2, respectively (13, 
32). PTS1-dependent targeting of both Eci1 and Dci1 has been demonstrated in 
wild-type cells (32). Surprisingly, although Eci1 peroxisomal targeting does in fact 
require the PEX5-dependent PTS1 pathway, it does not require a PTS1 of its 
own (32). It has been suggested that the PEX5-dependent import of Eci1 is due 
to interaction and co-import with its partner Dci1 (32). 
 Long-chain acyl-CoA synthetase (LACS) activities are critically involved in 
the breakdown of the stored lipid reserves to release free fatty acids and feed the 
β-oxidation cycle in peroxisomes. Two genes, LACS6 and LACS7, from 
Arabidopsis thaliana have been identified that code for peroxisomal LACS 
proteins. While LACS6 is targeted by a single peroxisomal targeting sequence 
(PTS2), LACS7 possesses both a predicted PTS1 (SKL) as well as a PTS2 
(RLx5HI) (7) (Figure 1C). Subcellular localization studies of PTS fusions to the 
green fluorescent protein (GFP) reveal that localization of LACS7 is dependent 
on both PTS1 and PTS2 (7). Yeast two-hybrid analysis and co-
immunoprecipitation show LACS7 interactions with the PTS1 receptor PEX5 (1), 
indicative of PTS1-dependent import. No interaction with PEX7 was detected, 
although a clear PTS2 signal is present at the amino terminus of the protein. Still, 
both the PTS1 and PTS2 of LACS7 appear necessary to direct its peroxisome 
entry. For this reason, further characterization of LACS7 import is needed.  
 Among the results of a screen for novel low-abundance proteins of plant 
peroxisomes were two genes identified in the Arabidopsis genome (At5g37670 or 
Hsp15.7 and At1g06460 or ACD31.2) (26), encoding two predicted proteins 
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possessing both an α-crystallin domain, characteristic of small heat-shock 
proteins, and putative targeting signals for plant peroxisomes (24). ACD31.2 
(At1g06460) carries both a predicted PTS2 nonapeptide (RLx5HF) and a 
predicted PTS1 tripeptide (PKL), both of which have been defined as minor PTS 
peptides that indicate peroxisome targeting (17, 24) (Figure 1). Double-labeling 
experiments using full-length fusion proteins with enhanced yellow fluorescent 
protein, as well as deletion and mutagenic constructs lacking the putative 
targeting domains, suggest that Hsp15.7 and ACD31.2 are targeted to the 
peroxisome matrix by a functional PTS1 (SKL) and a functional PTS2 (RLX5HF), 
respectively (17). Though these experiments provide some evidence for PTS2-
dependent peroxisome localization of ACD31.2, further biochemical investigation 
will be useful to assess whether dual-PTS-containing enzymes are capable of 
peroxisome import using one, both, or neither of their putative PTSs.    
 Using an in vitro peroxisome protein import assay, we examined the 
import characteristics of both ACD31.2 and LACS7. Both are peroxisome matrix 
proteins that become protease-protected after incubation with isolated 
glyoxysomes under standard import conditions. Removal of the PTS1 did not 
significantly affect the import of either protein into peroxisomes in vitro, though  
the import efficiency of ACD31.2 was slightly decreased.  Likewise, mutations of 
the PTS2 signal that result in loss of import of PTS2 protein ASP3, did not 
significantly affect the PTS2-dependent import of ACD31.2 or LACS7. When the 
PTSs were simultaneously disabled for both ACD31.2 and LACS7, peroxisomal 
import was abolished.  These results suggest that both ACD31.2 and LACS7 
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were capable of peroxisome protein import directed by either of their PTS1 or 
their PTS2.   
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MATERIALS AND METHODS 
 
DNA constructs Plasmids containing the full-length cDNA inserts for isocitrate 
lyase (IL) from Brassica napus, spinach (Spinacia oleracea), glycolate oxidase 
(GLO), and thiolase (THL) from Arabidopsis were previously described (3, 4, 12). 
The plasmids pASP3 and pACD31.2, containing the full-length cDNA insert 
coding for aspartate aminotransferase 3 (ASP3) and ACD31.2 in the pZL1 
expression vector, were each obtained from the Arabidopsis Biological Resource 
Center (EST stocks 136A4T7 and 31B9T7; GenBank accession nos. P46644 
and T04728; Arabidopsis Genome Initiative locus At5g11520 and At1g06460, 
respectively).  
 To clone LACS7, the full-length gene was PCR-amplified from an 
Arabidopsis cDNA library, λ-Yes (6) using the following LACS7 gene-specific 
primers: forward- 5’ CAC CAT GGA ATT TGC TTC GCC GG 3’ and reverse- 5’ 
TCA CAG TTT AGA AGG AAT GGG GTT CGA GGC 3’. Following PCR 
amplification, full-length LACS7 cDNA was cloned into the Gateway entry vector 
pENTR SD/D-TOPO according to the manufacturer’s instructions  (Invitrogen). 
Plasmids containing LACS7 were isolated and the inserts confirmed by 
sequencing. Subsequently, an expression construct encoding full-length LACS7 
fused with an amino-terminal GST in vector pDEST15 was made by 
recombination using the LR Clonase II enzyme according to the manufacturer’s 
instructions (Invitrogen). Transformants were screened by PCR amplification 
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using LACS7 gene-specific primers. DNA sequencing was used to confirm all 
DNA constructs. 
 PTS1-deletion constructs were created by restriction enzyme digestion 
with the appropriate enzyme to cleave several amino acids from the carboxyl 
terminus of the full-length DNA constructs.  Restriction enzymes (Promega) used 
and the resulting deletion constructs for each protein are given in Table 1. All 
PTS2 mutant constructs were obtained using the Site-Directed Mutagenesis kit 
(Statagene); mutations and primers are shown in Table 2. 
 
Preparation of [35S-met]-radiolabeled peroxisome proteins. To synthesize 
radiolabeled GLO, THL, ASP3, ACD31.2 and LACS7 proteins, all DNA templates 
were linearized with an appropriate restriction enzyme such that a single 
cleavage occurred 3' to the coding region to be transcribed/translated (GLO, 
HindIII; THL, ASP3 and ACD31.2, NotI or XbaI; LACS7, NheI). Transcription of 
the linearized DNA with SP6 RNA polymerase for pGLO and T7 RNA 
polymerase for all others was performed as described previously (16, 21). 
Radiolabeled proteins were synthesized in a cell-free wheat germ lysate system 
in the presence of L- methionine, [35S] (specific activity 43.5 TBq/mmol) 
purchased from MP Biomedicals, Inc. (Irvine, CA). The efficiency of translation 
was assessed by trichloroacetic acid precipitation onto glass fiber filters, followed 
by ethanol washes and quantitation in a liquid scintillation counter (model LS 
6800, Beckman Coulter, Fullerton, CA). Radiolabeled THL and ASP3 were 
synthesized in their full-length precursor protein forms. Radiolabeled LACS7 was 
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synthesized with an amino-terminal GST fusion tag attached to the full-length 
protein product.  
 
Isolation of pumpkin glyoxysomes. Pumpkin seeds (Cucurbita pepo var 
Connecticut Fields) purchased from Siegers Seed Co. (Zeeland, MI) seedlings 
were grown in moist vermiculite for 5-to-7 days in the dark at 25°C. 
Approximately 25-40 g cotyledons were harvested manually in dim light and 
glyoxysomes were isolated by slight modification of the procedure described 
previously (3). Initial homogenization occurred with three 3-second bursts using a 
Waring blender. Filtration was performed through one layer of Miracloth 
(Calbiochem). The final glyoxysomal pellet was resuspended in isolation buffer to 
a final concentration of 20 mg/ml total protein. 
 
In vitro Import Assays. Standard in vitro import reactions were initiated by the 
addition of 200 µg isolated glyoxysomes to 500,000 cpm trichloroacetic acid 
precipitable, radiolabeled protein in the presence of import buffer (25 mm MES-
KOH, pH 6, 500 mM sucrose, 10 mM KCl, 1 mM MgCl2 and 5 mM MgATP) in a 
final volume of 200 µl. Import reactions were performed at 26°C for 30 min. in the 
case of PTS1 protein import, and 1 hour in the case of PTS2 protein import. 
Following incubation, the import reactions were treated with thermolysin (freshly 
dissolved in import buffer containing 5 mM CaCl2) to completely digest proteins 
that were not imported. Protease treatments were incubated for 30 min. on ice; 
reactions were stopped by the addition of EDTA (25 mM final concentration) to 
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inhibit the thermolysin.  After protease treatment, the glyoxysomes were 
repurified on a 0.7 M sucrose, solubilized in 1X (Laemmli) sample buffer, 
subjected to 10% SDS-PAGE and visualized by autoradiography after a 12-16 
hour overnight exposure at -70°C. Some samples (as indicated in the figures) 
were incubated at -20°C during import to provide negative import controls. The 
protein from these samples was fully digested after treatment with thermolysin 
and not recovered by the subsequent repurification of glyoxysomes on sucrose. 
In cases where import efficiency is reported, import levels were determined as 



















ACD31.2 and LACS7 imported into isolated glyoxysomes of pumpkins 
(Cucurbita pepo) in vitro despite the removal of their putative PTS1. In vitro 
synthesis of [35S-met]-radiolabeled protein, using a cell-free wheat germ lysate 
system, was carried out. Visualization of radiolabeled proteins by 
autoradiography is shown in Figure 2. To study the import characteristics of 
ACD31.2 and LACS7, in vitro import assays were performed by incubation of 
radiolabeled import proteins with glyoxysomes isolated from etiolated pumpkin 
cotyledons. Protease resistance was used as the hallmark of protein import (i.e., 
proteins protected by the glyoxysomal membrane are not degraded by 
exogenous protease digestion). In each import experiment, all protease-
protected protein was considered as imported. The results of a typical import 
experiment are shown in Figure 2A, full-length GLO. The pattern of ACD31.2 and 
LACS7 import into peroxisomes was similar to that of the control PTS1 
photorespiration enzyme, glycolate oxidase (GLO), whose import has been 
previously characterized (Brickner et al., 1997; Brickner and Olsen, 1998). Lane 
2 represents all protein bound to the membrane or imported into the organelle. 
Protease was added to the samples shown in lane 3 to degrade proteins not 
protected by the glyoxysome membrane, leaving only protease-protected, 
imported protein. Import reactions were also performed at -20°C (lane 4) to 
demonstrate that under conditions not conducive to import, the amount of 
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protease added to the samples was enough to completely digest unprotected 
protein.  
 Truncated GLO, ACD31.2, and LACS7 proteins lacking 46, 15, and 106 
amino acids from the carboxyl terminus, respectively, were created by restriction 
enzyme digestion (Table 1). Results from standard import reactions with isolated 
pumpkin glyoxysomes revealed a loss of import of GLO lacking the PTS1 signal 
(Figure 2A, GLO panel, lane 6). In contrast, ACD31.2 and LACS7 carboxyl 
terminal truncation mutants showed no significant loss of import competency 
(Figure 2A, ACD31.2 and LACS7 panels, lane 6). These results indicate that both 
ACD31.2 and LACS7 are capable of peroxisomal import in the absence of their 
putative PTS1.  
 
Mutations in the PTS2 sequence that inhibit the import of PTS2 proteins 
THL and ASP3 did not affect the import of ACD31.2 or LACS7. The results of 
a typical PTS2 protein import experiment are shown in Figure 3. The pattern of 
ACD31.2 and LACS7 import into peroxisomes was similar to that of control 
proteins thiolase (THL), the PTS2 β-oxidation enzyme (12), and aspartate amino 
transferase 3 (ASP3), the PTS2-containing enzyme responsible for transferring 
an amino group to ketoacids (Williams and Olsen, unpublished data), whose 
import has been previously described (12; Chapter 3, this thesis).  All protein 
remained protease-protected (Figure 3, lane 3).  
 In plants, three of the four residues from the PTS2 nonapeptide 
consensus sequence are highly conserved; positions 1, 8 and 9, which are R, H 
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and L, respectively (24). In previous studies to determine functionality of the 
PTS2, site-directed mutagenesis was used to change the R in the first amino 
acid position of the nonapeptide to an A (see Chapter 3, this thesis). These 
mutations resulted in the loss of import for both THL and ASP3; no protease-
resistant protein was observed following import in vitro (Figure 3, THL and ASP3 
panels, lane 6). To determine whether the putative PTS2 signal is necessary for 
import of ACD31.2 and LACS7, site-directed mutagenesis was used to create the 
same arginine to alanine (R1A) mutations in the first amino acid positions of the 
putative PTS2 of ACD31.2 and LACS7. Protease-protected protein was observed 
following import for both the ACD31.2RA and the LACS7RA mutant (Figure 3, 
ACD31.2 and LACS7 panels, lane 6). Thus, these results indicate that both 
proteins are capable of import despite mutations in their putative PTS2.  
 
Simultaneous disabling of PTS1 and PTS2 abolished import of both 
ACD31.2 and LACS7.  Restriction digestion with the appropriate enzymes 
(Table 1) to remove the carboxyl terminus of ACD31.2 and LACS7 was 
performed on their PTS2 R1A mutants to create double-import-signal mutants. 
The results of a standard import assay are shown in Figure 4. As expected, no 
protease-resistant protein was observed following import of these double-signal 
mutants in vitro (lane 2).  These results indicate that only when both targeting 







 Most peroxisome matrix proteins are expected to follow an exclusive 
import pathway directed by either a PTS1 or PTS2. However, unique 
peroxisome-targeted matrix enzymes have been identified that contain both a 
PTS1 and PTS2 (23, 28, 30). In Arabidopsis, two genes, ACD31.2 and LACS7, 
have been identified that code for peroxisome enzymes possessing putative 
redundant PTSs (7, 17). Subcellular localization of PTS-dependent variants of 
each protein fused to fluorescent tags reveals that localization of LACS7 is 
dependent on either PTS1 or PTS2 (7), while ACD31.2 is strictly PTS2 
dependent (17). Interestingly, studies focused on determining LACS7 binding 
partners only show interactions with the PTS1 receptor PEX5 (1), indicative of 
PTS1-dependent import.  
 Using an in vitro biochemical assay reconstituting import into pumpkin 
glyoxysomes we have examined the import characteristics of ACD31.2 and 
LACS7. We show that either the PTS1 or the PTS2 alone is sufficient to direct 
the import of both ACD31.2 and LACS7 into the peroxisome matrix, consistent 
with localization data previously reported for a similarly dual-targeted protein, 
PEX8, in yeast (15, 28, 34). 
 Although the results from our biochemical analysis are also consistent with 
the fluorescence localization data previously reported for LACS7 (1), some 
discrepancies remain in the case of ACD31.2. Using an in vitro import assay, we 
demonstrated dependence upon either PTS1 or PTS2 for ACD31.2 import rather 
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than just the single PTS2 (24). Localization determined by fluorescence 
microscopy does not distinguish between intra-organelle localization and 
organelle-membrane association. Type 1 targeting signals that deviate from the 
canonical sequence also require accessory residues that assist in import (19, 20, 
24), therefore careful consideration of the nature of the deletion constructs must 
be made. In the analysis ACD31.2 localization involving fluorescence 
microscopy, only the 3 amino acids belonging to the carboxyl terminal PTS1 
were eliminated in the deletion construct (24). Thus, the remaining accessory 
proteins, along with the intact PTS2, could potentially aid in cargo/receptor 
binding in the cytosol and subsequent association at the peroxisome membrane 
– a result not easily distinguished by fluorescence microscopy alone. Our 
biochemical studies utilized constructs with deletions of at least 15 amino acids 
from the carboxyl terminus; the resulting constructs lacked not only their PTS1 
but also potential accessory residues. It is also noteworthy to mention that the 
construct made to test ACD31.2 import dependence on the PTS2, not only 
possessed a mutated PTS2 sequence, but also a carboxyl terminal fluorescent 
tag (24), the presence of which has been previously shown to eliminate PTS1 
import (10, 18). Thus, both PTSs were eliminated and mislocalization of ACD31.2 
to the cytosol was likely a result of the loss of both signals rather than an 
insufficient PTS1. In fact, we have shown that the simultaneous elimination of 
both targeting signals results in the loss of import of both ACD31.2 and LACS7 
(Figure 4). Thus, without the need for consideration of where fluorescence tags 
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should be placed, we were able to eliminate just one PTS at a time and 
demonstrate that either is sufficient for ACD31.2 import. 
 Data from the fluorescent analysis of LACS7 localization and our 
biochemical in vitro import assays seem to agree. However, neither result can 
reconcile the enigma concerning the lack of binding to PEX7 (1). Perhaps the 
lack of PEX7 interaction could be explained by fusion of the Gal4-binding domain 
to the amino terminus of LACS7, resulting in a bait protein with a PTS2 sequence 
located too far from the amino terminus of LACS7 to be an effective targeting 
sequence. On the other hand, there are documented examples of amino-terminal 
fusions to enzymes that can still be recognized as PTS2 import proteins in yeast 
two-hybrid systems (5). In fact, the LACS7 protein used in this study was 
expressed with a GST fusion attached to its amino-terminus; this fusion protein 
was able to import into glyoxysomes in a PTS2-dependent manner in vitro.   
 It is interesting to speculate about the requirement of potentially redundant 
targeting signals. One could speculate that peroxisome import could benefit from 
two targeting signals during stages of peroxisome biogenesis consistent with 
changes in the developmental stage of an organism or conditions that might 
warrant the immediate import of certain proteins (i.e. germination, senescence, 
stress). In the case of LACS7, dual PTSs could actually prove to be an 
advantage in times of early germination when rapid peroxisome proliferation and 
the import of large amounts of enzymes for β-oxidation and the glyoxylate cycle 
are essential (8, 25). Certainly, the examination of LACS7 gene expression 
compared with the expression profile of genes for peroxisomal enzymes involved 
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in β-oxidation and glyoxylate cycle demonstrates a synchronized induction of 
both at the onset of germination (25). Thus, it is reasonable to consider the 
possibility that if the import machinery of one pathway is totally saturated, it is 
more favorable for a specific protein to carry both targeting signals to ensure its 
import and subsequent activity inside the organelle via a second pathway. 
Proteins are targeted to the peroxisome by a PTS2 less frequently than by its 
predominant partner, the PTS1.  In plants, PTS2-containing proteins account for 
about 10% of all proteins targeted to the peroxisome matrix (24). Therefore one 
could imagine that proteins carrying both signals are able to default to the PTS2 
pathway for import and ensure their proper localization and activity inside the 
peroxisome.  
 If this is true, it may be slightly harder to reconcile the usefulness of dual 
signals for ACD31.2. While it is relatively easy to speculate that the import and 
putative chaperone activity of ACD31.2 may be upregulated and crucial at times 
of stress to prevent unspecific aggregation of partially denatured proteins, the 
results from expression studies by reverse transcription-PCR reveal that 
AtACD31.2 is constitutively expressed (17). But plants are exceptional among 
eukaryotes in employing sHsps in the peroxisome matrix to prevent nonspecific 
aggregation of partially denatured proteins under both physiological and stress 
conditions. Thus, for ACD31.2, an import strategy similar to the one considered 
for LACS7 described above may be useful to ensure it’s constitutive function; 
when one pathway is blocked, the other pathway is utilized. 
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 Using our in vitro peroxisome import assay, we have studied the import 
characteristics of two proteins found in Arabidopsis thaliana that possess both a 
putative PTS1 and a PTS2, LACS7 and ACD31.2. Our results suggest that in 
both cases, ACD31.2 and LACS7, either the PTS1 or PTS2 was sufficient to 






 It is clear that both ACD31.2 and LACS7 are peroxisome matrix enzymes 
whose localization is dependent on PTS1 and/or PTS2. What remains unclear is 
an understanding of how these signals might work in a coordinate fashion with 
their distinct and specific receptors to facilitate import along two different 
peroxisome import pathways. To better understand these relationships, it is 
important to rigorously tease out the factors involved in the successful import of 
these dual-targeted proteins.  
 Analysis should begin with an in-depth approach to studying the binding 
relationships between these proteins and their import receptors. Despite the 
successful identification of thousands of binding partners of various proteins from 
a variety of organisms, the yeast two-hybrid approach is subject to certain 
limitations - false negatives due to interference of the fused domains, false 
positives caused by nonspecific interactions giving rise to biologically irrelevant 
yeast two-hybrid interactions, inability to detect weak or transient interactions 
involving low abundance proteins, and low reproducibility. A better and more 
definitive, approach would be to use over-expressed, purified protein in direct 
binding interactions in vitro. The advantage of this method is that it indicates the 
reaction between the two participating proteins independent of any other factors 
that might influence or interfere with their binding.  
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 A more elegant approach to show direct protein-protein interaction 
between LACS7, ACD31.2 and their import receptors would be to use 
Flourescence Resonance Energy Transfer (FRET) microscopy. FRET technology 
relies on the interaction between native proteins and eliminates counterfeit 
results that could be produced. Plant cells can be transformed with suitable 
FRET-fluorescence (CFP, YFP, etc.) labeled ACD32.1, LACS7, PEX5 or PEX7 
constructs. Using confocal microscopy, FRET is able to capture weak and 
transient interactions through fluorescent signals that indicate a direct interaction 
between participating proteins in single living or fixed cells. This technique can be 
used to answer interesting questions on a wide variety of background conditions. 
For example, it would be interesting to observe the hierarchy of binding between 
PEX5, PEX7 as it relates to in vivo import of LACS7 or ACD31.2 in wild-type 
plants in comparison to conditions where PEX5 or PEX7 binding is defective 
(11).  
 By establishing the protein-protein interactions that participate in the 
import of these proteins, one could begin to understand the precise nature by 
which these proteins import into peroxisomes, especially as it relates to the 






Table 4.1. GLO, ACD31.2 and LACS7 PTS1 deletion constructs. The table 
above lists the PTS1 deletion constructs obtained by restriction digest. The 
restriction enzymes used to create each construct are shown. The number of 
amino acids cleaved from the carboxyl terminus (CT) of each protein is given. 
This number includes the PTS1 tripeptide. Note that the resulting extreme 
carboxyl terminal tripeptide sequence shown is not a PTS1. These proteins are 
not expected to be protease protected in an in vitro import assay. GLO, glycolate 
oxidase; ACD31.2, alpha-crystalline domain protein 31.2kDa; LACS7, long-chain 
acyl-CoA synthetase 7. 
 
 
Protein RE digestion 
 Enzyme CT amino acid 
truncation 
Resulting extreme CT 
tripeptide 
GLO PstI 46 -AGV 
ACD31.2 MspAI 15  -NVS 




Primer pairs used Protein Mutation 
FORWARD REVERSE 
THL R7A 5’ GAG AAA GCG ATC 
GAG GCA CAA CGC GTT 
CTT C 3’ 
5’ GAA GAA CGC GTT GTG 




5’ TCT TCT TCT TCC GAT 
CGC GCT ATC GGT GCT 
CTG CTC C 3’ 
5’ GGA GCA GAG CAC 
CGA TAG CGC GAT CGG 
AAG AAG AAG A3’ 
ACD31.2 R11A 5’ CAC CGC TCG ACG 
CGC TCT CGC TGC CTT 
CGC 3’ 
5’ GCG AAG GCA GAG 
AGA GCG CGT CGA GCG 
GTG 3’ 
LACS7 R10A 5’ CGC CGG AAC AAC 
GTG CTC TCG AAA CCA 
TTC 3’ 
5’ GAA TGG TTT CGA GAG 
CAC GTT GTT CCG GCG 3’ 
 
Table 4.2. THL, ASP3, ACD31.2 and LACS7 R1A mutants and primers. The 
positions of the arginines in the protein are given. ASP3, aspartate 
aminotransferase 3; ACD31.2, alpha-crystalline domain protein 31.2kDa; LACS7, 







Figure 4.1. Plant PTSs and the protein sequences of ACD31.2 and LACS7. 
A) The extreme carboxyl terminal tripeptide PTS1 sequences of matrix proteins 
in plants are shown. B) The amino-terminal PTS2 nonapeptides of matrix 
proteins in plants are depicted. Major PTS sequences (red, light gray shade) are 
present in at least 10 sequences and 3 orthologous groups. Minor PTS 
sequences (blue) are present in at least 2 sequences. Adapted from Reumann 
(2004). C) The complete amino acid sequences for ACD31.2 and LACS7 are 





















Figure 4.2. Deletion of the PTS1 signal decreased the import of the PTS1 
protein GLO, but not ACD31.2 and LACS7 in vitro. A) PTS1 deletion 
constructs were created by restriction enzyme digestion of the full-length genes 
GLO, ACD31.2 and LACS7 upstream of their carboxyl terminal ends. The 
resulting truncated proteins lacked the PTS1. Isolated glyoxysomes were 
incubated with radiolabeled proteins GLO, ACD31.2, LACS7, and all truncation 
import mutants (ΔPTS1) for 60 minutes under standard import conditions, as 
described in Materials and Methods. Samples were prepared for analysis by 
SDS-PAGE. An autoradiograph after 12 hours’ exposure is shown. All full-length 
proteins were protease-protected, consistent with peroxisomal localization (lane 
3). Note that only the removal of the PTS1 from GLO resulted in loss of import 
(lane 6). B) Import efficiency was quantitated by phosphorimaging analysis. All 
results are from representative experiments that were repeated at least 3 times. 









Figure 4.3. Mutating the highly conserved arginine in position 1 of the PTS2 
consensus sequence inhibits the import of THL and ASP3, but not ACD31.2 
and LACS7.  Site-directed mutagenesis was used to change the arginine residue 
in the first position of each PTS2 sequence in THL, ASP3, ACD31.2 and LACS7 
to an alanine. These PTS2 import mutants are indicated in the figure as R1A. 
Following import under standard import conditions, all samples were incubated 
with thermolysin for 30 minutes on ice. Intact glyoxysomes were reisolated and 
samples were prepared for analysis by SDS-PAGE. Note that placing an alanine 
in the first position of the PTS2 changes the consensus sequence. Except in the 
case of ACD31.2 and LACS7, PTS2-dependent import of these mutants is 
decreased. B) Import levels were quantitated by phosphorimaging as described 
in Materials and Methods. All results are from representative experiments that 





Figure 4.4. Neither ACD31.2 nor LACS7 was imported when both PTSs were 
disabled. R1A mutants were subjected to restriction digestion with the 
appropriate enzymes to delete carboxyl terminal regions that include the PTS1. 
The autoradiograph from a standard import experiment is shown. Note that the 
elimination of both import signals resulted in protease-sensitivity after standard 
import incubation at 26°C for 60 minutes. All results are from representative 
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